MUSC Foundation for Research Development v. AstraZeneca Pharmaceuticals LP
2:13-cv-02078
Overview
Case Number
2:13-cv-02078
Filing Date
2013-07-31
Status
Terminated
Termination Date
2016-02-19
Court
District Court, D. South Carolina (scd)
Presiding Judge
Richard M Gergel
Nature of Suit
830 Patent
Jurisdiction Type
Federal Question
Cause of Action
35:271 Patent Infringement
Jury Demand
Plaintiff
Parties
Defendant
AstraZeneca Pharmaceuticals LP
Represented By
16 Attorneys ListedCovington and Burling LLP (DC)
Tel: +1 (202) 662-6000
Fax: +1 (202) 662-6291
One City Center, 850 Tenth Street NW
Nexsen Pruet Jacobs and Pollard
Tel: +1 (803) 253-8221
Fax: +1 (803) 253-8277
Nexsen Pruet Jacobs and Pollard, PO Drawer 2426
Covington and Burling LLP (DC)
Tel: +1 (202) 662-6000
Fax: +1 (202) 662-6291
One City Center, 850 Tenth Street NW
Nexsen Pruet (Gville)
Tel: +1 (864) 282-1171
Nexsen Pruet (Gville), PO Box 10648
Covington and Burling LLP (DC)
Tel: +1 (202) 662-6000
Fax: +1 (202) 662-6291
One City Center, 850 Tenth Street NW
Covington and Burling LLP (DC)
Tel: +1 (202) 662-6000
Fax: +1 (202) 662-6291
One City Center, 850 Tenth Street NW
Nexsen Pruet Jacobs and Pollard
Tel: +1 (803) 771-8900
Fax: +1 (803) 253-8277
Nexsen Pruet Jacobs and Pollard, PO Drawer 2426
Covington and Burling (DC)
Tel: +1 (202) 662-5215
Covington and Burling (DC), One CityCenter
Covington and Burling (DC)
Tel: +1 (202) 662-5531
Covington and Burling (DC), One CityCenter
Covington and Burling (DC)
Tel: +1 (202) 662-5249
Covington and Burling (DC), 1201 Pennsylvania Avenue NW
Covington and Burling (DC)
Tel: +1 (202) 662-5376
Covington and Burling (DC), One CityCenter
Covington and Burling (DC)
Tel: +1 (202) 662-5241
Covington and Burling (DC), One CityCenter
Federal Public Defender's Office (Cola)
Tel: +1 (803) 765-5076
Fax: +1 (803) 765-5084
1901 Assembly Street, Suite 200
Covington and Burling LLP (DC)
Tel: +1 (202) 662-6000
Fax: +1 (202) 662-6291
One City Center, 850 Tenth Street NW
Covington and Burling (DC)
Tel: +1 (202) 662-5514
Covington and Burling (DC), One CityCenter
Plaintiff
MUSC Foundation for Research Development
Represented By
14 Attorneys ListedMotley Rice (Ch)
Tel: +1 (843) 216-9623
Motley Rice (Ch), 28 Bridgeside Boulevard
Tinkler Law Firm LLC
Tel: +1 (843) 853-5203
Fax: +1 (843) 261-5647
154 King Street, 3rd Floor
McKool Smith PC
Tel: +1 (214) 978-4000
Fax: +1 (214) 978-4044
300 Crescent Court, Suite 1500
Charleston Medical Therapeutics Inc
Represented By
14 Attorneys ListedMotley Rice (Ch)
Tel: +1 (843) 216-9623
Motley Rice (Ch), 28 Bridgeside Boulevard
Tinkler Law Firm LLC
Tel: +1 (843) 853-5203
Fax: +1 (843) 261-5647
154 King Street, 3rd Floor
McKool Smith PC
Tel: +1 (214) 978-4000
Fax: +1 (214) 978-4044
300 Crescent Court, Suite 1500
Court & Judges
Court
District Court, D. South Carolina (scd)
Presiding Judge
Richard M Gergel
Docket Entries
COMPLAINT against AstraZeneca Pharmaceuticals LP ( Filing fee $ 400 receipt number 0420-4855116.), filed by Medical University of South Carolina Foundation for Research Development, Charleston Medical Therapeutics Inc.Service due by 12/5/2013. (Attachments: # 1 Exhibit A: '800 Patent)(vdru, ) (Entered: 08/01/2013)
2013-07-31
1
Summons Issued as to AstraZeneca Pharmaceuticals LP. (vdru, ) (Entered: 08/01/2013)
2013-07-31
1
Local Rule 26.01 Answers to Interrogatories by Charleston Medical Therapeutics Inc, Medical University of South Carolina Foundation for Research Development.(vdru, ) (Entered: 08/01/2013)
2013-07-31
1
Report on the Filing or Determination of an Action or Appeal Regarding a Patent or Trademark. (vdru, ) (Entered: 08/01/2013)
2013-08-01
1
***DOCUMENT MAILED 5 Report on the Filing or Determination of Patent or Trademark placed in U.S. Mail to Director of the US Patent and Trademark Office (vdru, ) (Entered: 08/01/2013)
2013-08-01
1
SUMMONS Returned Executed by Medical University of South Carolina Foundation for Research Development, Charleston Medical Therapeutics Inc. AstraZeneca Pharmaceuticals LP served on 8/5/2013, answer due 8/26/2013. (Rice, Joseph) (Main Document 8 replaced on 8/7/2013) (vdru, ). Modified to replace with corrected document provided by filing user on 8/7/2013 (vdru, ). Modified to edit text on 11/1/2013 (vdru, ). (Entered: 08/06/2013)
2013-08-06
1
NOTICE of Appearance by Daniel C Leonardi on behalf of AstraZeneca Pharmaceuticals LP (Leonardi, Daniel) (Entered: 08/09/2013)
2013-08-09
1
NOTICE of Appearance by Susan Pedrick McWilliams on behalf of AstraZeneca Pharmaceuticals LP (McWilliams, Susan) (Entered: 08/09/2013)
2013-08-09
1
NOTICE of Appearance by Nikole Setzler Mergo on behalf of AstraZeneca Pharmaceuticals LP (Mergo, Nikole) (Entered: 08/09/2013)
2013-08-09
1
NOTICE of Appearance by Marguerite S Willis on behalf of AstraZeneca Pharmaceuticals LP (Willis, Marguerite) (Entered: 08/09/2013)
2013-08-09
1
Consent MOTION for Extension of Time to File Answer re 1 Complaint, by AstraZeneca Pharmaceuticals LP, Medical University of South Carolina Foundation for Research Development and Charleston Medical Therapeutics. Response to Motion due by 8/26/2013. No proposed order.(Leonardi, Daniel) Modified to add filers listed on document on 8/12/2013 (vdru, ). (Entered: 08/09/2013)
2013-08-09
1
TEXT ORDER Granting 13 Consent MOTION for Extension of Time to File Answer re 1 Complaint, filed by AstraZeneca Pharmaceuticals. LP. The Deadline for AstraZeneca to file a responsive pleading is 9/23/2012. Entered at the Direction of The Honorable Sol Blatt, Jr on 8/12/2013. (vdru, ) (Entered: 08/12/2013)
2013-08-12
1
AMENDED COMPLAINT against AstraZeneca Pharmaceuticals LP, filed by Medical University of South Carolina Foundation for Research Development, Charleston Medical Therapeutics Inc. Service due by 12/16/2013 (Attachments: # 1 Exhibit A: '800 Patent, # 2 Exhibit B: '219 Patent Issue Notification, # 3 Exhibit C: '219 Patent Preliminary Amendment ) (Rice, Joseph) Modified to add descriptions to exhibits on 8/16/2013 (vdru, ). (Entered: 08/13/2013)
2013-08-13
1
MOTION to Appear Pro Hac Vice by Samuel F. Baxter ( Filing fee $ 250 receipt number 0420-4888574) by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 9/6/2013. (Attachments: # 1 Affidavit - Application/Affidavit for Pro Hac Vice Admission, # 2 Exhibit - Certificate of Good Standing)Proposed order is being emailed to chambers with copy to opposing counsel.(Littlejohn, Joshua) (Entered: 08/19/2013)
2013-08-19
1
MOTION to Appear Pro Hac Vice by John F. Garvish, II ( Filing fee $ 250 receipt number 0420-4888616) by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 9/6/2013. (Attachments: # 1 Affidavit - Application/Affidavit for Pro Hac Vice Admission, # 2 Exhibit - Certificate of Good Standing)Proposed order is being emailed to chambers with copy to opposing counsel.(Littlejohn, Joshua) (Entered: 08/19/2013)
2013-08-19
1
MOTION to Appear Pro Hac Vice by Stacie L. Greskowiak ( Filing fee $ 250 receipt number 0420-4888636) by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 9/6/2013. (Attachments: # 1 Affidavit - Application/Affidavit for Pro Hac Vice Admission, # 2 Exhibit - Certificate of Good Standing)Proposed order is being emailed to chambers with copy to opposing counsel.(Littlejohn, Joshua) (Entered: 08/19/2013)
2013-08-19
1
MOTION to Appear Pro Hac Vice by Ryan A. Hargrave ( Filing fee $ 250 receipt number 0420-4888643) by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 9/6/2013. (Attachments: # 1 Affidavit - Application/Affidavit for Pro Hac Vice Admission, # 2 Exhibit - Certificate of Good Standing)Proposed order is being emailed to chambers with copy to opposing counsel.(Littlejohn, Joshua) (Entered: 08/19/2013)
2013-08-19
1
ORDER granting 18 Motion to Appear Pro Hac Vice. Samuel F. Baxter who represents the Plaintiffs is granted admission pro hac vice in this case. Signed by Honorable Sol Blatt, Jr on 8/21/2013.(vdru, ) (Entered: 08/22/2013)
2013-08-22
1
ORDER granting 19 Motion to Appear Pro Hac Vice. John F. Garvish who represents the Plaintiffs is granted admission pro hac vice in this case. Signed by Honorable Sol Blatt, Jr on 8/21/2013.(vdru, ) (Entered: 08/22/2013)
2013-08-22
1
ORDER granting 20 Motion to Appear Pro Hac Vice. Stacie L. Greskowiak who represents the Plaintiffs is granted admission pro hac vice in this case. Signed by Honorable Sol Blatt, Jr on 8/21/2013.(vdru, ) (Entered: 08/22/2013)
2013-08-22
1
ORDER granting 21 Motion to Appear Pro Hac Vice. Ryan A. Hargrave who represents the Plaintiffs is granted admission pro hac vice in this case. Signed by Honorable Sol Blatt, Jr on 8/21/2013.(vdru, ) (Entered: 08/22/2013)
2013-08-22
1
Consent MOTION for Extension of Time to File Answer re 16 Amended Complaint, by AstraZeneca Pharmaceuticals LP. Response to Motion due by 9/9/2013. No proposed order.(Leonardi, Daniel) (Entered: 08/23/2013)
2013-08-23
1
TEXT ORDER granting 26 Consent MOTION for Extension of Time to File Answer re 16 Amended Complaint, filed by AstraZeneca Pharmaceuticals LP Entered at the Direction of the Honorable Sol Blatt, Jr on 8/28/13. (jwol, ) (Entered: 08/28/2013)
2013-08-28
1
Letter from Marguerite Willis for AstraZeneca. (Attachments: # 1 Exhibit 9-13-13 Joseph Rice Letter to Judge Blatt)(Willis, Marguerite) Modified to correct filing date on 9/19/2013 (vdru, ). (Entered: 09/18/2013)
2013-09-13
1
DELETION OF DOCKET ENTRY NUMBER 30 Reason: Attorney refiled document so that document is signed by filing attorney.Corrected Filing Document Number 32 Modified filing date to that of original filing: 9/13/2013. (vdru, ) (Entered: 09/19/2013)
2013-09-13
1
Letter from Marguerite Willis for AstraZeneca. (Willis, Marguerite) Modified to correct filing date on 9/19/2013 (vdru, ). (Entered: 09/18/2013)
2013-09-17
1
DELETION OF DOCKET ENTRY NUMBER 31 Reason: Attorney refiled document so that document is signed by filing attorney.Corrected Filing Document Number 33 Modified filing date to that of original filing: 9/17/2013 (vdru, ) (Entered: 09/19/2013)
2013-09-17
1
MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM by AstraZeneca Pharmaceuticals LP. Response to Motion due by 11/12/2013. (Attachments: # 1 Memo in Support, # 2 Exhibit A - Palm. Pharm. v. AstraZeneca, # 3 Exhibit B - Nazomi Comm. v. Nokia Corp., # 4 Exhibit C - Vasudevan Software v. TIBCO Software, # 5 Exhibit D - Worldwide Home Prod. v. Time, Inc., # 6 Exhibit E - Classen Immunotherapies v. Biogen IDEC, # 7 Exhibit F - Weyer v. MySpace, Inc., # 8 Exhibit G - Rembrandt Social Media v. Facebook, Inc., # 9 Exhibit H - Solannex v. MiaSole, # 10 Exhibit I - Sealant Sys. v. TEK Global, # 11 Exhibit J - Proxyconn v. Microsoft)No proposed order.(Leonardi, Daniel) (Entered: 10/23/2013)
2013-10-23
1
MOTION to Appear Pro Hac Vice by Christopher Neil Sipes ( Filing fee $ 250 receipt number 0420-5004198) by AstraZeneca Pharmaceuticals LP. Response to Motion due by 11/12/2013. (Attachments: # 1 Affidavit /Application for Christopher Neil Sipes)No proposed order.(Leonardi, Daniel) (Entered: 10/24/2013)
2013-10-24
1
MOTION to Appear Pro Hac Vice by Stephen Pierce Anthony ( Filing fee $ 250 receipt number 0420-5004246) by AstraZeneca Pharmaceuticals LP. Response to Motion due by 11/12/2013. (Attachments: # 1 Affidavit /Application for Stephen Pierce Anthony)No proposed order.(Leonardi, Daniel) (Entered: 10/24/2013)
2013-10-24
1
MOTION to Appear Pro Hac Vice by William Edward Zapf ( Filing fee $ 250 receipt number 0420-5004257) by AstraZeneca Pharmaceuticals LP. Response to Motion due by 11/12/2013. (Attachments: # 1 Affidavit /Application for William Edward Zapf)No proposed order.(Leonardi, Daniel) (Entered: 10/24/2013)
2013-10-24
1
MOTION to Appear Pro Hac Vice by R. Jason Fowler ( Filing fee $ 250 receipt number 0420-5004265) by AstraZeneca Pharmaceuticals LP. Response to Motion due by 11/12/2013. (Attachments: # 1 Affidavit /Application for R. Jason Fowler)No proposed order.(Leonardi, Daniel) (Entered: 10/24/2013)
2013-10-24
1
MOTION to Appear Pro Hac Vice by Julia Finkel Post ( Filing fee $ 250 receipt number 0420-5004277) by AstraZeneca Pharmaceuticals LP. Response to Motion due by 11/12/2013. (Attachments: # 1 Affidavit /Application for Julia Finkel Post)No proposed order.(Leonardi, Daniel) (Entered: 10/24/2013)
2013-10-24
1
ORDER granting 37 Motion to Appear Pro Hac Vice. Christopher Neil Sipes who represents Astrazeneca Pharmaceuticals LP is granted admission pro hac vice in this case. Signed by Honorable Sol Blatt, Jr on 10/28/2013.(vdru, ) (Entered: 10/29/2013)
2013-10-29
1
ORDER granting 38 Motion to Appear Pro Hac Vice. Stephen Pierce Anthony who represents Astrazeneca Pharmaceuticals LP is granted admission pro hac vice in this case. Signed by Honorable Sol Blatt, Jr on 10/28/2013.(vdru, ) (Entered: 10/29/2013)
2013-10-29
1
ORDER granting 39 Motion to Appear Pro Hac Vice. William Edward Zapf who represents Astrazeneca Pharmaceuticals LP is granted admission pro hac vice in this case. Signed by Honorable Sol Blatt, Jr on 10/28/2013.(vdru, ) (Entered: 10/29/2013)
2013-10-29
1
ORDER granting 40 Motion to Appear Pro Hac Vice. R. Jason Fowler who represents Astrazeneca Pharmaceuticals LP is granted admission pro hac vice in this case. Signed by Honorable Sol Blatt, Jr on 10/28/2013.(vdru, ) (Entered: 10/29/2013)
2013-10-29
1
ORDER granting 41 Motion to Appear Pro Hac Vice. Julia Finkel Post who represents Astrazeneca Pharmaceuticals LP is granted admission pro hac vice in this case. Signed by Honorable Sol Blatt, Jr on 10/28/2013.(vdru, ) (Entered: 10/29/2013)
2013-10-29
1
NOTICE of Hearing on Motion 36 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM : Motion Hearing set for Thursday, 12/5/2013 at 11:00 AM in Charleston Courtroom 3, U. S. Court House, 81 Meeting St, Charleston before Honorable Sol Blatt Jr. (vdru, ) (Entered: 10/30/2013)
2013-10-30
1
NOTICE OF RESCHEDULED HEARING on 36 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM : Motion Hearing previously set for 12/5/2013 at 11:00 AM is cancelled and rescheduled to: Motion Hearing set for 12/4/2013 at 03:00 PM in Charleston Courtroom 3, U. S. Court House, 81 Meeting St, Charleston before Honorable Sol Blatt Jr. (vdru, ) Modified to edit text on 11/4/2013 (vdru, ). (Entered: 11/04/2013)
2013-11-04
1
RESPONSE in Opposition re 36 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 11/22/2013 (Attachments: # 1 Exhibit A - Second Am Complaint, # 2 Exhibit A.1 - 800 Patent, # 3 Exhibit A.2 - 219 Patent, # 4 Exhibit A.3 - Crestor Product Label, # 5 Exhibit A.4 - Patient Prescribing Info, # 6 Exhibit A.5 - 07-15-13 Emails, # 7 Exhibit A.6 - 07-18-03 Witcher Email, # 8 Exhibit A.7 - 01-13-04 & 01-14-04 Emails, # 9 Exhibit A.8 - 03-05-04 to 04-21-04 Emails, # 10 Exhibit A.9 - 11-25-03 Email, # 11 Exhibit A.10 - 07-18-03 Brostoff Email, # 12 Exhibit A.11 - 12-16-03 Email, # 13 Exhibit B - Smith & Nephew v Arthrex, # 14 Exhibit C - Sprint Nextel v Simple Cell, # 15 Exhibit D - Rembrandt v Facebook, # 16 Exhibit E - Intellect v Sharp, # 17 Exhibit F - Achates v Symantec, # 18 Exhibit G - Trading Techs v BCG, # 19 Exhibit H - Symantec v Veeam, # 20 Exhibit I - Pacing Tech v Garmin Intl, # 21 Exhibit J - TracBeam v AT&T, # 22 Exhibit K - Ill Tool Works v MOC Prods, # 23 Exhibit L - Ronald A Katz Tech v Consol Edison, # 24 Exhibit M - Solannex v MiaSole, # 25 Exhibit N - In re Bldg Materials v GAF, # 26 Exhibit O - Ethox Chem v Coca-Cola)(Littlejohn, Joshua) (Entered: 11/12/2013)
2013-11-12
1
REPLY to Response to Motion re 36 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM Response filed by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Unreported Cases)(Leonardi, Daniel) (Entered: 11/22/2013)
2013-11-22
1
Letter from Joseph F. Rice on behalf of Plaintiffs. (Rice, Joseph) (Entered: 12/03/2013)
2013-12-03
1
Minute Entry. Proceedings held before Honorable Sol Blatt, Jr: granting in part and denying in part 36 Motion to Dismiss for Failure to State a Claim; Motion Hearing held on 12/4/2013 re 36 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM filed by AstraZeneca Pharmaceuticals LP. Court Reporter Amy Diaz. (jwol, ) (Entered: 12/04/2013)
2013-12-04
1
NOTICE OF FILING OF OFFICIAL TRANSCRIPT of Proceedings. Motion Hearing held on December 4, 2013, before Judge Sol Blatt, Jr.. Court Reporter/Transcriber Amy Diaz, Telephone number/E-mail 367-4604. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Parties have 7 calendar days from the filing of the transcript to file with the court a Notice of Intent to Request Redaction.. Redaction Request due 12/27/2013. Redacted Transcript Deadline set for 1/6/2014. Release of Transcript Restriction set for 3/6/2014. (adia, ) (Entered: 12/06/2013)
2013-12-06
1
ORDER granting in part and denying in part 36 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM filed by AstraZeneca Pharmaceuticals LP for reasons explained during the hearing and as set forth in this Order. Signed by Honorable Sol Blatt, Jr on 12/06/2013. (vdru, ) (Entered: 12/09/2013)
2013-12-09
1
Local Rule 26.01 Answers to Interrogatories by AstraZeneca Pharmaceuticals LP.(Leonardi, Daniel) (Entered: 12/12/2013)
2013-12-12
1
Consent MOTION for Extension of Time to File Answer re 16 Amended Complaint, by AstraZeneca Pharmaceuticals LP. Response to Motion due by 1/2/2014. No proposed order.(Leonardi, Daniel) (Entered: 12/16/2013)
2013-12-16
1
TEXT ORDER granting 56 Motion for Extension of Time to Answer. AstraZeneca Pharmaceuticals LP answer due 1/6/2014. Entered at the Direction of The Honorable Sol Blatt, Jr on 12/17/2013.(vdru, ) (Entered: 12/17/2013)
2013-12-17
1
SCHEDULING ORDER: Rule 26(f) Conference Deadline 1/7/2014, 26(a) Initial Disclosures due by 1/21/2014, Motions to Amend Pleadings due by 2/3/2014, Plaintiffs ID of Expert Witness due by 3/4/2014, Defendants ID of Expert Witnesses Due by 4/3/2014, Records Custodian Affidavit due by 4/3/2014, Discovery due by 6/2/2014, Motion in Limine due by 9/23/2014, Motions due by 6/17/2014, Rule 26(a)(3) Disclosures due by 9/2/2014, Pretrial Briefs due by 10/9/2014, Jury Selection Deadline 10/14/2014, Mediation Due by 8/18/2014. Signed by Honorable Sol Blatt, Jr on 12/18/2013. (vdru, ) (Entered: 12/19/2013)
2013-12-19
1
ANSWER to 16 Amended Complaint, by AstraZeneca Pharmaceuticals LP.(Willis, Marguerite) (Entered: 01/06/2014)
2014-01-06
1
MOTION to Consolidate Cases by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 2/7/2014. No proposed order.Associated Cases: 2:13-cv-02078-SB, 2:13-cv-03438-SB(Littlejohn, Joshua) (Entered: 01/21/2014)
2014-01-21
1
Joint Rule 26(f) Report by AstraZeneca Pharmaceuticals LP, Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. (Attachments: # 1 Supporting Documents Joint Discovery Plan and LR 26.03s, # 2 Exhibit A Plaintiffs Proposed Scheduling Order, # 3 Exhibit B Defendants Proposed Scheduling Order, # 4 Exhibit C E-discovery Model Order, # 5 Exhibit D Proposed Confidentiality Order)(Littlejohn, Joshua) (Entered: 01/21/2014)
2014-01-21
1
MOTION to Appear Pro Hac Vice by Sangjoon Han ( Filing fee $ 250 receipt number 0420-5147746) by AstraZeneca Pharmaceuticals LP. Response to Motion due by 2/10/2014. (Attachments: # 1 Supporting Documents Pro Hac Application and Certificate of Good Standing)No proposed order.(Leonardi, Daniel) (Main Document 62 replaced on 1/27/2014) (vdru, ). Modified to replace with corrected document provided by filing user on 1/27/2014 (vdru, ). (Entered: 01/24/2014)
2014-01-24
1
ORDER granting 62 Motion to Appear Pro Hac Vice. It is ordered that Sangjoon Han, who represents AstraZeneca Pharmaceuticals LP shall be granted admission pro hac vice in this case. Signed by Honorable Sol Blatt, Jr on 1/27/2014.(vdru, ) (Entered: 01/31/2014)
2014-01-31
1
RESPONSE in Opposition re (60 in 2:13-cv-02078-SB, 22 in 2:13-cv-03438-SB) MOTION to Consolidate Cases Response filed by AstraZeneca Pharmaceuticals LP.Reply to Response to Motion due by 2/18/2014 (Attachments: # 1 Exhibit - Fawcett v. Ditkowsky)Associated Cases: 2:13-cv-02078-SB, 2:13-cv-03438-SB(Leonardi, Daniel) (Entered: 02/07/2014)
2014-02-07
1
REPLY to Response to Motion re (60 in 2:13-cv-02078-SB, 22 in 2:13-cv-03438-SB) MOTION to Consolidate Cases Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. (Attachments: # 1 Exhibit A - AstraZeneca First Set of Interrogatories, # 2 Exhibit B - AstraZeneca Second Set of Requests for Production, # 3 Exhibit C - Corder Subpoena, # 4 Exhibit D - Parker Highlander Subpoena, # 5 Exhibit E - Krawzsenek Subpoena, # 6 Exhibit F - Rasheed Subpoena, # 7 Exhibit G - SciMed Life Sys v Advanced Cardiovascular Sys)Associated Cases: 2:13-cv-02078-SB, 2:13-cv-03438-SB(Littlejohn, Joshua) (Entered: 02/18/2014)
2014-02-18
1
NOTICE of Hearing on Motion (60 in 2:13-cv-02078-SB, 22 in 2:13-cv-03438-SB) MOTION to Consolidate Cases, (16 in 2:13-cv-03438-SB) MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM : Motion Hearing set for Tuesday, 4/8/2014 at 11:00 AM in Charleston Courtroom 3, U. S. Court House, 81 Meeting St, Charleston before Honorable Sol Blatt Jr. Associated Cases: 2:13-cv-02078-SB, 2:13-cv-03438-SB(vdru, ) (Entered: 02/19/2014)
2014-02-19
1
MOTION to Compel Answers to Interrogatories and Production of Documents by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 4/7/2014. (Attachments: # 1 Exhibit A - Defendants Objections/Response to Plaintiffs First Interrogatories, # 2 Exhibit B - E.D. Tex. Case Management Order, # 3 Exhibit C - Saint-Gobain v Xinyi Glass, # 4 Exhibit D - Defendants Initial Disclosures, # 5 Exhibit E - Singh Disclosure Statement, # 6 Exhibit F - Singh Affidavit, # 7 Exhibit G - Tessera v Sony Electronics, # 8 Exhibit H - Defendants Objections/Responses to Plaintiffs First RFP)No proposed order.(Littlejohn, Joshua) (Entered: 03/20/2014)
2014-03-20
1
NOTICE of Appearance by Max N Gruetzmacher on behalf of Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development (Gruetzmacher, Max) (Entered: 03/24/2014)
2014-03-24
1
MOTION to Appear Pro Hac Vice by Kristina S. Baehr ( Filing fee $ 250 receipt number 0420-5267880) by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 4/21/2014. (Attachments: # 1 Affidavit Application/Affidavit for Pro Hac Vice Admission, # 2 Exhibit Certificate of Good Standing)Proposed order is being emailed to chambers with copy to opposing counsel.(Littlejohn, Joshua) (Entered: 04/03/2014)
2014-04-03
1
ORDER granting 70 Motion to Appear Pro Hac Vice. It is ordered that Kristina Scurry Baehr, who represents Plaintiffs, is granted admission pro hac vice in this case. Signed by Honorable Sol Blatt, Jr on 4/4/2014.(vdru, ) (Entered: 04/04/2014)
2014-04-04
1
RESPONSE in Opposition re 68 MOTION to Compel Answers to Interrogatories and Production of Documents Response filed by AstraZeneca Pharmaceuticals LP.Reply to Response to Motion due by 4/17/2014 (Attachments: # 1 Exhibit A - Plaintiffs' Proposed Scheduling Order, # 2 Exhibit B - Defendant's Proposed Scheduling Order, # 3 Exhibit C - Defendant's Obj. & Resp. to 1st RFP, # 4 Exhibit D - Defendant's Obj. & Resp. to Plaintiff's 1st of Interrogatories, # 5 Exhibit E - Corr. from J. Littlejohn, # 6 Exhibit F - Corr. from J. Garvish (Mar. 6, 2014), # 7 Exhibit G - Corr. from J. Fowler, # 8 Exhibit H - Corr. from Garvish (Mar. 17, 2014), # 9 Exhibit I - Defendant's First Suppl. Initial Disclosures, # 10 Exhibit J - Defendant's First Supp. to Plaintiff's First Set of Interrogatories, # 11 Exhibit K - Plaintiffs' First Set of Interrogatories, # 12 Exhibit L - Pages from '219 Patent File History, # 13 Exhibit M - Gillette v. S.C. Johnson)(Leonardi, Daniel) (Entered: 04/07/2014)
2014-04-07
1
Minute Entry. Proceedings held before Honorable Sol Blatt, Jr: granting (60) Motion to Consolidate Cases in case 2:13-cv-02078-SB; denying (16) Motion to Dismiss for Failure to State a Claim; granting (22) Motion to Consolidate Cases in case 2:13-cv-03438-SB; Motion Hearing held on 4/8/2014 re (16 in 2:13-cv-03438-SB) MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM filed by AstraZeneca Pharmaceuticals LP, (60 in 2:13-cv-02078-SB, 22 in 2:13-cv-03438-SB) MOTION to Consolidate Cases filed by MUSC Foundation for Research Development, Charleston Medical Therapeutics Inc in case 2:13-cv-02078-SB. Court Reporter Debbie Potocki. Associated Cases: 2:13-cv-02078-SB, 2:13-cv-03438-SB(jwol, ) (Entered: 04/08/2014)
2014-04-08
1
ORAL ORDER denying the motion to dismiss and granting the motion to consolidate cases for the reasons stated on the record during the hearing of April 8, 2014. Entered at the Direction of the Honorable Sol Blatt, Jr on 4/9/14. Associated Cases: 2:13-cv-02078-SB, 2:13-cv-03438-SB(jwol, ) (Entered: 04/09/2014)
2014-04-09
1
NOTICE OF FILING OF OFFICIAL TRANSCRIPT of motions hearing held on 4-8-14, before Judge Sol Blatt, Jr. Court Reporter/Transcriber Debra Potocki, Telephone number/E-mail 843-723-2208/potockidebra@bellsouth.net. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Parties have 7 calendar days from the filing of the transcript to file with the court a Notice of Intent to Request Redaction.. Redaction Request due 5/5/2014. Redacted Transcript Deadline set for 5/15/2014. Release of Transcript Restriction set for 7/14/2014. (dpotocki, ) (Main Document 76 replaced with correct document provided by filer on 4/17/2014) (ssam, ). (Entered: 04/14/2014)
2014-04-14
1
Consent MOTION for Extension of Time to File Response/Reply as to (68 in 2:13-cv-02078-SB) MOTION to Compel Answers to Interrogatories and Production of Documents by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 5/2/2014. No proposed order.Associated Cases: 2:13-cv-02078-SB, 2:13-cv-03438-SB(Littlejohn, Joshua) (Entered: 04/15/2014)
2014-04-15
1
MOTION For Entry of Scheduling Order by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 5/5/2014. (Attachments: # 1 Exhibit A - Pls' Proposed Scheduling Order, # 2 Exhibit B - Def's Objections & Resps. to Pls' First Interrogs.)No proposed order.Associated Cases: 2:13-cv-02078-SB, 2:13-cv-03438-SB(Littlejohn, Joshua) (Entered: 04/18/2014)
2014-04-18
1
MOTION For Adoption of AstraZeneca's Proposed Amended Scheduling Order by AstraZeneca Pharmaceuticals LP. Response to Motion due by 5/5/2014. (Attachments: # 1 Exhibit A - AstraZeneca's Proposed Scheduling Order)Proposed order is being emailed to chambers with copy to opposing counsel.Associated Cases: 2:13-cv-02078-SB, 2:13-cv-03438-SB(Leonardi, Daniel) (Entered: 04/18/2014)
2014-04-18
1
Joint MOTION for Confidentiality Order by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development and AstraZeneca Pharmaceuticals LP. Response to Motion due by 5/8/2014. (Attachments: # 1 Exhibit A - Proposed Confidentiality Order, # 2 Exhibit B - Redline of Modifications to Proposed Confidentiality Order)Proposed order is being emailed to chambers with copy to opposing counsel.Associated Cases: 2:13-cv-02078-SB, 2:13-cv-03438-SB(Littlejohn, Joshua) Modified to add filer listed on document on 4/22/2014 (vdru, ). (Entered: 04/21/2014)
2014-04-21
1
TEXT ORDER granting (77) Consent Motion for Extension of Time to File Response/Reply re (68 in 2:13-cv-02078-SB) MOTION to Compel Answers to Interrogatories and Production of Documents in case 2:13-cv-02078-SB; granting (35) Consent Motion for Extension of Time to File Response/Reply re (68 in 2:13-cv-02078-SB) MOTION to Compel Answers to Interrogatories and Production of Documents in case 2:13-cv-03438-SB in case 2:13-cv-02078-SB Replies due by 5/2/2014. Entered at the Direction of The Honorable Sol Blatt, Jr on 4/21/2014.Associated Cases: 2:13-cv-02078-SB, 2:13-cv-03438-SB(vdru, ) (Entered: 04/21/2014)
2014-04-21
1
ORDER granting (80) Motion for Confidentiality Order in case 2:13-cv-02078-SB; granting (39) Motion for Confidentiality Order in case 2:13-cv-03438-SB. The parties have stipulated that certain discovery material is and should be treated as confidential. Details regarding the treatment and protection of confidential information are set forth in order. Signed by Honorable Sol Blatt, Jr on 4/21/2014.Associated Cases: 2:13-cv-02078-SB, 2:13-cv-03438-SB(vdru, ) (Entered: 04/22/2014)
2014-04-22
1
AMENDED SCHEDULING ORDER: Identification of asserted infringement claims deadline 5/9/2014, claims of invalidity due by 5/30/2014, Exchange of Claim Terms due by 6/18/2014, Proposed claim construction due by 7/11/2014, experts available for depositions by 8/1/2014, claim construction briefs due by 8/29/2014 and Claim Construction Hearing on or after 10/1/2014. Additional deadlines set forth in Order. Signed by Honorable Sol Blatt, Jr on 4/22/2014. Associated Cases: 2:13-cv-02078-SB, 2:13-cv-03438-SB(vdru, ) (Entered: 04/23/2014)
2014-04-23
1
TEXT ORDER denying (78) Plaintiff's motion for scheduling order in case 2:13-cv-02078-SB; denying (37) Plaintiff's motion for scheduling order in case 2:13-cv-03438-SB. Entered at the Direction of The Honorable Sol Blatt, Jr on 4/23/2014.Associated Cases: 2:13-cv-02078-SB, 2:13-cv-03438-SB(vdru, ) (Entered: 04/23/2014)
2014-04-23
1
TEXT ORDER granting (79) Defendant's Motion for Scheduling Order in case 2:13-cv-02078-SB; granting (38) Defendant's Motion for Scheduling Order in case 2:13-cv-03438-SB. Entered at the Direction of The Honorable Sol Blatt, Jr on 4/23/2014.Associated Cases: 2:13-cv-02078-SB, 2:13-cv-03438-SB(vdru, ) (Entered: 04/23/2014)
2014-04-23
1
Consent MOTION for Extension of Time to File Response/Reply as to (68 in 2:13-cv-02078-SB) MOTION to Compel Answers to Interrogatories and Production of Documents by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 5/16/2014. No proposed order.Associated Cases: 2:13-cv-02078-SB, 2:13-cv-03438-SB(Littlejohn, Joshua) (Entered: 04/29/2014)
2014-04-29
1
TEXT ORDER granting (86) Motion for Extension of Time to File Response/Reply in case 2:13-cv-02078-SB; granting (45) Motion for Extension of Time to File Response/Reply in case 2:13-cv-03438-SB. AstraZeneca shall supplement its discovery requests on or before April 30, 2014; and Plaintiffs shall file any Reply in Support of their Motion to Compel on or before May 7, 2014. Entered at the Direction of The Honorable Sol Blatt, Jr on 5/6/2014.Associated Cases: 2:13-cv-03438-SB, 2:13-cv-02078-SB(vdru, ) (Entered: 05/06/2014)
2014-05-06
1
REPLY to Response to Motion re (68 in 2:13-cv-02078-SB) MOTION to Compel Answers to Interrogatories and Production of Documents Reply to Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. (Attachments: # 1 Exhibit A - In re MI Windows & Doors, # 2 Exhibit B - Volumetrics v Toshiba, # 3 Exhibit C - Defendants Initial Disclosures, # 4 Exhibit D - Defendants Supplemental Objections/Responses to Plaintiffs First RFP, # 5 Exhibit E - Ridkers JUPITER Presentation, # 6 Exhibit F - Rich v Shrader, # 7 Exhibit G - Defendants Supplemental Objections/Responses to Plaintiffs First Interrogatories, # 8 Exhibit H - Tessera v. Sony Electronics, # 9 Exhibit I - Saint-Gobain v Xinyi Glass)Associated Cases: 2:13-cv-02078-SB, 2:13-cv-03438-SB(Littlejohn, Joshua) (Entered: 05/07/2014)
2014-05-07
1
CERTIFICATE OF SERVICE by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development of Plaintiffs Preliminary Disclosure of Asserted Claims and Infringement Contentions via E-mail on 05-09-14 (Littlejohn, Joshua) (Entered: 05/12/2014)
2014-05-12
1
Consent MOTION for Leave to File a Sur-Reply in Opposition to Plaintiffs' Motion to Compel by AstraZeneca Pharmaceuticals LP. Response to Motion due by 6/2/2014. (Attachments: # 1 AZ's Sur-Reply in Opposition to Plaintiff's Motion to Compel, # 2 Exhibit 1 - AZ's Supplemental Responses to Plaintiffs First Request for Production, # 3 Exhibit 2 - Garvish Letter of Mar. 17, 2014, # 4 Exhibit 3 - Apotex Docket, # 5 Exhibit 4 - Apotex Plaintiffs' Answering Brief in Opposition to Motion to Dismiss, # 6 Exhibit 5 - AZ's Supplemental Responses to Plaintiffs' First Set of Interrogatories, # 7 Exhibit 6 - AZ's First Set of Requests for Production to Plaintiffs, # 8 Exhibit 7 - Garvish E-mail of May 16, 2014, # 9 Exhibit 8 - Garvish Letter of Jan. 23, 2014)No proposed order.Associated Cases: 2:13-cv-02078-SB, 2:13-cv-03438-SB(Leonardi, Daniel) (Entered: 05/16/2014)
2014-05-16
1
ORAL ORDER granting (90) Motion for Leave to File in case 2:13-cv-02078-SB; granting (50) Motion for Leave to File in case 2:13-cv-03438-SB Entered at the Direction of Honorable Sol Blatt, Jr on 5/19/14.Associated Cases: 2:13-cv-03438-SB, 2:13-cv-02078-SB(jwol, ) (Entered: 05/19/2014)
2014-05-19
1
Consent MOTION for Leave to File Response to Defendant's Sur-Reply to Motion to Compel by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 6/9/2014. (Attachments: # 1 Exhibit A - Plaintiffs Response to Defendants Sur-Reply to Motion to Compel (Redacted), # 2 Exhibit A.1 - Defendants Confidential Document (Redacted), # 3 Exhibit A.2 - Plaintiffs Preliminary Infringement Contentions, # 4 Exhibit A.3 - Garvish E-mail of May 16, 2014, # 5 Exhibit A.4 - Great Lakes Anesthesia v State Farm)No proposed order.Associated Cases: 2:13-cv-02078-SB, 2:13-cv-03438-SB(Littlejohn, Joshua) (Entered: 05/21/2014)
2014-05-21
1
Consent MOTION to Seal Document (92 in 2:13-cv-02078-SB) Consent MOTION for Leave to File Response to Defendant's Sur-Reply to Motion to Compel - Exhibits A and A.1 by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 6/9/2014. (Attachments: # 1 Exhibit 1 - Non-confidential Index of Document to be Filed Under Seal, # 2 Exhibit 2 - Certificate of Compliance)No proposed order.Associated Cases: 2:13-cv-02078-SB, 2:13-cv-03438-SB(Littlejohn, Joshua) (Entered: 05/21/2014)
2014-05-21
1
TEXT ORDER granting (92) Motion for Leave to File in case 2:13-cv-02078-SB; granting (52) Motion for Leave to File in case 2:13-cv-03438-SB Entered at the Direction of the Honorable Sol Blatt, Jr on 5/21/14.Associated Cases: 2:13-cv-03438-SB, 2:13-cv-02078-SB(jwol, ) (Entered: 05/21/2014)
2014-05-21
1
TEXT ORDER granting (93) Motion to Seal Document in case 2:13-cv-02078-SB; granting (53) Motion to Seal Document in case 2:13-cv-03438-SB Entered at the Direction of the Honorable Sol Blatt, Jr on 5/21/14.Associated Cases: 2:13-cv-03438-SB, 2:13-cv-02078-SB(jwol, ) (Entered: 05/21/2014)
2014-05-21
1
Letter from Marguerite S. Willis. Associated Cases: 2:13-cv-02078-SB, 2:13-cv-03438-SB(Willis, Marguerite) (Entered: 05/29/2014)
2014-05-29
1
NOTICE of Hearing on Motion 68 MOTION to Compel Answers to Interrogatories and Production of Documents : Motion Hearing set for 6/19/2014 11:00 AM in Judge Blatt's Hearing Room, 2nd Floor, U. S. Court House, 81 Meeting St, Charleston before Honorable Sol Blatt Jr. (jwol, ) (Entered: 05/30/2014)
2014-05-30
1
DELETION OF DOCKET ENTRY NUMBER 98 Reason: Letter filed in error. Deleted per request of filer. Modified filing date to that of original filing: 5/30/2014. (vdru, ) . (Entered: 05/30/2014)
2014-05-30
1
Letter from Marguerite S. Willis. Associated Cases: 2:13-cv-02078-SB, 2:13-cv-03438-SB(Willis, Marguerite) (Entered: 06/03/2014)
2014-06-03
1
NOTICE OF RESCHEDULED HEARING 68 MOTION to Compel Answers to Interrogatories and Production of Documents : Motion Hearing set for 6/19/2014 cancelled and rescheduled to: Motion Hearing set for Thursday, 7/10/2014 at 11:30 AM before Honorable Sol Blatt Jr. in Judge Blatt's Hearing Room, 2nd Floor, U. S. Court House, 81 Meeting St. (vdru, ) (Entered: 06/05/2014)
2014-06-05
1
Joint MOTION for Entry of E-Discovery Order by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 6/27/2014. (Attachments: # 1 Exhibit A - Proposed E-Discovery Order)Proposed order is being emailed to chambers with copy to opposing counsel.Associated Cases: 2:13-cv-02078-SB, 2:13-cv-03438-SB(Littlejohn, Joshua) (Entered: 06/10/2014)
2014-06-10
1
ORDER granting (102) Motion for Entry of E-Discovery Order in case 2:13-cv-02078-SB and 2:13-cv-03438-SB. Details regarding the production of Electronically Stored Information set forth in Order. Signed by Honorable Sol Blatt, Jr on 6/10/2014.Associated Cases: 2:13-cv-02078-SB, 2:13-cv-03438-SB(vdru, ) (Entered: 06/11/2014)
2014-06-11
1
Case Reassigned to Judge Honorable Richard M Gergel. Judge Honorable Sol Blatt, Jr no longer assigned to the case. (suro, ) (Entered: 06/27/2014)
2014-06-27
1
NOTICE of Cancellation of Hearing scheduled for 7/10/2014. Case reassigned on 6/27 --Hearing may be rescheduled at later date after review. (ltap, ) (Entered: 06/30/2014)
2014-06-30
1
Letter from Joseph F. Rice. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Rice, Joseph) (Entered: 07/02/2014)
2014-07-02
1
Joint MOTION to Amend/Correct (82 in 2:13-cv-02078-RMG) Order on Motion for Confidentiality Order, by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development, AstraZeneca Pharmaceuticals LP. Response to Motion due by 7/25/2014. (Attachments: # 1 Exhibit A - Proposed First Amended Confidentiality Order, # 2 Exhibit B - Redline of Modifications to Confidentiality Order)Proposed order is being emailed to chambers with copy to opposing counsel.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) Modified on 7/9/2014 to add joint filers listed on document (egra, ). (Entered: 07/08/2014)
2014-07-08
1
NOTICE of Hearing on 68 MOTION to Compel: Telephone Conference set for 7/16/2014 at 10:00 AM before Honorable Richard M Gergel. Attorneys must initiate telephone conference and then call into Chambers.(ltap, ) (Entered: 07/09/2014)
2014-07-09
1
Letter from Marguerite S. Willis. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 07/10/2014)
2014-07-10
1
Letter from Joseph F. Rice & Marguerite S. Willis. (Attachments: # 1 Exhibit A - AstraZeneca's First Supplemental Objections & Responses to Plaintiffs' First Set of Interrogatories)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Rice, Joseph) (Entered: 07/15/2014)
2014-07-15
1
Minute Entry. Proceedings held before Honorable Richard M Gergel: Motion Hearing held on 7/16/2014 re 68 MOTION to Compel Answers to Interrogatories and Production of Documents filed by MUSC Foundation for Research Development, Charleston Medical Therapeutics Inc. Court to issue written order. Court Reporter Debbie Potocki. (cper, ) (Entered: 07/16/2014)
2014-07-16
1
ORDER granting in part 68 Plaintiffs' Motion to Compel. Details set forth in Order Signed by Honorable Richard M Gergel on 7/16/2014.(sshe, ) (Entered: 07/16/2014)
2014-07-16
1
FIRST AMENDED CONFIDENTIALITY ORDER Signed by Honorable Richard M Gergel on 7/17/2014.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 07/17/2014)
2014-07-17
1
NOTICE of Informal Science Tutorial set for 9/3/2014 at 9:00 AM in Charleston Courtroom TBD, U. S. Court House, 81 Meeting St, Charleston before Honorable Richard M Gergel. No Court Staff needed.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(ltap, ) (Entered: 07/22/2014)
2014-07-22
1
NOTICE OF FILING OF OFFICIAL TRANSCRIPT of telephone conference held on 7-16-14, before Judge Richard M. Gergel. Court Reporter/Transcriber Debra Potocki, Telephone number/E-mail 843-723-2208/potockidebra@bellsouth.net. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Parties have 7 calendar days from the filing of the transcript to file with the court a Notice of Intent to Request Redaction.. Redaction Request due 8/13/2014. Redacted Transcript Deadline set for 8/25/2014. Release of Transcript Restriction set for 10/21/2014. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(dpotocki, ) (Entered: 07/23/2014)
2014-07-23
1
MOTION to Appear Pro Hac Vice by Kevin Lee Burgess ( Filing fee $ 250 receipt number 0420-5461693) by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 8/11/2014. (Attachments: # 1 Affidavit - Application/Affidavit for Pro Hac Vice Admission, # 2 Exhibit - Certificate of Good Standing)Proposed order is being emailed to chambers with copy to opposing counsel.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 07/25/2014)
2014-07-25
1
MOTION to Appear Pro Hac Vice by John B. Campbell ( Filing fee $ 250 receipt number 0420-5461739) by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 8/11/2014. (Attachments: # 1 Affidavit - Application/Affidavit for Pro Hac Vice Admission, # 2 Exhibit - Certificate of Good Standing)Proposed order is being emailed to chambers with copy to opposing counsel.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 07/25/2014)
2014-07-25
1
ORDER granting (117) Motion to Appear Pro Hac Vice; granting (118) Motion to Appear Pro Hac Vice in case 2:13-cv-02078-RMG; granting (69) Motion to Appear Pro Hac Vice; granting (70) Motion to Appear Pro Hac Vice in case 2:13-cv-03438-RMG; Kevin Lee Burgess and John B Campbell for Plaintiffs Signed by Honorable Richard M Gergel on 7/28/2014.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 07/29/2014)
2014-07-29
1
Letter from Marguerite S. Willis. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Main Document 120 replaced on 8/18/2014) (jbry, ). Modified on 8/18/2014 to replace illegible document #120 as provided by filing user (jbry, ). (Entered: 08/15/2014)
2014-08-15
1
Letter from John F. Garvish II on behalf of Plaintiffs. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Main Document 121 replaced on 8/20/2014) (jbry, ). Modified on 8/20/2014 to replace document with corrected signature as provided by filing user (jbry, ). (Entered: 08/19/2014)
2014-08-19
1
TEXT ORDER: AstraZeneca has filed a letter stating that it contends the '152 patent invalidates the asserted claims of the patents-in-suit. (Dkt. No. 120, 72). Plaintiff complains that AstraZeneca had to serve invalidity contentions by May 30, 2014, and the '152 patent was not mentioned in those contentions. (Dkt. No. 121, 73). IT IS ORDERED THAT on or before Monday, August 25, 2014, AstraZeneca file motion to amend its Invalidity Contentions and address whether it has good cause under Rule 16 to do so. IT IS FURTHER ORDERED that Plaintiffs file a response on or before August 29, 2014, addressing whether such an amendment would prejudice Plaintiffs. AND IT IS SO ORDERED. Entered at the Direction of Honorable Richard M Gergel on 8/19/2014. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 08/20/2014)
2014-08-19
1
MOTION to Amend/Correct Invalidity Contentions by AstraZeneca Pharmaceuticals LP. Response to Motion due by 9/11/2014. (Attachments: # 1 Exhibit 1 - Proposed Supplemental Invalidity Contentions for '152 Ridker Patent)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 08/25/2014)
2014-08-25
1
CLAIM CONSTRUCTION BRIEF by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. (Attachments: # 1 Exhibit 1 - Lawrence Solomon MD Declaration, # 2 Exhibit 2 - Charles Lowenstein MD Declaration, # 3 Exhibit 3 - Agreed Claim Constructions, # 4 Exhibit 4 - May 25, 2000 Trademark Amendment, # 5 Exhibit 5 - Charles Lowenstein MD Deposition Excerpts, # 6 Exhibit 6 - May 27, 2011 Further Preliminary Amendment, # 7 Exhibit 7 - Websters New World Dictionary Excerpt, # 8 Exhibit 8 - Crestor Indications, # 9 Exhibit 9 - 2004 AHA Article - Exogenous Thioredoxin, # 10 Exhibit 10 - New England Book Review - Inflammation and Cardiac Disease, # 11 Exhibit 11 - Journal of Cell Biology Article - Hydrogen peroxide regulation, # 12 Exhibit 12 - Journal of Biological Chemistry Article - Carbohydrates, # 13 Exhibit 13 - Blood Journal Article - Vav-vav-vav-voom, # 14 Exhibit 14 - AHA Article - HMG-CoA, # 15 Exhibit 15 - Defendants Invalidity Contentions, # 16 Exhibit 16 - Lawrence Solomon MD Deposition Excerpts, # 17 Exhibit 17 - Concise Dictionary of Biomedicine Excerpt, # 18 Exhibit 18 - AstraZeneca v Dr Reddy, # 19 Exhibit 19 - Cytomedix v Little Rock Foot Clinic, # 20 Exhibit 20 - Nutrition 21 v General Nutrition Corp, # 21 Exhibit 21 Charles Lowenstein MD Declaration Exhibit List)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 08/29/2014)
2014-08-29
1
RESPONSE in Opposition re (75 in 2:13-cv-03438-RMG, 123 in 2:13-cv-02078-RMG) MOTION to Amend/Correct Invalidity Contentions Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 9/8/2014 (Attachments: # 1 Exhibit 1 - Ridker March 10, 2014 Subpoena Duces Tecum, # 2 Exhibit 2 - Garvish E-mail of March 26, 2014, # 3 Exhibit 3 - Garvish E-mail of April 14, 2014, # 4 Exhibit 4 - Garvish E-mail of April 18, 2014, # 5 Exhibit 5 - Garvish E-mail of June 5, 2014, # 6 Exhibit 6 - Plaintiffs Second Request for Production to Defendant (Nos. 96-205), # 7 Exhibit 7 - Defendants Confidential Document 1 (Redacted), # 8 Exhibit 8 - Defendants Confidential Document 2 (Redacted), # 9 Exhibit 9- Miller v. Transcend Services, # 10 Exhibit 10 - Atmel Corp v. Info Storage Devices, # 11 Exhibit 11 - Volumetrics v Toshiba, # 12 Exhibit 12 - Aptalis v Mylan, # 13 Exhibit 13 - Defendants Initial Disclosures, # 14 Exhibit 14 - Wonderland v Thorley, # 15 Exhibit 15 - NEJM Ridker Article - Inflammation, Aspirin & Risk, # 16 Exhibit 16 - Tyco v Applied, # 17 Exhibit 17 - Realtime Data v Packeteer, # 18 Exhibit 18 - LML Patent Corp v JPMorgan Chase, # 19 Exhibit 19 - Ring Indus Group v EZ Set Tank)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) Modified on 9/9/2014 to reference 136 Additional Attachments, Exh 7 and Exh 8, filed 9/9/2014(sshe, ). (Entered: 08/29/2014)
2014-08-29
1
CLAIM CONSTRUCTION BRIEF by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit 1 - '800 Patent)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) Modified on 9/2/2014 to reference ( 128 129 130 131 in 2:13-cv-02078-RMG, 80 81 82 83 in 2:13-cv-03438-RMG) Additional Attachments filed 8/29/2014(sshe, ). (sshe, ). (Entered: 08/29/2014)
2014-08-29
1
Consent MOTION to Seal Document (125 in 2:13-cv-02078-RMG) Response in Opposition to Motion,,,,, by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 9/15/2014. (Attachments: # 1 Exhibit 1 - Non-confidential Index of Documents to be Filed Under Seal, # 2 Exhibit 2 - Certificate of Compliance)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 08/29/2014)
2014-08-29
1
Additional Attachments to Main Document (78 in 2:13-cv-03438-RMG) Claim Construction Brief. First attachment description: Exhibit 2 - '219 Patent . (Attachments: # 1 Exhibit 3 - Pahan Article, # 2 Exhibit 4 - Lowenstein Declaration, # 3 Exhibit 5 - Prolifiq v. Veeva, # 4 Exhibit 6 - Solomon Deposition, # 5 Exhibit 7 - Lowenstein Deposition, # 6 Exhibit 8 - Preliminary Amendment (June 6, 2013))Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 08/29/2014)
2014-08-29
1
Additional Attachments to Main Document (78 in 2:13-cv-03438-RMG) Claim Construction Brief. First attachment description: Exhibit 9 - ATP II Guidelines (Part 1 of 2) . Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 08/29/2014)
2014-08-29
1
Additional Attachments to Main Document (78 in 2:13-cv-03438-RMG) Claim Construction Brief. First attachment description: Exhibit 9 - ATP II Guidelines (Part 2 of 2) . Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 08/29/2014)
2014-08-29
1
Additional Attachments to Main Document (78 in 2:13-cv-03438-RMG) Claim Construction Brief. First attachment description: Exhibit 10 - Rossouw Article . (Attachments: # 1 Exhibit 11 - Broussard v. Go-Devil, # 2 Exhibit 12 - Blum Article, # 3 Exhibit 13 - Pentikainen Article, # 4 Exhibit 14 - Preliminary Amendment (May 27, 2011), # 5 Exhibit 15 - Preliminary Amendment (Oct. 26, 2012), # 6 Exhibit 16 - Interview Summary, # 7 Exhibit 17 - Further Preliminary Amendment (June 17, 2013), # 8 Exhibit 18 - Garvish Letter dated Aug. 27, 2014, # 9 Exhibit 19 - Garvish Letter dated Aug. 14, 2014)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 08/29/2014)
2014-08-29
1
TEXT ORDER: Plaintiffs have moved for an Order permitting them to file two documents under seal because these documents have been designated by a party as "confidential." (Dkt. No. 127, 79). The Confidentiality Order in this case does not require that any document designated as "confidential" be filed under seal. Rather, Paragraph 7 of the Confidentiality Order specifically provides that the parties will consider less restrictive alternatives. (Dkt. No. 82, 41 at 6). Furthermore, a party's designation of a document as "confidential" does not inform the Court as to why sealing is necessary. Plaintiffs are directed to comply with Local Rule 5.03(A). Specifically, within seven (7) days of the date of this Order, Plaintiffs must file a memorandum that states the reasons why sealing is necessary and explains why less drastic alternatives to sealing will not afford adequate protection. AND IT IS SO ORDERED. Entered at the direction of the Honorable Richard M Gergel on 9/2/14. (ltap, )Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG. Refiled to spread to related case.(sshe, ) (Entered: 09/02/2014)
2014-09-02
1
ORDER granting AstraZeneca's (123) Motion in case 2:13-cv-02078-RMG; granting (75) Motion in case 2:13-cv-03438-RMG to Amend Invalidity Contentions. The Scheduling Order (Dkt. No. 83) is amended; see Order for details and dates. The Court will conduct a Claim Construction Hearing on 11/10/2014 at 10:00 AM. Signed by Honorable Richard M Gergel on 9/3/2014.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 09/03/2014)
2014-09-03
1
NOTICE of Hearing: Claim Construction Hearing set for 11/10/2014 10:00 AM in Charleston Courtroom To Be Determined, U. S. Court House, 81 Meeting St, Charleston before Honorable Richard M Gergel. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 09/03/2014)
2014-09-03
1
Withdrawal of Motions: (79 in 2:13-cv-03438-RMG, 127 in 2:13-cv-02078-RMG) Consent MOTION to Seal Document (125 in 2:13-cv-02078-RMG) Response in Opposition to Motion,,,,, filed by MUSC Foundation for Research Development, Charleston Medical Therapeutics Inc.. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 09/09/2014)
2014-09-09
1
Additional Attachments to Main Document (77 in 2:13-cv-03438-RMG, 125 in 2:13-cv-02078-RMG) Response in Opposition to Motion,,,,,. First attachment description: Notice of Filing of Additional Documents (to Replace ECF Nos. 125-7 & 125-8) . (Attachments: # 1 Exhibit 7 - Dr. Ridker Production Documents (BWHM00034726 - BWHM00034738), # 2 Exhibit 8 - Dr. Ridker Production Documents (BWHM00034739 - BWHM00034822))Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 09/09/2014)
2014-09-09
1
Letter from Marguerite S. Willis. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 09/16/2014)
2014-09-16
1
MOTION to Amend/Correct E-Discovery Order by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 10/3/2014. (Attachments: # 1 Exhibit A - Proposed Amended E-Discovery Order, # 2 Exhibit B - Fowler E-Mail of June 4, 2014, # 3 Exhibit C - Garvish E-Mail of June 16, 2014, # 4 Exhibit D - Garvish E-Mail of July 15, 2014, # 5 Exhibit E - Keatley Letter of August 25, 2014, # 6 Exhibit F - Hargrave E-Mail of September 11, 2014, # 7 Exhibit G - Fowler E-Mail of September 12, 2014, # 8 Exhibit H - Keatley E-Mail of August 7, 2014, # 9 Exhibit I - Redline of Proposed Amended E-Discovery Order)Proposed order is being emailed to chambers with copy to opposing counsel.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 09/16/2014)
2014-09-16
1
Joint MOTION for Extension of Time to Take the Deposition of Dr. Ridker and to File Opening Claim Construction Briefs by AstraZeneca Pharmaceuticals LP. Response to Motion due by 10/6/2014. Proposed order is being emailed to chambers with copy to opposing counsel.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 09/17/2014)
2014-09-17
1
ORDER granting (140) Motion for Extension of Time in case 2:13-cv-02078-RMG; granting (92) Motion for Extension of Time in case 2:13-cv-03438-RMG; Plaintiffs are allowed to take the deposition of Dr. Paul Ridker, the first deposition is extended from September 26, 2014 to October 2, 2014, and the second deposition of Dr. Paul Ridker shall be scheduled at a time that is convenient for both parties and the witness. In addition, the deadline for filing opening claim construction briefs is extended from October 3, 2014 to October 10, 2014. Signed by Honorable Richard M Gergel on 9/18/2014.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 09/18/2014)
2014-09-18
1
Emergency MOTION Regarding Plaintiffs' Failure to Comply with Local Civil Rule 30.04(H), DSC by AstraZeneca Pharmaceuticals LP. Response to Motion due by 10/20/2014. (Attachments: # 1 Exhibit Hoskins v. Snipes-King)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 10/01/2014)
2014-10-01
1
TEXT ORDER: Astrazeneca's Emergency Motion (Dkt. No. 142) is DENIED. While Plaintiffs' initial identification may have been too broad, the current identification of seven categories of documents fulfills the requirements of Local Civil Rule 30.04(H). AND IT IS SO ORDERED. Entered at the direction of the Honorable Richard M Gergel on 10/1/14.(ltap, ) (Entered: 10/01/2014)
2014-10-01
1
Consent MOTION for Extension of Time to File Response/Reply by AstraZeneca Pharmaceuticals LP. Response to Motion due by 10/20/2014. No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 10/03/2014)
2014-10-03
1
TEXT ORDER granting (144) Consent Motion for Extension of Time to File Response/Reply and (96) Consent Motion for Extension of Time to File Response/Reply. Response to Motion due by 10/6/2013. Entered at the direction of the Honorable Richard M Gergel on 10/3/14.Associated Cases: 2:13-cv-03438-RMG, 2:13-cv-02078-RMG(ltap, ) (Entered: 10/03/2014)
2014-10-03
1
MOTION for Trial Date Certain by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 10/23/2014. No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Rice, Joseph) (Entered: 10/06/2014)
2014-10-06
1
RESPONSE in Opposition re (91 in 2:13-cv-03438-RMG) MOTION to Amend/Correct E-Discovery Order Response filed by AstraZeneca Pharmaceuticals LP.Reply to Response to Motion due by 10/17/2014 (Attachments: # 1 Exhibit 1 - 3-26-2014 Garvish Email Attaching Proposed ESI Order, # 2 Exhibit 2 - 4-17-2014 Zapf Email Attaching Proposed ESI Order, # 3 Exhibit 3 - 4-29-2014 Baehr Email Attaching Proposed ESI Order, # 4 Exhibit 4 - 5-12-2014 Baehr Email, # 5 Exhibit 5 - 5-13-2014 Garvish Email, # 6 Exhibit 6 - 5-7-2014 Zapf Email Attaching Proposed ESI Order, # 7 Exhibit 7 - 5-16-2014 Garvish Email, # 8 Exhibit 8 - 5-23-2014 Zapf Email, # 9 Exhibit 9 - 5-23-2014 Baehr Email Attaching Proposed ESI Order, # 10 Exhibit 10 - 6-9-2014 Zapf Email, # 11 Exhibit 11 - 6-25-2014 Fowler Email, # 12 Exhibit 12 - Fed. Cir. E-Discovery Model Order)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 10/06/2014)
2014-10-06
1
REPLY to Response to Motion re (139 in 2:13-cv-02078-RMG, 91 in 2:13-cv-03438-RMG) MOTION to Amend/Correct E-Discovery Order Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. (Attachments: # 1 Exhibit A - Garvish E-mail of 09-25-14)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 10/09/2014)
2014-10-09
1
ORDER granting in part and denying in part Plaintiffs' (139) Motion to Amend/Correct in case 2:13-cv-02078-RMG; granting in part and denying in part (91) Motion to Amend/Correct in case 2:13-cv-03438-RMG Signed by Honorable Richard M Gergel on 10/9/2014.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 10/10/2014)
2014-10-09
1
REPLY by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development to (141 in 2:13-cv-02078-RMG) Order on Motion for Extension of Time,, . Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 10/10/2014)
2014-10-10
1
REPLY by AstraZeneca Pharmaceuticals LP to (93 in 2:13-cv-03438-RMG, 141 in 2:13-cv-02078-RMG) Order on Motion for Extension of Time,, . (Attachments: # 1 Exhibit 1 - Letter of Oct. 7, 2014)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 10/10/2014)
2014-10-10
1
MOTION to Withdraw as Attorney (Stacie L. Greskowiak) by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 11/3/2014. No proposed order.(Littlejohn, Joshua) (Entered: 10/17/2014)
2014-10-17
1
RESPONSE in Opposition re (98 in 2:13-cv-03438-RMG, 146 in 2:13-cv-02078-RMG) MOTION for Trial Date Certain Response filed by AstraZeneca Pharmaceuticals LP.Reply to Response to Motion due by 11/3/2014 Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 10/23/2014)
2014-10-23
1
TEXT ORDER granting 152 Motion of Stacie L. Greskowiak to Withdraw as Attorney. Entered at the Direction of Honorable Richard M Gergel on 10/23/2014.(sshe, ) (Entered: 10/23/2014)
2014-10-23
1
REPLY Responsive Claim Construction Brief by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development to (124 in 2:13-cv-02078-RMG, 76 in 2:13-cv-03438-RMG) Claim Construction Brief,,,,, (78 in 2:13-cv-03438-RMG, 126 in 2:13-cv-02078-RMG) Claim Construction Brief, . (Attachments: # 1 Exhibit A - USPTO Report of all elevated patents, # 2 Exhibit B - USPTO Report of AZ elevated patents, # 3 Exhibit C - 715 Patent, # 4 Exhibit D - Otter Prods Inc v Treefrog Devs Inc, # 5 Exhibit E - Alfa Leisure v King of the Road, # 6 Exhibit F - Formax Inc v Alkar RapidPak MP Equip, # 7 Exhibit G - Smith v Garlock Equip Co, # 8 Exhibit H - Interval Licensing LLC v AOL Inc, # 9 Exhibit I - Endo Pharms v Watson Labs, # 10 Exhibit J - Paul Ridker MD Deposition Excerpts, # 11 Exhibit K - Ridker Article - Rosuvastatin to Prevent Vascular Events, # 12 Exhibit L - 152 Patent, # 13 Exhibit M - 2013 AHA/ACC Guideline on the Treatment of Blood Cholesterol, # 14 Exhibit N - AstraZeneca AB v Dr Reddys Labs, # 15 Exhibit O - Nutrition 21 LLC v Gen Nutrition Corp, # 16 Exhibit P - BASF Agro BV v Cheminova Inc, # 17 Exhibit Q - Cytomedix v Little Rock Foot Clinic, # 18 Exhibit R - Broussard v Go-Devil Mfg Co of La, # 19 Exhibit S - Preliminary Amendment - 06-06-14, # 20 Exhibit T - j2 Global Commcns v Vitelity Commcns, # 21 Exhibit U - IpLearn LLC v Blackboard Inc, # 22 Exhibit V - S Snow Mfg v SnoWizard Holdings, # 23 Exhibit W - Silver State Intellectual Techs v Garmin Intl, # 24 Exhibit X - Ficep Corp v Voortman USA Corp)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) Modified docket text to add event specific description on 10/27/2014 (sshe, ). (Entered: 10/24/2014)
2014-10-24
1
Responsive CLAIM CONSTRUCTION BRIEF by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit Exhibit 20-St. Clair Intellectual Property Co. v. Cannon Inc., # 2 Exhibit Exhibit 21 - Amended Opening Expert Declaration of Solomon, # 3 Exhibit Exhibit 22 - Excerpts from Ridker Deposition, # 4 Exhibit Exhibit 23 - US7030152, # 5 Exhibit Exhibit 24 - US6147109, # 6 Exhibit Exhibit 25 - Everett et al, # 7 Exhibit Exhibit 26 - Excerpt from 2014 05 09 Plaintiffs' Disclosure of Asserted Claims, # 8 Exhibit Exhibit 27 - CV of Lawrence Solomon)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) Modified docket text to add event specific description on 10/27/2014 (sshe, ). (Entered: 10/24/2014)
2014-10-24
1
Minute Entry. Proceedings held before Honorable Richard M Gergel: Status Conference held on 11/10/2014. Court to issue a Claim Construction, and order parties to mediation. Court Reporter Debbie Potocki. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(erav, ) Modified on 11/13/2014 to reference 159, 160 Supplement(s), Claim Construction Hearing presentation(s), filed 11/11/2014(sshe, ). (Entered: 11/10/2014)
2014-11-10
1
SUPPLEMENT by AstraZeneca Pharmaceuticals LP Claim Construction Hearing PowerPoint Slides. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 11/11/2014)
2014-11-11
1
SUPPLEMENT by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development Plaintiffs' Claim Construction Presentation. (Attachments: # 1 Exhibit 1 - Background, # 2 Exhibit 2 - Elevated Terms, # 3 Exhibit 3 - Effective Amount Terms, # 4 Exhibit 4 - Administering Terms, # 5 Exhibit 5 - Preamble Terms, # 6 Exhibit 6 - Mediated Terms, # 7 Exhibit 7 - Indicator Terms)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 11/11/2014)
2014-11-11
1
Letter from John F. Garvish II on behalf of Plaintiffs. (Attachments: # 1 Exhibit 1 - J. Am. C. Cardiology Article, # 2 Exhibit 2 - J. Neuroimmunology Article, # 3 Exhibit 3 - Am. J. Tropical Med. & Hygiene Article, # 4 Exhibit 4 - J. Acquired Immune Deficiency Syndromes Article, # 5 Exhibit 5 - Schizophrenia Res. Article, # 6 Exhibit 6 - Clinical & Experimental Immunology Article, # 7 Exhibit 7 - Am. J. Respiratory & Critical Care Med. Article, # 8 Exhibit 8 - 122 Patent)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 11/13/2014)
2014-11-13
1
TEXT ORDER: Plaintiffs have filed a letter addressing two issues raised at the Claim Construction hearing held on November 10, 2014. (Dkt. No. 161, 110). If Defendants wish to file a response, they may do so by November 18, 2014. AND IT IS SO ORDERED. Entered at the direction of the Honorable Richard M Gergel on 11/14/14. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(ltap, ) (Entered: 11/14/2014)
2014-11-14
1
NOTICE OF FILING OF OFFICIAL TRANSCRIPT of Claim Construction hearing held on 11-10-14, before Judge Richard M. Gergel. Court Reporter/Transcriber Debra Potocki, Telephone number/E-mail 843-723-2208/potockidebra@bellsouth.net. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Parties have 7 calendar days from the filing of the transcript to file with the court a Notice of Intent to Request Redaction.. Redaction Request due 12/8/2014. Redacted Transcript Deadline set for 12/18/2014. Release of Transcript Restriction set for 2/17/2015. Associated Cases: 2:13-cv-03438-RMG, 2:13-cv-02078-RMG(dpotocki, ) (Entered: 11/17/2014)
2014-11-17
1
Letter from Marguerite Willis. (Attachments: # 1 Letter from Christopher Sipes, # 2 Exhibit A - Fortner v. Roper Saint Francis Hosp., # 3 Exhibit B - Mutcherson v. Care Core Nat., # 4 Exhibit C - Ridker Dep. Tr. 243-245, # 5 Exhibit D - Sekiyama, Circulating Proinflammatory Cytokines, # 6 Exhibit E - Lipscomb ยง 14.9 (Compositions may be patented for all uses.))Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 11/18/2014)
2014-11-18
1
CLAIM CONSTRUCTION ORDER Signed by Honorable Richard M Gergel on 11/25/2014. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 11/25/2014)
2014-11-25
1
AMENDED SCHEDULING ORDER Advice of Counsel Disclosure due by 12/23/2014, Close of Expert Discovery due by 4/17/2015, Expert Reports Due by 2/13/2015 (Rebuttal expert reports due by 3/16/2015, Replies due by 3/30/2015), Close of Fact Discovery due by 1/30/2015, Motion in Limine due by 4/30/2015, Motions due by 5/8/2015, Rule 26(a)(3) Disclosures due by 21 days prio to jury selection, Pretrial Briefs due by 5 business days prior to date set for jury selection, Case ready for Jury Selection and/or Trial Deadline on or after 7/6/2015 Signed by Honorable Richard M Gergel on 11/25/2014. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 11/25/2014)
2014-11-25
1
ORDER TO CONDUCT MEDIATION Mediation Due by 1/30/2015 Signed by Honorable Richard M Gergel on 11/25/2014. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 11/25/2014)
2014-11-25
1
NOTICE of Change of Address by Daniel C Leonardi Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 12/10/2014)
2014-12-10
1
MOTION to Compel Production of Documents by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 1/5/2015. (Attachments: # 1 Exhibit A - JUPITER Presentation, # 2 Exhibit B - April 27, 2010 Press Release, # 3 Exhibit C - Garvish Letter, # 4 Exhibit D - Keatley Letter, # 5 Exhibit E - Pls. Second Set of RFPs to Def., # 6 Exhibit F - White E-mail of July 25, 2013, # 7 Exhibit G - April 30, 2010 Presentation, # 8 Exhibit H - 2011 Crestor Presentation, # 9 Exhibit I - AstraZeneca Press Release, # 10 Exhibit J - Ridker New Eng. J. Med article, # 11 Exhibit K - Ridker Patent Application)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 12/11/2014)
2014-12-11
1
MOTION to Compel Production of Documents by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 1/5/2015. (Attachments: # 1 Exhibit A - JUPITER Presentation, # 2 Exhibit B - April 27, 2010 Press Release, # 3 Exhibit C - Garvish Letter, # 4 Exhibit D - Keatley Letter, # 5 Exhibit E - Pls. Second Set of RFPs to Def., # 6 Exhibit F - White E-mail of July 25, 2013, # 7 Exhibit G - April 30, 2010 Presentation, # 8 Exhibit H - 2011 Crestor Presentation, # 9 Exhibit I - AstraZeneca Press Release, # 10 Exhibit J - Ridker New Eng. J. Med article, # 11 Exhibit K - Ridker Patent Application)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 12/11/2014)
2014-12-11
2
MOTION to Compel Production of Documents by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 1/5/2015. (Attachments: # 1 Exhibit A - JUPITER Presentation, # 2 Exhibit B - April 27, 2010 Press Release, # 3 Exhibit C - Garvish Letter, # 4 Exhibit D - Keatley Letter, # 5 Exhibit E - Pls. Second Set of RFPs to Def., # 6 Exhibit F - White E-mail of July 25, 2013, # 7 Exhibit G - April 30, 2010 Presentation, # 8 Exhibit H - 2011 Crestor Presentation, # 9 Exhibit I - AstraZeneca Press Release, # 10 Exhibit J - Ridker New Eng. J. Med article, # 11 Exhibit K - Ridker Patent Application)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 12/11/2014)
2014-12-11
2
MOTION to Compel Production of Documents by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 1/5/2015. (Attachments: # 1 Exhibit A - JUPITER Presentation, # 2 Exhibit B - April 27, 2010 Press Release, # 3 Exhibit C - Garvish Letter, # 4 Exhibit D - Keatley Letter, # 5 Exhibit E - Pls. Second Set of RFPs to Def., # 6 Exhibit F - White E-mail of July 25, 2013, # 7 Exhibit G - April 30, 2010 Presentation, # 8 Exhibit H - 2011 Crestor Presentation, # 9 Exhibit I - AstraZeneca Press Release, # 10 Exhibit J - Ridker New Eng. J. Med article, # 11 Exhibit K - Ridker Patent Application)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 12/11/2014)
2014-12-11
2
MOTION to Compel Production of Documents by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 1/5/2015. (Attachments: # 1 Exhibit A - JUPITER Presentation, # 2 Exhibit B - April 27, 2010 Press Release, # 3 Exhibit C - Garvish Letter, # 4 Exhibit D - Keatley Letter, # 5 Exhibit E - Pls. Second Set of RFPs to Def., # 6 Exhibit F - White E-mail of July 25, 2013, # 7 Exhibit G - April 30, 2010 Presentation, # 8 Exhibit H - 2011 Crestor Presentation, # 9 Exhibit I - AstraZeneca Press Release, # 10 Exhibit J - Ridker New Eng. J. Med article, # 11 Exhibit K - Ridker Patent Application)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 12/11/2014)
2014-12-11
2
MOTION to Compel Production of Documents by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 1/5/2015. (Attachments: # 1 Exhibit A - JUPITER Presentation, # 2 Exhibit B - April 27, 2010 Press Release, # 3 Exhibit C - Garvish Letter, # 4 Exhibit D - Keatley Letter, # 5 Exhibit E - Pls. Second Set of RFPs to Def., # 6 Exhibit F - White E-mail of July 25, 2013, # 7 Exhibit G - April 30, 2010 Presentation, # 8 Exhibit H - 2011 Crestor Presentation, # 9 Exhibit I - AstraZeneca Press Release, # 10 Exhibit J - Ridker New Eng. J. Med article, # 11 Exhibit K - Ridker Patent Application)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 12/11/2014)
2014-12-11
2
MOTION to Compel Production of Documents by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 1/5/2015. (Attachments: # 1 Exhibit A - JUPITER Presentation, # 2 Exhibit B - April 27, 2010 Press Release, # 3 Exhibit C - Garvish Letter, # 4 Exhibit D - Keatley Letter, # 5 Exhibit E - Pls. Second Set of RFPs to Def., # 6 Exhibit F - White E-mail of July 25, 2013, # 7 Exhibit G - April 30, 2010 Presentation, # 8 Exhibit H - 2011 Crestor Presentation, # 9 Exhibit I - AstraZeneca Press Release, # 10 Exhibit J - Ridker New Eng. J. Med article, # 11 Exhibit K - Ridker Patent Application)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 12/11/2014)
2014-12-11
2
MOTION to Compel Production of Documents by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 1/5/2015. (Attachments: # 1 Exhibit A - JUPITER Presentation, # 2 Exhibit B - April 27, 2010 Press Release, # 3 Exhibit C - Garvish Letter, # 4 Exhibit D - Keatley Letter, # 5 Exhibit E - Pls. Second Set of RFPs to Def., # 6 Exhibit F - White E-mail of July 25, 2013, # 7 Exhibit G - April 30, 2010 Presentation, # 8 Exhibit H - 2011 Crestor Presentation, # 9 Exhibit I - AstraZeneca Press Release, # 10 Exhibit J - Ridker New Eng. J. Med article, # 11 Exhibit K - Ridker Patent Application)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 12/11/2014)
2014-12-11
2
MOTION to Compel Production of Documents by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 1/5/2015. (Attachments: # 1 Exhibit A - JUPITER Presentation, # 2 Exhibit B - April 27, 2010 Press Release, # 3 Exhibit C - Garvish Letter, # 4 Exhibit D - Keatley Letter, # 5 Exhibit E - Pls. Second Set of RFPs to Def., # 6 Exhibit F - White E-mail of July 25, 2013, # 7 Exhibit G - April 30, 2010 Presentation, # 8 Exhibit H - 2011 Crestor Presentation, # 9 Exhibit I - AstraZeneca Press Release, # 10 Exhibit J - Ridker New Eng. J. Med article, # 11 Exhibit K - Ridker Patent Application)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 12/11/2014)
2014-12-11
2
MOTION to Compel Production of Documents by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 1/5/2015. (Attachments: # 1 Exhibit A - JUPITER Presentation, # 2 Exhibit B - April 27, 2010 Press Release, # 3 Exhibit C - Garvish Letter, # 4 Exhibit D - Keatley Letter, # 5 Exhibit E - Pls. Second Set of RFPs to Def., # 6 Exhibit F - White E-mail of July 25, 2013, # 7 Exhibit G - April 30, 2010 Presentation, # 8 Exhibit H - 2011 Crestor Presentation, # 9 Exhibit I - AstraZeneca Press Release, # 10 Exhibit J - Ridker New Eng. J. Med article, # 11 Exhibit K - Ridker Patent Application)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 12/11/2014)
2014-12-11
2
MOTION to Compel Production of Documents by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 1/5/2015. (Attachments: # 1 Exhibit A - JUPITER Presentation, # 2 Exhibit B - April 27, 2010 Press Release, # 3 Exhibit C - Garvish Letter, # 4 Exhibit D - Keatley Letter, # 5 Exhibit E - Pls. Second Set of RFPs to Def., # 6 Exhibit F - White E-mail of July 25, 2013, # 7 Exhibit G - April 30, 2010 Presentation, # 8 Exhibit H - 2011 Crestor Presentation, # 9 Exhibit I - AstraZeneca Press Release, # 10 Exhibit J - Ridker New Eng. J. Med article, # 11 Exhibit K - Ridker Patent Application)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 12/11/2014)
2014-12-11
2
MOTION to Compel Production of Documents by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 1/5/2015. (Attachments: # 1 Exhibit A - JUPITER Presentation, # 2 Exhibit B - April 27, 2010 Press Release, # 3 Exhibit C - Garvish Letter, # 4 Exhibit D - Keatley Letter, # 5 Exhibit E - Pls. Second Set of RFPs to Def., # 6 Exhibit F - White E-mail of July 25, 2013, # 7 Exhibit G - April 30, 2010 Presentation, # 8 Exhibit H - 2011 Crestor Presentation, # 9 Exhibit I - AstraZeneca Press Release, # 10 Exhibit J - Ridker New Eng. J. Med article, # 11 Exhibit K - Ridker Patent Application)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 12/11/2014)
2014-12-11
2
Consent MOTION to Modify Mediation Order re (116 in 2:13-cv-03438-RMG, 167 in 2:13-cv-02078-RMG) Mediation Order by AstraZeneca Pharmaceuticals LP. Response to Motion due by 1/9/2015. No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 12/23/2014)
2014-12-23
1
TEXT ORDER: The consent motion to modify the Court's mediation order to allow Defendant's senior counsel, Eric Santoro, to attend the mediation and to allow Defendant's Chief Financial Officer, John McKenna, to participate by phone is granted. AND IT IS SO ORDERED. (170) Motion in case 2:13-cv-02078-RMG; (119) Motion in case 2:13-cv-03438-RMG. Entered at the direction of the Honorable Richard M Gergel on 12/29/14.(ltap, ) (Entered: 12/29/2014)
2014-12-29
1
RESPONSE in Opposition re (169 in 2:13-cv-02078-RMG, 118 in 2:13-cv-03438-RMG) MOTION to Compel Production of Documents Response filed by AstraZeneca Pharmaceuticals LP.Reply to Response to Motion due by 1/15/2015 (Attachments: # 1 Exhibit 1 - Seroquel Settlement Agreement, # 2 Exhibit 2 - 2014.08.12 S. Han Email, # 3 Exhibit 3 - 2014.09.25 Garvish Letter, # 4 Exhibit 4 - 2014.10.08 J. Fowler Email, # 5 Exhibit 5 - 2014.12.09 Garvish Email, # 6 Exhibit 6 - Corporate Integrity Agreement, # 7 Exhibit 7 - AZM00494927 (Cover Page), # 8 Exhibit 8 - AZM00494928 (Cover Page), # 9 Exhibit 9 - AZM00499269-73 (Cover Page), # 10 Exhibit 10 - AZM00521540 (Cover Page))Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) Modified on 1/6/2015 to reference Additional Attachments filed 1/5/2015 (173, 174 in 2:13-cv-02078-RMG, 122, 123 in 2:13-cv-03438-RMG)(sshe, )(sshe, ). (Entered: 01/05/2015)
2015-01-05
1
Additional Attachments to Main Document (121 in 2:13-cv-03438-RMG, 172 in 2:13-cv-02078-RMG) Response in Opposition to Motion,,,. First attachment description: Exhibit 11 - AZM00551663 . (Attachments: # 1 Exhibit 12 - 2014.10.08 Keatley Letter, # 2 Exhibit 13 - 2014.08.25 Keatley Letter, # 3 Exhibit 14 - AZM00624910-32 (Cover Page), # 4 Exhibit 15 - AZM00624991-5016 (Cover Page), # 5 Exhibit 16 - AZM00602573-83 (Cover Page), # 6 Exhibit 17 - AZM00603839-71 (Cover Page), # 7 Exhibit 18 - AZM 00604582 (Cover Page), # 8 Exhibit 19 - AZM00605062-9 (Cover Page), # 9 Exhibit 20 - AZM00617145-61 (Cover Page))Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 01/05/2015)
2015-01-05
1
Additional Attachments to Main Document (121 in 2:13-cv-03438-RMG, 172 in 2:13-cv-02078-RMG) Response in Opposition to Motion,,,. First attachment description: Exhibit 21 - AZM00619271-2 (Cover Page) . (Attachments: # 1 Exhibit 22 - AZM00619271-2 (Cover Page), # 2 Exhibit 23 - AZM00626668-91 (Cover Page), # 3 Exhibit 24 - AZM00626977-89 (Cover Page), # 4 Exhibit 25 - AZM00625751-5 (Cover Page), # 5 Exhibit 26 - US6316460, # 6 Exhibit 27 - USRE37314, # 7 Exhibit 28 - US6858618, # 8 Exhibit 29 - US7964614, # 9 Exhibit 30 - Pahan et al., J. Clin. Invest.)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 01/05/2015)
2015-01-05
1
MOTION to Compel Plaintiffs to Respond to AstraZeneca's Interrogatory No. 15 by AstraZeneca Pharmaceuticals LP. Response to Motion due by 1/26/2015. (Attachments: # 1 Exhibit 1 Scandinavian Simvastatin Survival Study, # 2 Exhibit 2 Shepherd et al., Prevention of Coronary Heart Disease, # 3 Exhibit 3 Nov. 10, 2014 Hearing Transcript, # 4 Exhibit 4 Cover Document to AZs Invalidity Contentions, # 5 Exhibit 5 Appendix O to AZs Invalidity Contentions, # 6 Exhibit 6 Table Reflecting Bates Nos. for Prior Art References, # 7 Exhibit 7 Int. No. 15 of Def.s Third Set of Interrogs., # 8 Exhibit 8 Aug. 18, 2014 Objs. and Resps. to Interrog. No. 15, # 9 Exhibit 9 Dec. 11, 2014 Letter from J. Fowler, # 10 Exhibit 10 Dec. 23, 2014 Email from J. Garvish, # 11 Exhibit 11 Jan. 9, 2015 Email from W. Zapf, # 12 Exhibit 12 Dec. 15, 2014 Email from J. Garvish, # 13 Exhibit 13 Dec. 16, 2014 Email from J. Fowler, # 14 Exhibit 14 Def.s Supp. Objs. and Resps. To Pl.s First Set of Interrogs., # 15 Exhibit 15 Sacks et al., The Effect of Pravastatin on Coronary Events, # 16 Exhibit 16 Furberg, et al., Effect of Lovastatin on Early Carotid Atherosclerosis)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) Modified on 1/12/2015 to add descriptions for exhibits(sshe, ). (Entered: 01/09/2015)
2015-01-09
1
RESPONSE in Support re (169 in 2:13-cv-02078-RMG, 118 in 2:13-cv-03438-RMG) MOTION to Compel Production of Documents Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. (Attachments: # 1 Exhibit A - Tr. of July 16, 2014 Mot. to Compel Hr'g)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 01/15/2015)
2015-01-15
1
Consent MOTION to Appear Pro Hac Vice by Meghan Elizabeth Monaghan ( Filing fee $ 250 receipt number 0420-5740151) by AstraZeneca Pharmaceuticals LP. Response to Motion due by 2/2/2015. (Attachments: # 1 Affidavit of Meghan Elizabeth Monaghan)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 01/16/2015)
2015-01-16
1
Consent MOTION to Appear Pro Hac Vice by Emily A. Keatley ( Filing fee $ 250 receipt number 0420-5742139) by AstraZeneca Pharmaceuticals LP. Response to Motion due by 2/6/2015. (Attachments: # 1 Affidavit /Application for Pro Hac Vice Admission)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 01/20/2015)
2015-01-20
1
Consent MOTION to Appear Pro Hac Vice by Michael Newton Kennedy ( Filing fee $ 250 receipt number 0420-5747947) by AstraZeneca Pharmaceuticals LP. Response to Motion due by 2/9/2015. (Attachments: # 1 Affidavit in Support of Pro Hac Vice Admission of Michael Newton Kennedy)Proposed order is being emailed to chambers with copy to opposing counsel.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 01/22/2015)
2015-01-22
1
ORDER granting (177) Motion to Appear Pro Hac Vice; granting (178) Motion to Appear Pro Hac Vice; granting (179) Motion to Appear Pro Hac Vice in case 2:13-cv-02078-RMG; granting (126) Motion to Appear Pro Hac Vice; granting (127) Motion to Appear Pro Hac Vice; granting (128) Motion to Appear Pro Hac Vice in case 2:13-cv-03438-RMG; granting Meghan Elizabeth Monaghan, Emily Ayliffe Keatley, Michael Newton Kennedy to appear Pro Hac Vice for AstraZeneca Pharmacueticals LP Signed by Honorable Richard M Gergel on 1/23/2015.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 01/26/2015)
2015-01-26
1
RESPONSE in Opposition re (124 in 2:13-cv-03438-RMG, 175 in 2:13-cv-02078-RMG) MOTION to Compel Plaintiffs to Respond to AstraZeneca's Interrogatory No. 15 Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 2/5/2015 (Attachments: # 1 Exhibit A - Defs Interrog. No. 15, # 2 Exhibit B - Pls Response, # 3 Exhibit C - Defs Invalidity Contentions, # 4 Exhibit D - App. A to Defs Invalidity Contentions, # 5 Exhibit E - App. O to Defs Invalidity Contentions, # 6 Exhibit F - Garvish E-mail of June 3, 2014, # 7 Exhibit G - Garvish E-mail of Dec. 23, 2014, # 8 Exhibit H - Zapf E-mail of Jan. 9, 2015, # 9 Exhibit I - Pls 1st Interrogs., # 10 Exhibit J - Realtime Data v Packeteer)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 01/26/2015)
2015-01-26
1
MOTION to Appear Pro Hac Vice by Matthew B. Rappaport ( Filing fee $ 250 receipt number 0420-5755172) by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 2/17/2015. (Attachments: # 1 Affidavit Application/Affidavit for Pro Hac Vice Admission, # 2 Exhibit Certificate of Good Standing)Proposed order is being emailed to chambers with copy to opposing counsel.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 01/28/2015)
2015-01-28
1
Consent MOTION to Appear Pro Hac Vice by Jeremy Douglas Cobb ( Filing fee $ 250 receipt number 0420-5757493) by AstraZeneca Pharmaceuticals LP. Response to Motion due by 2/17/2015. (Attachments: # 1 Affidavit in Support of Motion for Admission Pro Hac Vice (including Certificate of Good Standing))Proposed order is being emailed to chambers with copy to opposing counsel.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 01/28/2015)
2015-01-28
1
MOTION to Appear Pro Hac Vice by Geoffrey L. Smith ( Filing fee $ 250 receipt number 0420-5762096) by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 2/17/2015. (Attachments: # 1 Affidavit Application/Affidavit for Pro Hac Vice Admission, # 2 Exhibit Certificate of Good Standing)Proposed order is being emailed to chambers with copy to opposing counsel.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 01/30/2015)
2015-01-30
1
MOTION for Extension of Time to Complete Discovery by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 2/17/2015. No proposed order.Associated Cases: 2:13-cv-03438-RMG, 2:13-cv-02078-RMG(Littlejohn, Joshua) (Entered: 01/30/2015)
2015-01-30
1
ORDER granting (183) Motion in case 2:13-cv-02078-RMG; granting (132) Motion in case 2:13-cv-03438-RMG for Jeremy Douglas Cobb to Appear Pro Hac Vice for AstraZeneca Pharmaceuticals LP Signed by Honorable Richard M Gergel on 2/2/2015.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 02/02/2015)
2015-02-02
1
RESPONSE in Support re (169 in 2:13-cv-02078-RMG, 118 in 2:13-cv-03438-RMG) MOTION to Compel Production of Documents Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. (Attachments: # 1 Exhibit A - Foote Complaint, # 2 Exhibit B - DeSouza Complaint, # 3 Exhibit C - Matesich Complaint, # 4 Exhibit D - Savarese Complaint, # 5 Exhibit E - McDonough Complaint)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 02/02/2015)
2015-02-02
1
ORDER granting (185) Motion for Extension of Time to Complete Discovery in case 2:13-cv-02078-RMG; granting (134) Motion for Extension of Time to Complete Discovery in case 2:13-cv-03438-RMG. Fact discovery is hereby extended for an additional thirteen days, or until February 12, 2015, for the purpose of completing written discovery, document productions, and the depositions of Mr. Blasetto, Ms. Varma, and the University of Wisconsin. Signed by Honorable Richard M Gergel on 2/3/2015.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 02/03/2015)
2015-02-03
1
ORDER granting (182) Motion, granting (184) Motion in case 2:13-cv-02078-RMG; granting (131) Motion, granting (133) Motion in case 2:13-cv-03438-RMG for Matthew B. Rappaport and Geoffrey L Smith to Appear Pro Hac Vice for Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development Signed by Honorable Richard M Gergel on 2/4/2015.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 02/04/2015)
2015-02-04
1
DECLARATION by AstraZeneca Pharmaceuticals LPre(169 in 2:13-cv-02078-RMG, 118 in 2:13-cv-03438-RMG) MOTION to Compel Production of Documents, (187 in 2:13-cv-02078-RMG) Response in Support of Motion,, Notice of Intent to File a Reply to Plaintiffs' Notice of Supplemental Material in Furtherance of Their Motion to Compel. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 02/04/2015)
2015-02-04
1
RESPONSE in Opposition re (169 in 2:13-cv-02078-RMG, 118 in 2:13-cv-03438-RMG) MOTION to Compel Production of Documents Defendant AstraZeneca's Opposition to Plaintiffs' "Notice of Supplemental Material in Furtherance of Their Motion to Compel" Response filed by AstraZeneca Pharmaceuticals LP.Reply to Response to Motion due by 2/17/2015 (Attachments: # 1 Exhibit 1 - Garvish Letter re JUPITER Lawsuits (Jan. 30, 2015), # 2 Exhibit 2 - Littlejohn Email (Jan. 30, 2015), # 3 Exhibit 3 - DeSouza 30(b)(1) Deposition Notice, # 4 Exhibit 4 - DeSouza v. AstraZeneca, # 5 Exhibit 5 - Layne Foote 30(b)(1) Deposition Notice)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) Modified on 2/5/2015 to reference 192 and 193 Additional Attachments filed 2/4/2015(sshe, ). Modified text on 2/5/2015 (sshe, ). (Entered: 02/04/2015)
2015-02-04
1
Additional Attachments to Main Document (191 in 2:13-cv-02078-RMG, 140 in 2:13-cv-03438-RMG) Response in Opposition to Motion,,. First attachment description: Exhibit 6 - Layne Foote v. AstraZeneca . (Attachments: # 1 Exhibit 7 - Fowler Email (Feb. 2, 2015), # 2 Exhibit 8 - Matesich Unsealing Order, # 3 Exhibit 9 - DeSouza Unsealing Order, # 4 Exhibit 10 - Foote Unsealing Order, # 5 Exhibit 11 - Savarese Unsealing Order, # 6 Exhibit 12 - McDonough Dismissal, # 7 Exhibit 13 - McDonoushg Docket Sheet, # 8 Exhibit 14 - DeSouza Decline to Intervene, # 9 Exhibit 15 - Foote Decline to Intervene, # 10 Exhibit 16 - Matesich Decline to Intervene, # 11 Exhibit 17 - Saverese Decline to Intervene, # 12 Exhibit 18 - Matesich Docket Sheet)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 02/04/2015)
2015-02-04
1
Additional Attachments to Main Document (191 in 2:13-cv-02078-RMG, 140 in 2:13-cv-03438-RMG) Response in Opposition to Motion,,. First attachment description: Exhibit 18 - Matesich Docket Sheet . (Attachments: # 1 Exhibit 19 - Matesich Joint Stip. for Dis., # 2 Exhibit 20 - Savarese Status Report, # 3 Exhibit 21 - DeSouza Dismissal, # 4 Exhibit 22 - AZM00499269, # 5 Exhibit 23 - AZM00614683, # 6 Exhibit 24 - AZM00614128, # 7 Exhibit 25 - AZM00498986, # 8 Exhibit 26 - Plaintiffs' Objs. and Resps. to AZ's 2nd Set of RFP (Mar. 3, 2014), # 9 Exhibit 27 - AZ's Objs. and Resps. to Plaintiffs' 2nd Set of RFP (July 14,2014))Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 02/04/2015)
2015-02-04
1
REPLY to Response to Motion re (124 in 2:13-cv-03438-RMG, 175 in 2:13-cv-02078-RMG) MOTION to Compel Plaintiffs to Respond to AstraZeneca's Interrogatory No. 15 Response filed by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit 17 - AstraZeneca's Fourth Set of Interrogatories, # 2 Exhibit 18 - Singh Deposition)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 02/05/2015)
2015-02-05
1
MOTION to Compel Plaintiffs to Produce Unredacted Documents (Redacted Version) by AstraZeneca Pharmaceuticals LP. Response to Motion due by 2/23/2015. (Attachments: # 1 Exhibit A - Redacted Documents, # 2 Exhibit B - Correspondence of Jan. 25, 2015, # 3 Exhibit C - Correspondence of Jan. 27, 2015, # 4 Exhibit D - Brostoff Dep. (Jan. 28, 2015))No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 02/06/2015)
2015-02-06
1
TEXT ORDER re (195 in 2:13-cv-02078-RMG) MOTION to Compel. The time to file a Response to Motion is shortened to 2/20/2015. AND IT IS SO ORDERED. Entered at the direction of the Honorable Richard M Gergel on 2/9/15. Associated Cases: 2:13-cv-03438-RMG, 2:13-cv-02078-RMG(ltap, ) (Entered: 02/09/2015)
2015-02-09
1
RESPONSE in Support re (169 in 2:13-cv-02078-RMG, 118 in 2:13-cv-03438-RMG) MOTION to Compel Production of Documents Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. (Attachments: # 1 Exhibit A - Def.s Objections to Pls. 30(b)(6) Dep., # 2 Exhibit B - Keatley E-mail)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 02/09/2015)
2015-02-09
1
PLAINTIFF'S ID OF EXPERT WITNESSES by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 02/17/2015)
2015-02-17
1
DEFENDANT'S ID OF EXPERT WITNESSES by AstraZeneca Pharmaceuticals LP.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 02/17/2015)
2015-02-17
1
Letter from Joshua C. Littlejohn. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 02/18/2015)
2015-02-18
1
Letter from Daniel C. Leonardi. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 02/18/2015)
2015-02-18
1
RESPONSE in Opposition re (195 in 2:13-cv-02078-RMG, 144 in 2:13-cv-03438-RMG) MOTION to Compel Plaintiffs to Produce Unredacted Documents (Redacted Version) Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 3/2/2015 (Attachments: # 1 Exhibit A - E-mail of 12-15-04, # 2 Exhibit B - E-mail of 12-21-04, # 3 Exhibit C - Brostoff Consulting Agreement, # 4 Exhibit D - Addendum to Brostoff Consulting Agreement, # 5 Exhibit E - Sexton Article, # 6 Exhibit F - MLC Auto v Town of S. Pines, # 7 Exhibit G - DE Techs. v Dell, # 8 Exhibit H - Johnson v Sea-Land Serv, # 9 Exhibit I - Weeks v Samsung Heavy Indus)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 02/20/2015)
2015-02-20
1
MOTION to Strike Portions of Defendants Invalidity Reports by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 3/9/2015. (Attachments: # 1 Memo in Support, # 2 Exhibit A - Defs Invalidity Contentions, # 3 Exhibit B - Garvish E-mail, # 4 Exhibit C - Harrison Report, # 5 Exhibit D - Raymond Report, # 6 Exhibit E - Creagri v Pinnaclife, # 7 Exhibit F - Atmel Corp v Info Storage Devices, # 8 Exhibit G - Fujitsu Ltd v Tellabs Operations, # 9 Exhibit H - Acer v Tech Props Ltd, # 10 Exhibit I - Realtime Data v Packeteer (Aug 2009), # 11 Exhibit J - Brilliant Instruments v Guidetech, # 12 Exhibit K - Asus Computer Intl v Round Rock Research, # 13 Exhibit L - Verinata Health v Sequenom, # 14 Exhibit M - Visto Corp v Seven Networks, # 15 Exhibit N - Life Techs v Biosearch Techs, # 16 Exhibit O - Largan Precision v Genius Elec Optical, # 17 Exhibit P - Anascape v Microsoft Corp, # 18 Exhibit Q - JDS Therapeutics v Pfizer, # 19 Exhibit R - Pactiv Corp v Multisorb Techs, # 20 Exhibit S - Merck Sharp & Dohme v Sandoz, # 21 Exhibit T - LML Patent v JPMorgan Chase, # 22 Exhibit U - Ex C to Def's Invalidity Contentions, # 23 Exhibit V - Realtime Data v Packeteer (Dec 2009), # 24 Exhibit W - Mediatek v Freescale Semiconductor)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 02/20/2015)
2015-02-20
1
REPLY to Response to Motion re (195 in 2:13-cv-02078-RMG, 144 in 2:13-cv-03438-RMG) MOTION to Compel Plaintiffs to Produce Unredacted Documents (Redacted Version) (Redacted Version of Reply) Response filed by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit A - Brostoff Deposition, # 2 Exhibit B - Intellect Wireless v. HTC Corp.)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 02/25/2015)
2015-02-25
1
ORDER granting in part and denying in part both Plaintiffs' Motion to Compel (169) in case 2:13-cv-02078-RMG, (118) in case 2:13-cv-03438-RMG; and Plaintiffs' request to reopen discovery for particular discovery requests (187) in case 2:13-cv-02078-RMG, (136) in case 2:13-cv-03438-RMG. The Scheduling Order is also amended; see Order for specific details. Close of Fact Discovery: 4/6/2015; Expert Reports: 4/17/2015 amended expert reports, 5/15/2015 rebuttal expert reports, 5/29/2015 replies; Close of Expert Discovery: 6/17/2015; Motions in Limine: 7/1/2015; Dispositive Motions: 7/10/2015; Pretrial Disclosures: due 21 days prior to jury selection; Pretrial Briefs: due 5 business days prior to date set for jury selection; Case ready for Jury Selection and/or Trial on or after 9/1/2015. Signed by Honorable Richard M Gergel on 3/4/2015.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 03/04/2015)
2015-03-04
1
ORDER CONDITIONALLY GRANTING Defendant's Motion to Compel (175) in case 2:13-cv-02078-RMG, (124) in case 2:13-cv-03438-RMG Signed by Honorable Richard M Gergel on 3/5/2015.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 03/05/2015)
2015-03-05
1
TEXT ORDER: Defendant has moved to compel redacted documents that Plaintiff MUSC Foundation for Research claims are privileged. (Dkt. No. 195). In its response, Plaintiff claims that the handwritten notes at issue memorialize a meeting between Dr. Brostoff and Plaintiff's in-house counsel but provides no evidence to support the claim. Plaintiff states that such evidence exists but is privileged and that it is "willing to provide these documents in camera for review at the Court's discretion." (Dkt. No. 202 at 7). IT IS ORDERED THAT Plaintiff MUSC Foundation for Research provide these documents in camera for the Court's review within five (5) days of the date of this order. AND IT IS SO ORDERED. Entered at the direction of the Honorable Richard M Gergel on 3/9/15. (ltap, ) (Entered: 03/09/2015)
2015-03-09
1
RESPONSE in Opposition re (203 in 2:13-cv-02078-RMG, 152 in 2:13-cv-03438-RMG) MOTION to Strike Portions of Defendants Invalidity Reports and AstraZeneca's MOTION to Strike Portions of Plaintiffs' Expert Reports Response filed by AstraZeneca Pharmaceuticals LP.Reply to Response to Motion due by 3/19/2015 (Attachments: # 1 Exhibit 1 - MUSC First Supp. Resp. to 4th Interrogatories, # 2 Exhibit 2 - MSUC Resp. to AZ's First Req. for Admission, # 3 Exhibit 3 - AZ's Invalidity Contentions, # 4 Exhibit 4 - Appendix O, # 5 Exhibit 5 - Dr. Harrison's Expert Report)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) Modified on 3/10/2015 to reference 209 210 211 212 213 Additional Attachments filed 3/9/2015(sshe, ). Modified on 3/20/2015 to edit docket text for clarification, as to RESPONSE to MOTION and MOTION, to reference (224 in 2:13-cv-02078-RMG, 171 in 2:13-cv-03438-RMG) (sshe, ). (Entered: 03/09/2015)
2015-03-09
1
Additional Attachments to Main Document (208 in 2:13-cv-02078-RMG, 156 in 2:13-cv-03438-RMG) Response in Opposition to Motion,,. First attachment description: Exhibit 6 - Appendix D . (Attachments: # 1 Exhibit 7 - Genain)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 03/09/2015)
2015-03-09
1
Additional Attachments to Main Document (208 in 2:13-cv-02078-RMG, 156 in 2:13-cv-03438-RMG) Response in Opposition to Motion,,. First attachment description: 8 - Sommer . (Attachments: # 1 Exhibit 9 - AZ's Report on ALD and Statins, # 2 Exhibit 10 - Hossein Ardehali's Expert Report (Placeholder), # 3 Exhibit 11 - Plaintiffs' Prelim. Infringement Contentions)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 03/09/2015)
2015-03-09
1
Additional Attachments to Main Document (208 in 2:13-cv-02078-RMG, 156 in 2:13-cv-03438-RMG) Response in Opposition to Motion,,. First attachment description: Exhibit 12 - Crestor Label . (Attachments: # 1 Exhibit 13 - Wecker Report, # 2 Exhibit 14 - MUSC 1st Supp. Resp. to AZ's 2nd Interrogs., # 3 Exhibit 15 - Sullivan Report (Placeholder))Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 03/09/2015)
2015-03-09
1
Additional Attachments to Main Document (208 in 2:13-cv-02078-RMG, 156 in 2:13-cv-03438-RMG) Response in Opposition to Motion,,. First attachment description: Exhibit 16 - Appendix C . (Attachments: # 1 Exhibit 17 - Lancet, (4S) Article, # 2 Exhibit 18 - 0,642,341 Patent)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 03/09/2015)
2015-03-09
1
Additional Attachments to Main Document (208 in 2:13-cv-02078-RMG, 156 in 2:13-cv-03438-RMG) Response in Opposition to Motion,,. First attachment description: Exhibit 19 - Journal of Leukocite Biology, Terkeltaub Article . (Attachments: # 1 Exhibit 20 - Nephrology, Guijarro Article, # 2 Exhibit 21 - Contributions to Nephrology)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 03/09/2015)
2015-03-09
1
Emergency MOTION to Take Deposition from qui tam relators by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 3/30/2015. (Attachments: # 1 Exhibit A - Pls 3rd RFP to Def, # 2 Exhibit B (pt 1) - Pls 2nd 30(b)(6) Depo Notice to Def, # 3 Exhibit B (pt 2) - Pls 2nd 30(b)(6) Depo Notice to Def, # 4 Exhibit C - DeSouza Subpoena duces tecum, # 5 Exhibit D - Foote Subpoena duces tecum, # 6 Exhibit E - Lorden Subpoena duces tecum, # 7 Exhibit F - Matesich Subpoena duces tecum, # 8 Exhibit G - McDonough Subpoena duces tecum, # 9 Exhibit H - Savarese Subpoena duces tecum, # 10 Exhibit I - Fowler Letter, # 11 Exhibit J - Baehr E-mail, # 12 Exhibit K - DeSouza Am Subpoena ad testificandum, # 13 Exhibit L - Foote Am Subpoena ad testificandum, # 14 Exhibit M - Lorden Am Subpoena ad testificandum, # 15 Exhibit N - McDonough Am Subpoena ad testificandum)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 03/12/2015)
2015-03-12
1
Letter from Marguerite S. Willis. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Main Document 215 replaced on 3/12/2015) (sshe, ). Modified on 3/12/2015 to replace with corrected document as requested and provided by filing user(sshe, ). (Entered: 03/12/2015)
2015-03-12
1
Letter from Marguerite S. Willis. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 03/12/2015)
2015-03-12
1
TEXT ORDER: The Court ordered Plaintiff to provide the Court with documents in camera that Plaintiff claims are privileged. (Dkt. No. 207). AstraZeneca seeks clarification as to whether Plaintiff must provide copies of these documents to AstraZeneca. (Dkt. No. 215). Because Plaintiff claims these documents are privileged, Plaintiff need not provide copies to AstraZeneca. However, Plaintiff must provide AstraZeneca with a privilege log for these documents. AND IT IS SO ORDERED. Entered at the direction of the Honorable Richard M Gergel on 3/12/15. (ltap, ) (Entered: 03/12/2015)
2015-03-12
1
TEXT ORDER: The time to file a Response to 214 Emergency Motion to Take Deposition is shortened to 12:00 noon on 3/16/2015. AND IT IS SO ORDERED. Entered at the direction of the Honorable Richard M Gergel on 3/12/15. (ltap, ) (Entered: 03/12/2015)
2015-03-12
1
TEXT ORDER: Plaintiffs' Motion for Trial Date Certain (Dkt. No. 146) is DENIED WITHOUT PREJUDICE. The Court will hold a bar meeting in early August after which it will set trial dates for its September-October term. AND IT IS SO ORDERED. Entered at the direction of the Honorable Richard M Gergel on 3/16/15.(ltap, ) (Entered: 03/16/2015)
2015-03-16
1
RESPONSE in Opposition re (214 in 2:13-cv-02078-RMG, 162 in 2:13-cv-03438-RMG) Emergency MOTION to Take Deposition from qui tam relators Response filed by AstraZeneca Pharmaceuticals LP.Reply to Response to Motion due by 3/26/2015 (Attachments: # 1 Exhibit A - J. Fowler to J. Garvish re Depositions (3.10.2015), # 2 Exhibit B - Plaintiff's 2nd Rule 30(b)(6) Dep. Notice, # 3 Exhibit C - 2013 AZ Annual Report, # 4 Exhibit D - 2012 AZ Annual Report, # 5 Exhibit E - 2011 AZ Annual Report)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 03/16/2015)
2015-03-16
1
REPLY to Response to Motion re (214 in 2:13-cv-02078-RMG, 162 in 2:13-cv-03438-RMG) Emergency MOTION to Take Deposition from qui tam relators Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 03/16/2015)
2015-03-16
1
ORDER granting in part and denying in part (195) Motion to Compel in case 2:13-cv-02078-RMG, (144) Motion to Compel in case 2:13-cv-03438-RMG. Plaintiff FRD must produce non-redacted copies of the emails at issue within seven (7) days of the date of this Order. Defendant's motion is otherwise denied. Signed by Honorable Richard M Gergel on 3/17/2015.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 03/17/2015)
2015-03-17
1
ORDER granting in part (214) Motion to Take Deposition from Relator in case 2:13-cv-02078-RMG, (162) Motion to Take Deposition from Relator in case 2:13-cv-03438-RMG. Plaintiffs may take the additional depositions requested but only by oral examination. Signed by Honorable Richard M Gergel on 3/17/2015.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 03/17/2015)
2015-03-17
1
REPLY to RESPONSE to Motion re (203 in 2:13-cv-02078-RMG, 152 in 2:13-cv-03438-RMG) MOTION to Strike Portions of Defendants Invalidity Reports and RESPONSE re (208 in 2:13-cv-02078-RMG, 156 in 2:13-cv-03438-RMG) AstraZeneca's MOTION to Strike Portions of Plaintiffs' Expert Reports Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion (AstraZeneca's Motion to Strike Portions of Plaintiffs' Expert Reports) due by 3/30/2015 (Attachments: # 1 Exhibit A - Defs Objections & Resps to Pls 3rd Interrogs, # 2 Exhibit B - Apple Inc v Samsung Elecs, # 3 Exhibit C - MediaTek v Freescale Semiconductor, # 4 Exhibit D - Asus Computer Intl v Round Rock Research, # 5 Exhibit E - Merck Sharp & Dohme v Sandoz, # 6 Exhibit F - Verinata Health v Sequenom, # 7 Exhibit G - Acer v Tech Props Ltd, # 8 Exhibit H - Life Techs v Biosearch Techs, # 9 Exhibit I - Brilliant Instruments v Guidetech, # 10 Exhibit J - Visto Corp v Seven Networks, # 11 Exhibit K - Largan Precision v Genius Elec Optical, # 12 Exhibit L - JDS Therapeutics v Pfizer, # 13 Exhibit M - Avago Techs v Elan Microelectronics, # 14 Exhibit N - LML Patent v JPMorgan Chase, # 15 Exhibit O - Realtime Data v Packeteer, # 16 Exhibit P - Intelligent Verification v Microsoft, # 17 Exhibit Q - Ortho-McNeil-Janssen Pharms v Watson Labs, # 18 Exhibit R - E-mails on 03-09-15, # 19 Exhibit S - Dotson v Avon Prods, # 20 Exhibit T - Belue v Aegon USA, # 21 Exhibit U - Ambu v Kohlbrat & Bunz, # 22 Exhibit V - MUSC_PX_00016286-87, # 23 Exhibit W - Pls Infringement Contentions, # 24 Exhibit X - Wecker Expert Report, # 25 Exhibit Y - MUSC_PX_00014906, # 26 Exhibit Z - AZM00499269-73)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) Modified on 3/20/2015 to edit docket text for clarification, as to correct event REPLY to RESPONSE/RESPONSE to MOTION, to add Reply to Response due deadline (sshe, ). (Entered: 03/19/2015)
2015-03-19
1
Letter from Marguerite S. Willis. (Attachments: # 1 Exhibit State of Texas' Limited Statement of Interest)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 03/26/2015)
2015-03-26
1
Letter from Marguerite S. Willis. (Attachments: # 1 Exhibit Kentucky Order re Motion to Quash)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 03/26/2015)
2015-03-26
1
Letter from Joshua C. Littlejohn. (Attachments: # 1 Exhibit FL Order, # 2 Exhibit DeSouza Motion to Quash, # 3 Exhibit Opposition to Motion to Quash, # 4 Exhibit Notice of Hearing, # 5 Exhibit Court Order, # 6 Exhibit DeSouza Second Motion to Quash, # 7 Exhibit Opposition to Second Motion to Quash, # 8 Exhibit TX Limited Statement of Interest, # 9 Certificate of Service)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 03/27/2015)
2015-03-27
1
ORDER DENYING Rose Marie De Souza's motions to quash her deposition subpoenas, filed by MUSC Foundation for Research Development, Charleston Medical Therapeutics Inc (227-2, 227-6 in 2:13-cv-02078-RMG; 175-2, 175-6 in 2:13-cv-03438-RMG). The Court MODIFIES the subpoenas. Further details set forth in Order. The parties to this action are to serve this Order on counsel for Ms. De Souza. Signed by Honorable Richard M Gergel on 3/27/2015. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 03/30/2015)
2015-03-27
1
REPLY to Response to Motion re (156 in 2:13-cv-03438-RMG, 208 in 2:13-cv-02078-RMG) AstraZeneca's MOTION to Strike Portions of Plaintiffs' Expert Reports Response filed by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit Letter from Garvish to Sipes, # 2 Exhibit Singh Testimony)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) Modified on 3/31/2015 to edit docket text for clarification, as to Reply to Response to Motion, to link/reference correct event entry(sshe, ). (Entered: 03/30/2015)
2015-03-30
1
Letter from Joshua C. Littlejohn. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Main Document 230 replaced on 4/7/2015) (sshe, ). Modified on 4/7/2015 to replace with corrected dated document as requested and provided by filing user(sshe, ). (Entered: 04/06/2015)
2015-04-06
1
TEXT ORDER Counsel's request for extension (Dkt. No. 230 ) is GRANTED. De Souza may supply subpoenaed documents on or before April 17, 2015. AND IT IS SO ORDERED. Entered at the Direction of Honorable Richard M Gergel on 4/6/2015. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 04/07/2015)
2015-04-07
1
ORDER granting in part and denying in part Plaintiffs' Motion to Strike Portions of Defendant's Expert Reports (Dkt. No. 203 in case 2:13-cv-02078-RMG, Dkt. No. 152 in case 2:13-cv-03438-RMG). The Court STRIKES the portions of Dr. Harrison's report that rely on the Sommer and Genain references as prior art. Plaintiffs' motion is otherwise DENIED. Defendant's Counter Motion to Strike Portions of Plaintiffs' Expert Reports is DENIED (Dkt. No. 208 in 2:13-cv-02078-RMG, 156 in 2:13-cv-03438-RMG). Signed by Honorable Richard M Gergel on 4/16/2015.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 04/16/2015)
2015-04-16
1
Letter from Daniel C. Leonardi and Joshua C. Littlejohn. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 06/16/2015)
2015-06-16
1
Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker by AstraZeneca Pharmaceuticals LP. Response to Motion due by 7/9/2015. (Attachments: # 1 Memo in Support, # 2 Exhibit 1 - Dr. Wecker's Expert Report, # 3 Exhibit 2 - Dr. Goodstein's Expert Report, # 4 Exhibit 3 - Dr. Steckel's Expert Report (Placeholder), # 5 Exhibit 4 - Dr. Foster's Expert Report, # 6 Exhibit 5 - Dr. Wecker's Reply Expert Report (Placeholder))No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 06/19/2015)
2015-06-19
1
Letter from John F. Garvish II on behalf of Plaintiffs. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 06/22/2015)
2015-06-22
1
TEXT ORDER: The time to respond to the Emergency Motion to Strike Dkt. #234 in 2:13-cv-2078 and Dkt. #182 in 2:13-cv-3438 is shortened to 6/26/2015. Replies are due by 6/30/2015. AND IT IS SO ORDERED. Entered at the direction of the Honorable Richard M Gergel on 6/22/15. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(ltap, ) Modified to edit text for correct case # on 6/23/2015 (sshe, ). (Entered: 06/22/2015)
2015-06-22
1
TEXT ORDER: The Court amends the Scheduling Order as follows: all dispositive motions and Daubert motions must be filed on or before July 10, 2015, with responses due within 20 days of the date that the motion is filed and any replies due within 10 days of the date a response if filed. Motions in limine must be filed at least fifteen (15) business days prior to jury selection. All other deadlines in the Court's March 4, 2015 Order remain in effect. AND IT IS SO ORDERED. Entered at the direction of the Honorable Richard M Gergel on 6/22/15. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(ltap, ) (Entered: 06/22/2015)
2015-06-22
1
RESPONSE in Opposition re (182 in 2:13-cv-03438-RMG, 234 in 2:13-cv-02078-RMG) Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 7/9/2015 (Attachments: # 1 Exhibit A - Stamm Reply Report, # 2 Exhibit B - Harrison Reply Report, # 3 Exhibit C - Harrison Materials Considered, # 4 Exhibit D - Raymond Reference List, # 5 Exhibit E - E-mail from Paul Fisette, # 6 Exhibit F - Keatley E-mail, # 7 Exhibit G - Fisette Letter, # 8 Exhibit H - Wecker Reply Report Timestamp List, # 9 Exhibit I - Hans v Tharaldson, # 10 Exhibit J - Boles v. United States, # 11 Exhibit K - Goodstein Survey Responses, # 12 Exhibit L - Harrison Deposition, # 13 Exhibit M - AZM00837031-7105, # 14 Exhibit N - AZM00836820-6854, # 15 Exhibit O - AZM00837515-7546, # 16 Exhibit P - Stamm Rebuttal Report, # 17 Exhibit Q - Exhibit 15 to Stamm Rebuttal Report, # 18 Exhibit R - Stamm Deposition)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 06/26/2015)
2015-06-26
1
RESPONSE in Opposition re (182 in 2:13-cv-03438-RMG, 234 in 2:13-cv-02078-RMG) Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 7/9/2015 (Attachments: # 1 Exhibit A - Stamm Reply Report, # 2 Exhibit B - Harrison Reply Report, # 3 Exhibit C - Harrison Materials Considered, # 4 Exhibit D - Raymond Reference List, # 5 Exhibit E - E-mail from Paul Fisette, # 6 Exhibit F - Keatley E-mail, # 7 Exhibit G - Fisette Letter, # 8 Exhibit H - Wecker Reply Report Timestamp List, # 9 Exhibit I - Hans v Tharaldson, # 10 Exhibit J - Boles v. United States, # 11 Exhibit K - Goodstein Survey Responses, # 12 Exhibit L - Harrison Deposition, # 13 Exhibit M - AZM00837031-7105, # 14 Exhibit N - AZM00836820-6854, # 15 Exhibit O - AZM00837515-7546, # 16 Exhibit P - Stamm Rebuttal Report, # 17 Exhibit Q - Exhibit 15 to Stamm Rebuttal Report, # 18 Exhibit R - Stamm Deposition)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 06/26/2015)
2015-06-26
2
RESPONSE in Opposition re (182 in 2:13-cv-03438-RMG, 234 in 2:13-cv-02078-RMG) Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 7/9/2015 (Attachments: # 1 Exhibit A - Stamm Reply Report, # 2 Exhibit B - Harrison Reply Report, # 3 Exhibit C - Harrison Materials Considered, # 4 Exhibit D - Raymond Reference List, # 5 Exhibit E - E-mail from Paul Fisette, # 6 Exhibit F - Keatley E-mail, # 7 Exhibit G - Fisette Letter, # 8 Exhibit H - Wecker Reply Report Timestamp List, # 9 Exhibit I - Hans v Tharaldson, # 10 Exhibit J - Boles v. United States, # 11 Exhibit K - Goodstein Survey Responses, # 12 Exhibit L - Harrison Deposition, # 13 Exhibit M - AZM00837031-7105, # 14 Exhibit N - AZM00836820-6854, # 15 Exhibit O - AZM00837515-7546, # 16 Exhibit P - Stamm Rebuttal Report, # 17 Exhibit Q - Exhibit 15 to Stamm Rebuttal Report, # 18 Exhibit R - Stamm Deposition)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 06/26/2015)
2015-06-26
2
RESPONSE in Opposition re (182 in 2:13-cv-03438-RMG, 234 in 2:13-cv-02078-RMG) Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 7/9/2015 (Attachments: # 1 Exhibit A - Stamm Reply Report, # 2 Exhibit B - Harrison Reply Report, # 3 Exhibit C - Harrison Materials Considered, # 4 Exhibit D - Raymond Reference List, # 5 Exhibit E - E-mail from Paul Fisette, # 6 Exhibit F - Keatley E-mail, # 7 Exhibit G - Fisette Letter, # 8 Exhibit H - Wecker Reply Report Timestamp List, # 9 Exhibit I - Hans v Tharaldson, # 10 Exhibit J - Boles v. United States, # 11 Exhibit K - Goodstein Survey Responses, # 12 Exhibit L - Harrison Deposition, # 13 Exhibit M - AZM00837031-7105, # 14 Exhibit N - AZM00836820-6854, # 15 Exhibit O - AZM00837515-7546, # 16 Exhibit P - Stamm Rebuttal Report, # 17 Exhibit Q - Exhibit 15 to Stamm Rebuttal Report, # 18 Exhibit R - Stamm Deposition)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 06/26/2015)
2015-06-26
2
RESPONSE in Opposition re (182 in 2:13-cv-03438-RMG, 234 in 2:13-cv-02078-RMG) Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 7/9/2015 (Attachments: # 1 Exhibit A - Stamm Reply Report, # 2 Exhibit B - Harrison Reply Report, # 3 Exhibit C - Harrison Materials Considered, # 4 Exhibit D - Raymond Reference List, # 5 Exhibit E - E-mail from Paul Fisette, # 6 Exhibit F - Keatley E-mail, # 7 Exhibit G - Fisette Letter, # 8 Exhibit H - Wecker Reply Report Timestamp List, # 9 Exhibit I - Hans v Tharaldson, # 10 Exhibit J - Boles v. United States, # 11 Exhibit K - Goodstein Survey Responses, # 12 Exhibit L - Harrison Deposition, # 13 Exhibit M - AZM00837031-7105, # 14 Exhibit N - AZM00836820-6854, # 15 Exhibit O - AZM00837515-7546, # 16 Exhibit P - Stamm Rebuttal Report, # 17 Exhibit Q - Exhibit 15 to Stamm Rebuttal Report, # 18 Exhibit R - Stamm Deposition)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 06/26/2015)
2015-06-26
2
RESPONSE in Opposition re (182 in 2:13-cv-03438-RMG, 234 in 2:13-cv-02078-RMG) Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 7/9/2015 (Attachments: # 1 Exhibit A - Stamm Reply Report, # 2 Exhibit B - Harrison Reply Report, # 3 Exhibit C - Harrison Materials Considered, # 4 Exhibit D - Raymond Reference List, # 5 Exhibit E - E-mail from Paul Fisette, # 6 Exhibit F - Keatley E-mail, # 7 Exhibit G - Fisette Letter, # 8 Exhibit H - Wecker Reply Report Timestamp List, # 9 Exhibit I - Hans v Tharaldson, # 10 Exhibit J - Boles v. United States, # 11 Exhibit K - Goodstein Survey Responses, # 12 Exhibit L - Harrison Deposition, # 13 Exhibit M - AZM00837031-7105, # 14 Exhibit N - AZM00836820-6854, # 15 Exhibit O - AZM00837515-7546, # 16 Exhibit P - Stamm Rebuttal Report, # 17 Exhibit Q - Exhibit 15 to Stamm Rebuttal Report, # 18 Exhibit R - Stamm Deposition)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 06/26/2015)
2015-06-26
2
RESPONSE in Opposition re (182 in 2:13-cv-03438-RMG, 234 in 2:13-cv-02078-RMG) Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 7/9/2015 (Attachments: # 1 Exhibit A - Stamm Reply Report, # 2 Exhibit B - Harrison Reply Report, # 3 Exhibit C - Harrison Materials Considered, # 4 Exhibit D - Raymond Reference List, # 5 Exhibit E - E-mail from Paul Fisette, # 6 Exhibit F - Keatley E-mail, # 7 Exhibit G - Fisette Letter, # 8 Exhibit H - Wecker Reply Report Timestamp List, # 9 Exhibit I - Hans v Tharaldson, # 10 Exhibit J - Boles v. United States, # 11 Exhibit K - Goodstein Survey Responses, # 12 Exhibit L - Harrison Deposition, # 13 Exhibit M - AZM00837031-7105, # 14 Exhibit N - AZM00836820-6854, # 15 Exhibit O - AZM00837515-7546, # 16 Exhibit P - Stamm Rebuttal Report, # 17 Exhibit Q - Exhibit 15 to Stamm Rebuttal Report, # 18 Exhibit R - Stamm Deposition)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 06/26/2015)
2015-06-26
2
RESPONSE in Opposition re (182 in 2:13-cv-03438-RMG, 234 in 2:13-cv-02078-RMG) Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 7/9/2015 (Attachments: # 1 Exhibit A - Stamm Reply Report, # 2 Exhibit B - Harrison Reply Report, # 3 Exhibit C - Harrison Materials Considered, # 4 Exhibit D - Raymond Reference List, # 5 Exhibit E - E-mail from Paul Fisette, # 6 Exhibit F - Keatley E-mail, # 7 Exhibit G - Fisette Letter, # 8 Exhibit H - Wecker Reply Report Timestamp List, # 9 Exhibit I - Hans v Tharaldson, # 10 Exhibit J - Boles v. United States, # 11 Exhibit K - Goodstein Survey Responses, # 12 Exhibit L - Harrison Deposition, # 13 Exhibit M - AZM00837031-7105, # 14 Exhibit N - AZM00836820-6854, # 15 Exhibit O - AZM00837515-7546, # 16 Exhibit P - Stamm Rebuttal Report, # 17 Exhibit Q - Exhibit 15 to Stamm Rebuttal Report, # 18 Exhibit R - Stamm Deposition)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 06/26/2015)
2015-06-26
2
RESPONSE in Opposition re (182 in 2:13-cv-03438-RMG, 234 in 2:13-cv-02078-RMG) Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 7/9/2015 (Attachments: # 1 Exhibit A - Stamm Reply Report, # 2 Exhibit B - Harrison Reply Report, # 3 Exhibit C - Harrison Materials Considered, # 4 Exhibit D - Raymond Reference List, # 5 Exhibit E - E-mail from Paul Fisette, # 6 Exhibit F - Keatley E-mail, # 7 Exhibit G - Fisette Letter, # 8 Exhibit H - Wecker Reply Report Timestamp List, # 9 Exhibit I - Hans v Tharaldson, # 10 Exhibit J - Boles v. United States, # 11 Exhibit K - Goodstein Survey Responses, # 12 Exhibit L - Harrison Deposition, # 13 Exhibit M - AZM00837031-7105, # 14 Exhibit N - AZM00836820-6854, # 15 Exhibit O - AZM00837515-7546, # 16 Exhibit P - Stamm Rebuttal Report, # 17 Exhibit Q - Exhibit 15 to Stamm Rebuttal Report, # 18 Exhibit R - Stamm Deposition)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 06/26/2015)
2015-06-26
2
RESPONSE in Opposition re (182 in 2:13-cv-03438-RMG, 234 in 2:13-cv-02078-RMG) Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 7/9/2015 (Attachments: # 1 Exhibit A - Stamm Reply Report, # 2 Exhibit B - Harrison Reply Report, # 3 Exhibit C - Harrison Materials Considered, # 4 Exhibit D - Raymond Reference List, # 5 Exhibit E - E-mail from Paul Fisette, # 6 Exhibit F - Keatley E-mail, # 7 Exhibit G - Fisette Letter, # 8 Exhibit H - Wecker Reply Report Timestamp List, # 9 Exhibit I - Hans v Tharaldson, # 10 Exhibit J - Boles v. United States, # 11 Exhibit K - Goodstein Survey Responses, # 12 Exhibit L - Harrison Deposition, # 13 Exhibit M - AZM00837031-7105, # 14 Exhibit N - AZM00836820-6854, # 15 Exhibit O - AZM00837515-7546, # 16 Exhibit P - Stamm Rebuttal Report, # 17 Exhibit Q - Exhibit 15 to Stamm Rebuttal Report, # 18 Exhibit R - Stamm Deposition)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 06/26/2015)
2015-06-26
2
RESPONSE in Opposition re (182 in 2:13-cv-03438-RMG, 234 in 2:13-cv-02078-RMG) Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 7/9/2015 (Attachments: # 1 Exhibit A - Stamm Reply Report, # 2 Exhibit B - Harrison Reply Report, # 3 Exhibit C - Harrison Materials Considered, # 4 Exhibit D - Raymond Reference List, # 5 Exhibit E - E-mail from Paul Fisette, # 6 Exhibit F - Keatley E-mail, # 7 Exhibit G - Fisette Letter, # 8 Exhibit H - Wecker Reply Report Timestamp List, # 9 Exhibit I - Hans v Tharaldson, # 10 Exhibit J - Boles v. United States, # 11 Exhibit K - Goodstein Survey Responses, # 12 Exhibit L - Harrison Deposition, # 13 Exhibit M - AZM00837031-7105, # 14 Exhibit N - AZM00836820-6854, # 15 Exhibit O - AZM00837515-7546, # 16 Exhibit P - Stamm Rebuttal Report, # 17 Exhibit Q - Exhibit 15 to Stamm Rebuttal Report, # 18 Exhibit R - Stamm Deposition)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 06/26/2015)
2015-06-26
2
RESPONSE in Opposition re (182 in 2:13-cv-03438-RMG, 234 in 2:13-cv-02078-RMG) Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 7/9/2015 (Attachments: # 1 Exhibit A - Stamm Reply Report, # 2 Exhibit B - Harrison Reply Report, # 3 Exhibit C - Harrison Materials Considered, # 4 Exhibit D - Raymond Reference List, # 5 Exhibit E - E-mail from Paul Fisette, # 6 Exhibit F - Keatley E-mail, # 7 Exhibit G - Fisette Letter, # 8 Exhibit H - Wecker Reply Report Timestamp List, # 9 Exhibit I - Hans v Tharaldson, # 10 Exhibit J - Boles v. United States, # 11 Exhibit K - Goodstein Survey Responses, # 12 Exhibit L - Harrison Deposition, # 13 Exhibit M - AZM00837031-7105, # 14 Exhibit N - AZM00836820-6854, # 15 Exhibit O - AZM00837515-7546, # 16 Exhibit P - Stamm Rebuttal Report, # 17 Exhibit Q - Exhibit 15 to Stamm Rebuttal Report, # 18 Exhibit R - Stamm Deposition)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 06/26/2015)
2015-06-26
2
RESPONSE in Opposition re (182 in 2:13-cv-03438-RMG, 234 in 2:13-cv-02078-RMG) Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 7/9/2015 (Attachments: # 1 Exhibit A - Stamm Reply Report, # 2 Exhibit B - Harrison Reply Report, # 3 Exhibit C - Harrison Materials Considered, # 4 Exhibit D - Raymond Reference List, # 5 Exhibit E - E-mail from Paul Fisette, # 6 Exhibit F - Keatley E-mail, # 7 Exhibit G - Fisette Letter, # 8 Exhibit H - Wecker Reply Report Timestamp List, # 9 Exhibit I - Hans v Tharaldson, # 10 Exhibit J - Boles v. United States, # 11 Exhibit K - Goodstein Survey Responses, # 12 Exhibit L - Harrison Deposition, # 13 Exhibit M - AZM00837031-7105, # 14 Exhibit N - AZM00836820-6854, # 15 Exhibit O - AZM00837515-7546, # 16 Exhibit P - Stamm Rebuttal Report, # 17 Exhibit Q - Exhibit 15 to Stamm Rebuttal Report, # 18 Exhibit R - Stamm Deposition)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 06/26/2015)
2015-06-26
2
RESPONSE in Opposition re (182 in 2:13-cv-03438-RMG, 234 in 2:13-cv-02078-RMG) Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 7/9/2015 (Attachments: # 1 Exhibit A - Stamm Reply Report, # 2 Exhibit B - Harrison Reply Report, # 3 Exhibit C - Harrison Materials Considered, # 4 Exhibit D - Raymond Reference List, # 5 Exhibit E - E-mail from Paul Fisette, # 6 Exhibit F - Keatley E-mail, # 7 Exhibit G - Fisette Letter, # 8 Exhibit H - Wecker Reply Report Timestamp List, # 9 Exhibit I - Hans v Tharaldson, # 10 Exhibit J - Boles v. United States, # 11 Exhibit K - Goodstein Survey Responses, # 12 Exhibit L - Harrison Deposition, # 13 Exhibit M - AZM00837031-7105, # 14 Exhibit N - AZM00836820-6854, # 15 Exhibit O - AZM00837515-7546, # 16 Exhibit P - Stamm Rebuttal Report, # 17 Exhibit Q - Exhibit 15 to Stamm Rebuttal Report, # 18 Exhibit R - Stamm Deposition)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 06/26/2015)
2015-06-26
2
RESPONSE in Opposition re (182 in 2:13-cv-03438-RMG, 234 in 2:13-cv-02078-RMG) Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 7/9/2015 (Attachments: # 1 Exhibit A - Stamm Reply Report, # 2 Exhibit B - Harrison Reply Report, # 3 Exhibit C - Harrison Materials Considered, # 4 Exhibit D - Raymond Reference List, # 5 Exhibit E - E-mail from Paul Fisette, # 6 Exhibit F - Keatley E-mail, # 7 Exhibit G - Fisette Letter, # 8 Exhibit H - Wecker Reply Report Timestamp List, # 9 Exhibit I - Hans v Tharaldson, # 10 Exhibit J - Boles v. United States, # 11 Exhibit K - Goodstein Survey Responses, # 12 Exhibit L - Harrison Deposition, # 13 Exhibit M - AZM00837031-7105, # 14 Exhibit N - AZM00836820-6854, # 15 Exhibit O - AZM00837515-7546, # 16 Exhibit P - Stamm Rebuttal Report, # 17 Exhibit Q - Exhibit 15 to Stamm Rebuttal Report, # 18 Exhibit R - Stamm Deposition)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 06/26/2015)
2015-06-26
2
RESPONSE in Opposition re (182 in 2:13-cv-03438-RMG, 234 in 2:13-cv-02078-RMG) Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 7/9/2015 (Attachments: # 1 Exhibit A - Stamm Reply Report, # 2 Exhibit B - Harrison Reply Report, # 3 Exhibit C - Harrison Materials Considered, # 4 Exhibit D - Raymond Reference List, # 5 Exhibit E - E-mail from Paul Fisette, # 6 Exhibit F - Keatley E-mail, # 7 Exhibit G - Fisette Letter, # 8 Exhibit H - Wecker Reply Report Timestamp List, # 9 Exhibit I - Hans v Tharaldson, # 10 Exhibit J - Boles v. United States, # 11 Exhibit K - Goodstein Survey Responses, # 12 Exhibit L - Harrison Deposition, # 13 Exhibit M - AZM00837031-7105, # 14 Exhibit N - AZM00836820-6854, # 15 Exhibit O - AZM00837515-7546, # 16 Exhibit P - Stamm Rebuttal Report, # 17 Exhibit Q - Exhibit 15 to Stamm Rebuttal Report, # 18 Exhibit R - Stamm Deposition)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 06/26/2015)
2015-06-26
2
RESPONSE in Opposition re (182 in 2:13-cv-03438-RMG, 234 in 2:13-cv-02078-RMG) Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 7/9/2015 (Attachments: # 1 Exhibit A - Stamm Reply Report, # 2 Exhibit B - Harrison Reply Report, # 3 Exhibit C - Harrison Materials Considered, # 4 Exhibit D - Raymond Reference List, # 5 Exhibit E - E-mail from Paul Fisette, # 6 Exhibit F - Keatley E-mail, # 7 Exhibit G - Fisette Letter, # 8 Exhibit H - Wecker Reply Report Timestamp List, # 9 Exhibit I - Hans v Tharaldson, # 10 Exhibit J - Boles v. United States, # 11 Exhibit K - Goodstein Survey Responses, # 12 Exhibit L - Harrison Deposition, # 13 Exhibit M - AZM00837031-7105, # 14 Exhibit N - AZM00836820-6854, # 15 Exhibit O - AZM00837515-7546, # 16 Exhibit P - Stamm Rebuttal Report, # 17 Exhibit Q - Exhibit 15 to Stamm Rebuttal Report, # 18 Exhibit R - Stamm Deposition)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 06/26/2015)
2015-06-26
2
RESPONSE in Opposition re (182 in 2:13-cv-03438-RMG, 234 in 2:13-cv-02078-RMG) Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 7/9/2015 (Attachments: # 1 Exhibit A - Stamm Reply Report, # 2 Exhibit B - Harrison Reply Report, # 3 Exhibit C - Harrison Materials Considered, # 4 Exhibit D - Raymond Reference List, # 5 Exhibit E - E-mail from Paul Fisette, # 6 Exhibit F - Keatley E-mail, # 7 Exhibit G - Fisette Letter, # 8 Exhibit H - Wecker Reply Report Timestamp List, # 9 Exhibit I - Hans v Tharaldson, # 10 Exhibit J - Boles v. United States, # 11 Exhibit K - Goodstein Survey Responses, # 12 Exhibit L - Harrison Deposition, # 13 Exhibit M - AZM00837031-7105, # 14 Exhibit N - AZM00836820-6854, # 15 Exhibit O - AZM00837515-7546, # 16 Exhibit P - Stamm Rebuttal Report, # 17 Exhibit Q - Exhibit 15 to Stamm Rebuttal Report, # 18 Exhibit R - Stamm Deposition)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 06/26/2015)
2015-06-26
2
RESPONSE in Opposition re (182 in 2:13-cv-03438-RMG, 234 in 2:13-cv-02078-RMG) Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 7/9/2015 (Attachments: # 1 Exhibit A - Stamm Reply Report, # 2 Exhibit B - Harrison Reply Report, # 3 Exhibit C - Harrison Materials Considered, # 4 Exhibit D - Raymond Reference List, # 5 Exhibit E - E-mail from Paul Fisette, # 6 Exhibit F - Keatley E-mail, # 7 Exhibit G - Fisette Letter, # 8 Exhibit H - Wecker Reply Report Timestamp List, # 9 Exhibit I - Hans v Tharaldson, # 10 Exhibit J - Boles v. United States, # 11 Exhibit K - Goodstein Survey Responses, # 12 Exhibit L - Harrison Deposition, # 13 Exhibit M - AZM00837031-7105, # 14 Exhibit N - AZM00836820-6854, # 15 Exhibit O - AZM00837515-7546, # 16 Exhibit P - Stamm Rebuttal Report, # 17 Exhibit Q - Exhibit 15 to Stamm Rebuttal Report, # 18 Exhibit R - Stamm Deposition)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 06/26/2015)
2015-06-26
2
MOTION to Appear Pro Hac Vice by Bryant Lee ( Filing fee $ 250 receipt number 0420-6024726) by AstraZeneca Pharmaceuticals LP. Response to Motion due by 7/16/2015. (Attachments: # 1 Exhibit Pro Hac Vice Application, # 2 Exhibit Proposed Order)Proposed order is being emailed to chambers with copy to opposing counsel.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 06/29/2015)
2015-06-29
1
MOTION to Withdraw as Attorney Sangjoon Han by AstraZeneca Pharmaceuticals LP. Response to Motion due by 7/17/2015. No proposed order.(Willis, Marguerite) (Entered: 06/30/2015)
2015-06-30
1
ORDER granting 239 Motion for Bryant Lee to Appear Pro Hac Vice for AstraZeneca Pharmaceuticals LP. Signed by Honorable Richard M Gergel on 6/29/2015.(sshe, ) (Entered: 06/30/2015)
2015-06-30
1
REPLY to Response to Motion re 234 Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit Expert Report of William Wecker, # 2 Exhibit Reply Expert Report of William Wecker, # 3 Exhibit Deposition of William Wecker, # 4 Exhibit Rebuttal Expert Report of Ronald Goodstein, # 5 Exhibit Garvish E-mail Re Goodstein Deposition, June 1, 2015, # 6 Exhibit Garvish E-mail Re Foster Deposition, June 14, 2015, # 7 Exhibit Garvish E-mail Re Steckel Deposition, June 16, 2015, # 8 Exhibit Reply Expert Report of Ryan Sullivan)(Willis, Marguerite) (Entered: 06/30/2015)
2015-06-30
1
REPLY to Response to Motion re 234 Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit Expert Report of William Wecker, # 2 Exhibit Reply Expert Report of William Wecker, # 3 Exhibit Deposition of William Wecker, # 4 Exhibit Rebuttal Expert Report of Ronald Goodstein, # 5 Exhibit Garvish E-mail Re Goodstein Deposition, June 1, 2015, # 6 Exhibit Garvish E-mail Re Foster Deposition, June 14, 2015, # 7 Exhibit Garvish E-mail Re Steckel Deposition, June 16, 2015, # 8 Exhibit Reply Expert Report of Ryan Sullivan)(Willis, Marguerite) (Entered: 06/30/2015)
2015-06-30
2
REPLY to Response to Motion re 234 Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit Expert Report of William Wecker, # 2 Exhibit Reply Expert Report of William Wecker, # 3 Exhibit Deposition of William Wecker, # 4 Exhibit Rebuttal Expert Report of Ronald Goodstein, # 5 Exhibit Garvish E-mail Re Goodstein Deposition, June 1, 2015, # 6 Exhibit Garvish E-mail Re Foster Deposition, June 14, 2015, # 7 Exhibit Garvish E-mail Re Steckel Deposition, June 16, 2015, # 8 Exhibit Reply Expert Report of Ryan Sullivan)(Willis, Marguerite) (Entered: 06/30/2015)
2015-06-30
2
REPLY to Response to Motion re 234 Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit Expert Report of William Wecker, # 2 Exhibit Reply Expert Report of William Wecker, # 3 Exhibit Deposition of William Wecker, # 4 Exhibit Rebuttal Expert Report of Ronald Goodstein, # 5 Exhibit Garvish E-mail Re Goodstein Deposition, June 1, 2015, # 6 Exhibit Garvish E-mail Re Foster Deposition, June 14, 2015, # 7 Exhibit Garvish E-mail Re Steckel Deposition, June 16, 2015, # 8 Exhibit Reply Expert Report of Ryan Sullivan)(Willis, Marguerite) (Entered: 06/30/2015)
2015-06-30
2
REPLY to Response to Motion re 234 Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit Expert Report of William Wecker, # 2 Exhibit Reply Expert Report of William Wecker, # 3 Exhibit Deposition of William Wecker, # 4 Exhibit Rebuttal Expert Report of Ronald Goodstein, # 5 Exhibit Garvish E-mail Re Goodstein Deposition, June 1, 2015, # 6 Exhibit Garvish E-mail Re Foster Deposition, June 14, 2015, # 7 Exhibit Garvish E-mail Re Steckel Deposition, June 16, 2015, # 8 Exhibit Reply Expert Report of Ryan Sullivan)(Willis, Marguerite) (Entered: 06/30/2015)
2015-06-30
2
REPLY to Response to Motion re 234 Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit Expert Report of William Wecker, # 2 Exhibit Reply Expert Report of William Wecker, # 3 Exhibit Deposition of William Wecker, # 4 Exhibit Rebuttal Expert Report of Ronald Goodstein, # 5 Exhibit Garvish E-mail Re Goodstein Deposition, June 1, 2015, # 6 Exhibit Garvish E-mail Re Foster Deposition, June 14, 2015, # 7 Exhibit Garvish E-mail Re Steckel Deposition, June 16, 2015, # 8 Exhibit Reply Expert Report of Ryan Sullivan)(Willis, Marguerite) (Entered: 06/30/2015)
2015-06-30
2
REPLY to Response to Motion re 234 Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit Expert Report of William Wecker, # 2 Exhibit Reply Expert Report of William Wecker, # 3 Exhibit Deposition of William Wecker, # 4 Exhibit Rebuttal Expert Report of Ronald Goodstein, # 5 Exhibit Garvish E-mail Re Goodstein Deposition, June 1, 2015, # 6 Exhibit Garvish E-mail Re Foster Deposition, June 14, 2015, # 7 Exhibit Garvish E-mail Re Steckel Deposition, June 16, 2015, # 8 Exhibit Reply Expert Report of Ryan Sullivan)(Willis, Marguerite) (Entered: 06/30/2015)
2015-06-30
2
REPLY to Response to Motion re 234 Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit Expert Report of William Wecker, # 2 Exhibit Reply Expert Report of William Wecker, # 3 Exhibit Deposition of William Wecker, # 4 Exhibit Rebuttal Expert Report of Ronald Goodstein, # 5 Exhibit Garvish E-mail Re Goodstein Deposition, June 1, 2015, # 6 Exhibit Garvish E-mail Re Foster Deposition, June 14, 2015, # 7 Exhibit Garvish E-mail Re Steckel Deposition, June 16, 2015, # 8 Exhibit Reply Expert Report of Ryan Sullivan)(Willis, Marguerite) (Entered: 06/30/2015)
2015-06-30
2
REPLY to Response to Motion re 234 Emergency MOTION to Strike Reply Expert Report of Dr. William E. Wecker Response filed by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit Expert Report of William Wecker, # 2 Exhibit Reply Expert Report of William Wecker, # 3 Exhibit Deposition of William Wecker, # 4 Exhibit Rebuttal Expert Report of Ronald Goodstein, # 5 Exhibit Garvish E-mail Re Goodstein Deposition, June 1, 2015, # 6 Exhibit Garvish E-mail Re Foster Deposition, June 14, 2015, # 7 Exhibit Garvish E-mail Re Steckel Deposition, June 16, 2015, # 8 Exhibit Reply Expert Report of Ryan Sullivan)(Willis, Marguerite) (Entered: 06/30/2015)
2015-06-30
2
MOTION for Leave to File Excess Pages (Motion to Increase Page Limits for Summary Judgment Filings Due July 10, 2015) by AstraZeneca Pharmaceuticals LP. Response to Motion due by 7/20/2015. (Attachments: # 1 Exhibit Ex. 1 - Email)No proposed order.(Willis, Marguerite) (Entered: 07/02/2015)
2015-07-02
1
RESPONSE in Opposition re 243 MOTION for Leave to File Excess Pages (Motion to Increase Page Limits for Summary Judgment Filings Due July 10, 2015) Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 7/13/2015 (Attachments: # 1 Exhibit A - Littlejohn E-mail of June 14, 2015, # 2 Exhibit B - Littlejohn E-mail of July 1, 2015)(Littlejohn, Joshua) (Entered: 07/02/2015)
2015-07-02
1
REPLY to Response to Motion re 243 MOTION for Leave to File Excess Pages (Motion to Increase Page Limits for Summary Judgment Filings Due July 10, 2015) Response filed by AstraZeneca Pharmaceuticals LP. (Willis, Marguerite) (Entered: 07/02/2015)
2015-07-02
1
TEXT ORDER Sangjoon Han's motion to withdraw as counsel (Dkt. No. 240, 188) is GRANTED. Defendant will continue to be represented by other counsel of record from Covington & Burling, LLP and Nexsen Pruet, LLC. AND IT IS SO ORDERED. Entered at the Direction of Honorable Richard M Gergel on 7/2/2015.(sshe, ) (Entered: 07/06/2015)
2015-07-06
1
TEXT ORDER Defendant's Motion for Leave to File Excess Pages (Dkt. No. (243) in case 2:13-cv-02078-RMG; (191) in case 2:13-cv-03438-RMG) is GRANTED. Briefs in support of motions for summary judgment and briefs in opposition to summary judgment may not exceed sixty (60) pages. Reply briefs in support of motions for summary judgment may not exceed (20) pages. The parties are encouraged to be as concise as possible. AND IT IS SO ORDERED. Entered at the Direction of Honorable Richard M Gergel on 7/7/2015.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 07/07/2015)
2015-07-07
1
ORDER denying (234) Motion to Strike in case 2:13-cv-02078-RMG; denying (182) Motion to Strike in case 2:13-cv-03438-RMG. However, Defendant's experts will be allowed to address any alleged deficiencies in Dr. Wecker's supplemental survey on Daubert motions and at trial. Signed by Honorable Richard M Gergel on 7/8/2015.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(vdru, ) (Entered: 07/08/2015)
2015-07-08
1
MOTION to Exclude Certain Testimony of Plaintiffs' Expert Peter Rheinstein by AstraZeneca Pharmaceuticals LP. Response to Motion due by 7/30/2015; Reply due by 8/10/2015, per 237 (in 2:13-cv-2078-RMG)Text Order. (Attachments: # 1 Memo in Support Memo in Support to Exclude Opinions of Rheinstein, # 2 Exhibit May 29, 2015 Expert Report of Peter Rheinstein, # 3 Exhibit Excerpted Deposition of Peter Rheinstein, # 4 Exhibit Excerpted Deposition of Marie Martino)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) Modified on 7/21/2015 to edit docket text, per chambers(sshe, ). (Entered: 07/10/2015)
2015-07-10
1
MOTION to Exclude Certain Testimony of Plaintiffs' Expert Lawrence Steinman by AstraZeneca Pharmaceuticals LP. Response to Motion due by 7/30/2015; Reply due by 8/10/2015 per 237 (in 2:13-cv-2078-RMG)Text Order. (Attachments: # 1 Memo in Support, # 2 Exhibit A - Excerpted Rebuttal Expert Report of Lawrence Steinman, M.D. (Placeholder))No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) Modified on 7/21/2015 to edit docket text, per chambers(sshe, ). (Entered: 07/10/2015)
2015-07-10
1
MOTION to Exclude Certain Testimony of Plaintiffs' Expert Hossein Ardehali by AstraZeneca Pharmaceuticals LP. Response to Motion due by 7/30/2015; Reply due by 8/10/2015 per 237 (in 2:13-cv-2078-RMG)Text Order. (Attachments: # 1 Memo in Support, # 2 Exhibit A - Excerpted May 8, 2015 Amended Expert Report of Dr. Ardehali (Placeholder), # 3 Exhibit B - Excerpted May 29, 2015 Reply Expert Report of Dr. Ardehali (Placeholder), # 4 Exhibit C - Deposition of Dr. Ardehali)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) Modified on 7/21/2015 to edit docket text, per chambers(sshe, ). (Entered: 07/10/2015)
2015-07-10
1
MOTION to Exclude Expert Reports and Proposed Testimony of AstraZeneca Expert Gerald V. Raymond, M.D. by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 7/30/2015; Reply due by 8/10/2015 per 237 (in 2:13-cv-2078-RMG)Text Order. (Attachments: # 1 Exhibit A - Raymond Reply Report, # 2 Exhibit B - Singh Dep, # 3 Exhibit C - Harrison Dep, # 4 Exhibit D - Raymond Dep, # 5 Exhibit E - Syntrix v Illumina, # 6 Exhibit F - Apple v Samsung, # 7 Exhibit G - Harrison Rebuttal Report)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) Modified on 7/21/2015 to edit docket text, per chambers(sshe, ). (Entered: 07/10/2015)
2015-07-10
1
MOTION to Exclude Portions of the Expert Reports and Proposed Testimony of AstraZeneca Expert David G. Harrison, M.D. by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 7/30/2015; Reply due by 8/10/2015 per 237 (in 2:13-cv-2078-RMG)Text Order. (Attachments: # 1 Exhibit A - Harrison Suppl Report, # 2 Exhibit B - Pls Claim Constructions, # 3 Exhibit C - AZ Claim Constructions, # 4 Exhibit D - Garvish Ltr, # 5 Exhibit E - US v Eady, # 6 Exhibit F - Apple v Samsung, # 7 Exhibit G - Personalized Media v Zynga, # 8 Exhibit H - EZ Dock v Schafer, # 9 Exhibit I - Inline Connection v AOL, # 10 Exhibit J - MarcTec v Johnson & Johnson, # 11 Exhibit K - Velcro Indus v Taiwan Paiho, # 12 Exhibit L - Websters, # 13 Exhibit M - Harrison Dep Tr, # 14 Exhibit N - TruePosition v Andrew)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) Modified on 7/21/2015 to edit docket text, per chambers(sshe, ). (Entered: 07/10/2015)
2015-07-10
1
MOTION to Exclude Testimony of William Wecker by AstraZeneca Pharmaceuticals LP. Response to Motion due by 7/30/2015; Reply due by 8/10/2015 per 237 (in 2:13-cv-2078-RMG)Text Order. (Attachments: # 1 Memo in Support)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) Modified on 7/13/2015 to reference Additional Attachments Dkt. No. 288-308 filed 7/10-11/2015 (sshe, ). Modified on 7/21/2015 to edit docket text, per chambers(sshe, ). (Entered: 07/10/2015)
2015-07-10
1
MOTION to Exclude Portions of the Rebuttal Expert Report and Proposed Testimony of AstraZeneca Expert Laura B. Stamm by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 7/30/2015; Reply due by 8/10/2015 per 237 (in 2:13-cv-2078-RMG)Text Order. (Attachments: # 1 Exhibit A - Stamm Dep, # 2 Exhibit B - Toshiba v Imation, # 3 Exhibit C - Trademark Props v A&E, # 4 Exhibit D - Goodman v Revco, # 5 Exhibit E - Est of Ravenell v Pugmill, # 6 Exhibit F - Apple v Samsung, # 7 Exhibit G - Fairchild v Power Integrations, # 8 Exhibit H - Intelligent v Microsoft)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) Modified on 7/21/2015 to edit docket text, per chambers(sshe, ). (Entered: 07/10/2015)
2015-07-10
1
MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement by AstraZeneca Pharmaceuticals LP. Response to Motion due by 7/30/2015; Reply due by 8/10/2015 per 237 (in 2:13-cv-2078-RMG)Text Order. (Attachments: # 1 Memo in Support)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) Modified on 7/13/2015 to reference Additional Attachments Dkt. No. 272-287 filed 7/10-11/2015 (sshe, ). Modified on 7/21/2015 to edit docket text, per chambers(sshe, ). (Entered: 07/10/2015)
2015-07-10
1
MOTION to Exclude the Testimony of Ryan Sullivan by AstraZeneca Pharmaceuticals LP. Response to Motion due by 7/30/2015; Reply due by 8/10/2015 per 237 (in 2:13-cv-2078-RMG)Text Order. No proposed order. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) Modified on 7/13/2015 to reference Addition Attachments Dkt. No. 259-271 filed 7/10-11/2015(sshe, ). Modified on 7/21/2015 to edit docket text, per chambers(sshe, ). (Entered: 07/10/2015)
2015-07-10
1
Additional Attachments to Main Document (258 in 2:13-cv-02078-RMG, 206 in 2:13-cv-03438-RMG) MOTION to Exclude the Testimony of Ryan Sullivan. First attachment description: Memo in Support of Motion to Exclude Testimony of Sullivan . Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-10
1
Additional Attachments to Main Document (258 in 2:13-cv-02078-RMG, 206 in 2:13-cv-03438-RMG) MOTION to Exclude the Testimony of Ryan Sullivan. First attachment description: Exhibit 1 - Selected Pages of Second Amended Report of Ryan Sullivan . (Attachments: # 1 Exhibit 2 - Selected Pages from Rebuttal Steinman Expert Report, # 2 Exhibit 3 - Selected Pages from Rebuttal Stamm Expert Report, # 3 Exhibit 4 - Selected Pages of Sullivan Deposition, # 4 Exhibit 5 - 1998 License Agreement Between Shionogi and Zeneca, # 5 Exhibit 6 - AZM00012078)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (258 in 2:13-cv-02078-RMG, 206 in 2:13-cv-03438-RMG) MOTION to Exclude the Testimony of Ryan Sullivan. First attachment description: Exhibit 7 - FDA Approval Letter . (Attachments: # 1 Exhibit 8 - Medical Team Leader's Memo, # 2 Exhibit 9 - 2002 Shionogi Amendment, # 3 Exhibit 10 - 2014 - Shionogi Amendment, # 4 Exhibit 11 - Selected Pages of Mongan Deposition)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (258 in 2:13-cv-02078-RMG, 206 in 2:13-cv-03438-RMG) MOTION to Exclude the Testimony of Ryan Sullivan. First attachment description: Exhibit 12 - J.P. Morgan, "JUPITER Beats Expectations But..." . (Attachments: # 1 Exhibit 13 - Selected Pages of Wooten Transcript, # 2 Exhibit 14 - Law360 Article)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (258 in 2:13-cv-02078-RMG, 206 in 2:13-cv-03438-RMG) MOTION to Exclude the Testimony of Ryan Sullivan. First attachment description: Exhibit 15 - Selected Pages of Sullivan Reply Report . (Attachments: # 1 Exhibit 16 - 2013 Settlement Agreement, # 2 Exhibit 17 - Apr. 21, 2004 Brostoff Email to Carling, # 3 Exhibit 18 - 2002 BWH License, # 4 Exhibit 19 - 2012 BWH License, # 5 Exhibit 20 - Orange Book (Crestor), # 6 Exhibit 21 - Orange Book (Patent Use Codes), # 7 Exhibit 22 - May 12, 2004 Brostoff Email to Henderson)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (258 in 2:13-cv-02078-RMG, 206 in 2:13-cv-03438-RMG) MOTION to Exclude the Testimony of Ryan Sullivan. First attachment description: Exhibit 23 - Licensing Executive Society Survey Report (Part 1) . Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (258 in 2:13-cv-02078-RMG, 206 in 2:13-cv-03438-RMG) MOTION to Exclude the Testimony of Ryan Sullivan. First attachment description: Exhibit 23 - Licensing Executive Society Survey Report (Part 2) . Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (258 in 2:13-cv-02078-RMG, 206 in 2:13-cv-03438-RMG) MOTION to Exclude the Testimony of Ryan Sullivan. First attachment description: Exhibit 23 - Licensing Executive Society Survey Report (Part 3) . Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (258 in 2:13-cv-02078-RMG, 206 in 2:13-cv-03438-RMG) MOTION to Exclude the Testimony of Ryan Sullivan. First attachment description: Exhibit 24 - July 15, 2003 Email from Brostoff to Yochim . (Attachments: # 1 Exhibit 25 - Nov. 24, 2003 Email from Brostoff to Yochim, # 2 Exhibit 26 - FDA Approval Letter (Lipitor))Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (258 in 2:13-cv-02078-RMG, 206 in 2:13-cv-03438-RMG) MOTION to Exclude the Testimony of Ryan Sullivan. First attachment description: Exhibit 27 - Redburn Partners . (Attachments: # 1 Exhibit 28 - RBS)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement. First attachment description: Exhibit 1 - U.S. Patent 6,511,800 . Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (258 in 2:13-cv-02078-RMG, 206 in 2:13-cv-03438-RMG) MOTION to Exclude the Testimony of Ryan Sullivan. First attachment description: Exhibit 29 - Selected Pages from Crestor Strategy 2011 . (Attachments: # 1 Exhibit 30 - Macquarie Research, # 2 Exhibit 31 - Ridker Article (2008))Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (258 in 2:13-cv-02078-RMG, 206 in 2:13-cv-03438-RMG) MOTION to Exclude the Testimony of Ryan Sullivan. First attachment description: Exhibit 32 - Ridker Article (2009) . (Attachments: # 1 Exhibit 33 - Harrison Rebuttal Report)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Leonardi, Daniel) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement. First attachment description: Exhibit 2 - Harrison Declaration . Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Main Document 272 replaced on 7/13/2015) (sshe, ). (Additional attachment(s) added on 7/13/2015: # 1 Exhibit Ex-2 Harrison declaration in support of motion for summary judgment-Part 3, # 2 Exhibit Ex-2 Harrison declaration in support of motion for summary judgment-Part 3, # 3 Exhibit Ex-2 Harrison declaration in support of motion for summary judgment-Part 4) (sshe, ). Modified on 7/13/2015 to substitute/add corrected document (4 parts) as requested and provided by filing user(sshe, ). (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement. First attachment description: Exhibit 3 - Raymond Declaration . (Attachments: # 1 Exhibit 4 - Excerpted Steinman Rebuttal Report, # 2 Exhibit 5 - Steinman Deposition Excerpts, # 3 Exhibit 6 - Amended Opening Expert Report of Dr Ardehali, # 4 Exhibit 7 - Reply Expert Report of Dr Ardehali, # 5 Exhibit 8 - Ardehali Deposition Excerpts, # 6 Exhibit 9 - Solomon Deposition Excerpts, # 7 Exhibit 10 - Pahan Deposition Excerpts)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Main Document 273 replaced on 7/13/2015) (sshe, ). Modified on 7/13/2015 to substitute with corrected document as requested and provided by filing user(sshe, ). (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement. First attachment description: Exhibit 11 - Singh Deposition Excerpts . (Attachments: # 1 Exhibit 12 - Brostoff Deposition Excerpts, # 2 Exhibit 13 - Parker Deposition Excerpts, # 3 Exhibit 14 - Steinman Article Animal Studies, # 4 Exhibit 15 - Steinman Article Inflamatory Diseases)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement. First attachment description: Exhibit 16 - Engelen Article . Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement. First attachment description: Exhibit 17 - Crisby Article . Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement. First attachment description: Exhibit 18 - Greenwood Article Statin Therapy and autoimmune disease . Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement. First attachment description: Exhibit 19 - Ridker Article Rosuvastatin to Prevent Vascular Events . (Attachments: # 1 Exhibit 20 - Shepherd Article Prevention of Coronary Heart Disease with Pravastatin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Main Document 278 replaced on 7/14/2015) (sshe, ). Modified on 7/14/2015 to substitute with corrected document as requested and provided by filing user(sshe, ). (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement. First attachment description: Exhibit 21 - Sacks Article The Effects of Pravastatin on Coronary Events . (Attachments: # 1 Exhibit 22 - Scolnick International application number PCT-US94-07518)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement. First attachment description: Exhibit 23 - Myers WO 93-23034 . (Attachments: # 1 Exhibit 24 - Savion WO 96-08248, # 2 Exhibit 25 - Dorland's Med. Dictionary)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement. First attachment description: Exhibit 26 - Crestor Label . (Attachments: # 1 Exhibit 27 - Steinman Deposition, # 2 Exhibit 28 - Ardehali Deposition)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement. First attachment description: Exhibit 29 - Steinman Deposition Exhibit 11 . (Attachments: # 1 Exhibit 30 - Email Heistad to Ridker, # 2 Exhibit U.S. Patent 7,030,152)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement. First attachment description: Exhibit 32 - Email Cox to Brostoff . (Attachments: # 1 Exhibit 33 - Email Brostoff to Prehn, # 2 Exhibit 34 - Email Brostoff to Goldstein, # 3 Exhibit 35 - Email Henderson to Bill, # 4 Exhibit 36 - Excerpts Deposition of Alban, # 5 Exhibit 37 - Email Henderson to Hadley, # 6 Exhibit 38 - Email Brostoff to Hood)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Attachment 2 replaced on 7/13/2015) (sshe, ). Modified on 7/13/2015 to substitute with corrected document as requested and provided by filing user(sshe, ). (Attachment 2 replaced on 7/14/2015) (sshe, ). Modified on 7/14/2015 to substitute with corrected document as requested, per second request, and provided by filing user(sshe, ). (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement. First attachment description: Exhibit 39 - Email Brostoff to Hood 2005 . (Attachments: # 1 Exhibit 40 - Press Release Crestor, # 2 Exhibit 41 - Email from Schrager)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement. First attachment description: Exhibit 42 - LIcense Agreement MUSC-CMT 2010 . (Attachments: # 1 Exhibit 43 - LIcense Agreement MUSC-CMT 2012, # 2 Exhibit 44 - Application Issue Notification Patent 219, # 3 Exhibit 45 - Email Brostoff to Roozen, # 4 Exhibit 46 - Excerpts Finnegan Deposition)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Main Document 285 replaced on 7/13/2015) (sshe, ). Modified on 7/13/2015 to substitute with corrected document as requested and provided by filing user(sshe, ). (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement. First attachment description: Exhibit 47 - U.S. Patent App 12-001,553 . (Attachments: # 1 Exhibit 48 - Melchior v Hilite)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement. First attachment description: Exhibit 49 - In Re Ethanol Processing . (Attachments: # 1 Exhibit 50 - Beck v Strobel)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (255 in 2:13-cv-02078-RMG, 203 in 2:13-cv-03438-RMG) MOTION to Exclude Testimony of William Wecker. First attachment description: Exhibit 1 - Wecker Expert Report . (Attachments: # 1 Exhibit 2 - Bolton Article)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (255 in 2:13-cv-02078-RMG, 203 in 2:13-cv-03438-RMG) MOTION to Exclude Testimony of William Wecker. First attachment description: Exhibit 3 - Steckel Declaration . (Attachments: # 1 Exhibit 3A - Steckel Rebuttal Report, # 2 Exhibit 4 - Goodstein Report Exhibit 6)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (255 in 2:13-cv-02078-RMG, 203 in 2:13-cv-03438-RMG) MOTION to Exclude Testimony of William Wecker. First attachment description: Exhibit 5 - Goodstein Declaration . (Attachments: # 1 Exhibit 5A - Goldstein Rebuttal Report)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (255 in 2:13-cv-02078-RMG, 203 in 2:13-cv-03438-RMG) MOTION to Exclude Testimony of William Wecker. First attachment description: Exhibit 5B - Reference Manual on Scientific Evidence . (Attachments: # 1 Exhibit 6 - Wecker Reply Report)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Main Document 291 replaced on 7/13/2015) (sshe, ). Modified on 7/13/2015 to substitute with corrected document as requested and provided by filing user(sshe, ). (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (255 in 2:13-cv-02078-RMG, 203 in 2:13-cv-03438-RMG) MOTION to Exclude Testimony of William Wecker. First attachment description: Exhibit 7 - Wecker Deposition Excerpts . (Attachments: # 1 Exhibit 8 - Ravenel v Pugmill, # 2 Exhibit 9 - Reference Manual on Scientific Evidence 3rd Edition)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (255 in 2:13-cv-02078-RMG, 203 in 2:13-cv-03438-RMG) MOTION to Exclude Testimony of William Wecker. First attachment description: Exhibit 10 - Procter & Gamble Pharms v Hoffmann-LaRoche . (Attachments: # 1 Exhibit 11 - Coryn Gourp v O.C. Seacrets)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Attachment 1 replaced on 7/14/2015) (sshe, ). Modified on 7/14/2015 to substitute with corrected document as requested and provided by filing user(sshe, ). (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (255 in 2:13-cv-02078-RMG, 203 in 2:13-cv-03438-RMG) MOTION to Exclude Testimony of William Wecker. First attachment description: Exhibit 12 - Tunnell v Ford . (Attachments: # 1 Exhibit 13 - Morgan Judicial Standards for Survey Research)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (255 in 2:13-cv-02078-RMG, 203 in 2:13-cv-03438-RMG) MOTION to Exclude Testimony of William Wecker. First attachment description: Exhibit 14 - DeMaio Article . (Attachments: # 1 Exhibit 15 - AAPOR Best Practices, # 2 Exhibit 16 - York v Starbucks)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Attachment 2 replaced on 7/13/2015) (sshe, ). Modified on 7/13/2015 to substitute with corrected document as requested and provided by filing user(sshe, ). (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (255 in 2:13-cv-02078-RMG, 203 in 2:13-cv-03438-RMG) MOTION to Exclude Testimony of William Wecker. First attachment description: Exhibit 17 - 1-800 Contacts v Lens.com . (Attachments: # 1 Exhibit 18 - Solomon Deposition Excerpts, # 2 Exhibit 19 - Excerpt Conducting Surveys)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Attachment 1 replaced on 7/13/2015) (sshe, ). (Attachment 2 replaced on 7/13/2015) (sshe, ). Modified on 7/13/2015 to substitute with corrected documents as requested and provided by filing user(sshe, ). (Attachment 2 replaced on 7/14/2015) (sshe, ). Modified on 7/14/2015 to substitute with corrected document as requested and provided by filing user (sshe, ). (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (255 in 2:13-cv-02078-RMG, 203 in 2:13-cv-03438-RMG) MOTION to Exclude Testimony of William Wecker. First attachment description: Exhibit 20 - Payne Article . (Attachments: # 1 Exhibit 21 - Ardehali Amended Opening Report Excerpts, # 2 Exhibit 22 - Steinman Rebuttal Report Exerpts, # 3 Exhibit 23 - Rheinstein Deposition Excerpts, # 4 Exhibit 24 - Ford & Sullivan White Paper, Unmasking the Respondent)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (255 in 2:13-cv-02078-RMG, 203 in 2:13-cv-03438-RMG) MOTION to Exclude Testimony of William Wecker. First attachment description: Exhibit 25 - Wecker Report Attachment G (Part 1) . Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (255 in 2:13-cv-02078-RMG, 203 in 2:13-cv-03438-RMG) MOTION to Exclude Testimony of William Wecker. First attachment description: Exhibit 25 - Wecker Report Attachment G (Part 2) . Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (255 in 2:13-cv-02078-RMG, 203 in 2:13-cv-03438-RMG) MOTION to Exclude Testimony of William Wecker. First attachment description: Exhibit 25 - Wecker Report Attachment G (Part 3) . Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (255 in 2:13-cv-02078-RMG, 203 in 2:13-cv-03438-RMG) MOTION to Exclude Testimony of William Wecker. First attachment description: Exhibit 25 - Wecker Report Attachment G (Part 4) . Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (255 in 2:13-cv-02078-RMG, 203 in 2:13-cv-03438-RMG) MOTION to Exclude Testimony of William Wecker. First attachment description: Exhibit 26 - Crestor Label . Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Main Document 302 replaced on 7/13/2015) (sshe, ). Modified on 7/13/2015 to substitute with corrected document as requested and provided by filing user(sshe, ). (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (255 in 2:13-cv-02078-RMG, 203 in 2:13-cv-03438-RMG) MOTION to Exclude Testimony of William Wecker. First attachment description: Exhibit 27 - Wecker Reply Report Exhibit G . Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (255 in 2:13-cv-02078-RMG, 203 in 2:13-cv-03438-RMG) MOTION to Exclude Testimony of William Wecker. First attachment description: Exhibit 28 - Harrison Rebuttal Report Excerpts . (Attachments: # 1 Exhibit 29 - Dynetix Design v Synopsys, # 2 Exhibit 30 - MEMC Elec. v Mitisubishi Materials)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (255 in 2:13-cv-02078-RMG, 203 in 2:13-cv-03438-RMG) MOTION to Exclude Testimony of William Wecker. First attachment description: Exhibit 31 - Ardehali Deposition Excerpts . (Attachments: # 1 Exhibit 32 - Foster Declaration)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Main Document 305 replaced on 7/14/2015) (sshe, ). Modified on 7/14/2015 to substitute with corrected document as requested and provided by filing user(sshe, ). (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (255 in 2:13-cv-02078-RMG, 203 in 2:13-cv-03438-RMG) MOTION to Exclude Testimony of William Wecker. First attachment description: Exhibit 32A - Foster Rebuttal Report . (Attachments: # 1 Exhibit 32B - Harrison Rebuttal Report Excerpts)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (255 in 2:13-cv-02078-RMG, 203 in 2:13-cv-03438-RMG) MOTION to Exclude Testimony of William Wecker. First attachment description: Exhibit 33 - MA Transcript Excerpts . (Attachments: # 1 Exhibit 34 - GK Transcript Excerpts, # 2 Exhibit 35 - KS Transcript Excerpts, # 3 Exhibit 36 - DF Transcript Excerpts, # 4 Exhibit 37 - AP Transcript Excerpts, # 5 Exhibit 38 - Ardehali Reply Report Excerpts)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/11/2015)
2015-07-11
1
Additional Attachments to Main Document (255 in 2:13-cv-02078-RMG, 203 in 2:13-cv-03438-RMG) MOTION to Exclude Testimony of William Wecker. First attachment description: Exhibit 39 - Trading Techs Int'l, Inc 2014 WL 4477932 . (Attachments: # 1 Exhibit 40 - Sullivan Reply Report Excerpts)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Main Document 308 replaced on 7/14/2015) (sshe, ). Modified on 7/14/2015 to substitute with corrected document as requested and provided by filing user(sshe, ). (Entered: 07/11/2015)
2015-07-11
1
NOTICE of Appearance by Sara Centioni Kanos on behalf of AstraZeneca Pharmaceuticals LP (Kanos, Sara) (Entered: 07/14/2015)
2015-07-14
1
Consent MOTION to Withdraw as Attorney ( Response to Motion due by 8/3/2015.), MOTION to Withdraw by AstraZeneca Pharmaceuticals LP. Proposed order is being emailed to chambers with copy to opposing counsel.(McWilliams, Susan) (Entered: 07/15/2015)
2015-07-15
1
ORDER RELIEVING DANIEL C. LEONARDI, ESQUIRE, AS COUNSEL FOR DEFENDANT ASTRAZENECA PHARMACEUTICALS LP granting (310) Motion to Withdraw as Attorney in case 2:13-cv-02078-RMG; granting (258) Motion to Withdraw as Attorney in case 2:13-cv-03438-RMG Signed by Honorable Richard M Gergel on 7/15/2015.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 07/16/2015)
2015-07-16
1
NOTICE of Hearing: Bar Meeting set for 7/30/2015 11:00 AM in Charleston Courtroom To Be Determined, Hollings Judicial Center, 83 Meeting St, Charleston before Honorable Richard M Gergel. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 07/16/2015)
2015-07-16
1
Letter from Joseph F. Rice. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Rice, Joseph) (Entered: 07/28/2015)
2015-07-28
1
NOTICE of Request for Protection from Court Appearance by Joshua Cole Littlejohn for September 14-25, 2015 on behalf of SAMUEL F. BAXTER Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Littlejohn, Joshua) (Entered: 07/28/2015)
2015-07-28
1
NOTICE of Appearance by William Paul Tinkler on behalf of Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Tinkler, William) (Entered: 07/29/2015)
2015-07-29
1
Minute Entry. Proceedings held before Honorable Richard M Gergel: Bar Meeting held on 7/30/2015. Parties request oral arguments on motions for summary judgment. Court Reporter Amy Diaz. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(erav, ) (Entered: 07/30/2015)
2015-07-30
1
RESPONSE in Opposition re (256 in 2:13-cv-02078-RMG, 204 in 2:13-cv-03438-RMG) MOTION to Exclude Portions of the Rebuttal Expert Report and Proposed Testimony of AstraZeneca Expert Laura B. Stamm Response filed by AstraZeneca Pharmaceuticals LP.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit -A Layne-Farrar, # 2 Exhibit -B New Palgrave Dictionary, # 3 Exhibit -C Farrell-(Part-1), # 4 Exhibit -C Farrell-(Part-2), # 5 Exhibit -D Homstrom, # 6 Exhibit -E Williamson, # 7 Exhibit -F Lemley & Shapiro, # 8 Exhibit -G Lemley, # 9 Exhibit -H DOK FTC Antitrust Enforcement, # 10 Exhibit -I Becker, # 11 Exhibit -J Exec Office of President Patent Assertion, # 12 Exhibit -K 2008 AZ Form 20-F, # 13 Exhibit -L AZ Letter to Federal Circuit)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Main Document 318 replaced on 7/31/2015) (sshe, ). Modified on 7/31/2015 to replace with corrected document as provided by filing user (sshe, ). (Entered: 07/30/2015)
2015-07-30
1
RESPONSE in Opposition re (201 in 2:13-cv-03438-RMG, 253 in 2:13-cv-02078-RMG) MOTION to Exclude Expert Reports and Proposed Testimony of AstraZeneca Expert Gerald V. Raymond, M.D. Response filed by AstraZeneca Pharmaceuticals LP.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit -1 Raymond Deposition Excerpts, # 2 Exhibit -2 Singh Deposition Excerpts)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/30/2015)
2015-07-30
1
RESPONSE in Opposition re (254 in 2:13-cv-02078-RMG, 202 in 2:13-cv-03438-RMG) MOTION to Exclude Portions of the Expert Reports and Proposed Testimony of AstraZeneca Expert David G. Harrison, M.D. Response filed by AstraZeneca Pharmaceuticals LP.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit -A C.V. of Harrison, # 2 Exhibit -B Harrison et al, Restoration of Endothelium Dependent Relaxation, # 3 Exhibit -C Steinman Report Excerpts, # 4 Exhibit -D Steinman Deposition Excerpts, # 5 Exhibit -E Ardehali Deposition Excerpts, # 6 Exhibit -F Harrison Deposition Excerpts, # 7 Exhibit -G Solomon Deposition Excerpts)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 07/30/2015)
2015-07-30
1
RESPONSE in Opposition re (199 in 2:13-cv-03438-RMG, 251 in 2:13-cv-02078-RMG) MOTION to Exclude Certain Testimony of Plaintiffs' Expert Lawrence Steinman Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Palmetto Pharms v AstraZeneca, # 2 Exhibit B - Steinman Rebuttal Report, # 3 Exhibit C - Chisum on Patents sec 5.03, # 4 Exhibit D - UltimatePointer v Nintendo, # 5 Exhibit E - Highlighted Steinman Report, # 6 Exhibit F - ActiveVideo Networks v Verizon, # 7 Exhibit G - Saffran v Johnson & Johnson, # 8 Exhibit H - Sullivan 2nd Am Report, # 9 Exhibit I - Stamm Rebuttal Report, # 10 Exhibit J - Sullivan Report, # 11 Exhibit K- Steinman Dep)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
1
RESPONSE in Opposition re (250 in 2:13-cv-02078-RMG, 198 in 2:13-cv-03438-RMG) MOTION to Exclude Certain Testimony of Plaintiffs' Expert Peter Rheinstein Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Feigal Report, # 2 Exhibit B - Rheinstein Report, # 3 Exhibit C - Def Objns & Resps to 30(b)(6) Dep Notice, # 4 Exhibit D - Wooten Dep, # 5 Exhibit E - Matesich Dep, # 6 Exhibit F - Foote Dep, # 7 Exhibit G - Martino Dep, # 8 Exhibit H - Feigal Materials Considered, # 9 Exhibit I - Baldanado v Wyeth, # 10 Exhibit J - In re Yasmin, # 11 Exhibit K - In re Diet Drugs, # 12 Exhibit L - In re Ethicon, # 13 Exhibit M - In re Welding Fume Prods, # 14 Exhibit N - Stamm Rebuttal Report, # 15 Exhibit O - Harrison Rebuttal Report, # 16 Exhibit P - Chandler v Greenstone, # 17 Exhibit Q - Rheinstein Materials Considered, # 18 Exhibit R - Gregory v Oliver, # 19 Exhibit S - Kristensen v Spotnitz)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
1
RESPONSE in Opposition re (255 in 2:13-cv-02078-RMG, 203 in 2:13-cv-03438-RMG) MOTION to Exclude Testimony of William Wecker Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Cache v MZ Berger, # 2 Exhibit B - Apple v Samsung, # 3 Exhibit C - Wecker Reply Report, # 4 Exhibit D - Steckel Rebuttal Report, # 5 Exhibit E - Goodstein Survey Responses, # 6 Exhibit F - Stamm Rebuttal Report, # 7 Exhibit G - Coryn Grp II v OC Seacrets, # 8 Exhibit H - PBM Prods v Mead Johnson, # 9 Exhibit I - Whirlpool Props v LG Elecs, # 10 Exhibit J - Wecker Dep, # 11 Exhibit K - Steckel Decl in AT&T, # 12 Exhibit L - Steckel Decl in Maleski, # 13 Exhibit M - Steckel Report in Urban Outfitters, # 14 Exhibit N - Steckel Report in Doctors Assocs, # 15 Exhibit O - Steckel Report in Hershey, # 16 Exhibit P - Smartflash v Apple, # 17 Exhibit Q - Steckel Report in Larsen, # 18 Exhibit R - Steckel Report in TiVo, # 19 Exhibit S - Tr in Larsen, # 20 Exhibit T - Droplets v Overstock, # 21 Exhibit U - Sentius v Microsoft, # 22 Exhibit V - Galaxy at a Glance, # 23 Exhibit W - Foote Dep, # 24 Exhibit X - Martino Dep, # 25 Exhibit Y - AZM00498986, # 26 Exhibit Z - AZM00974277, # 27 Exhibit AA - JUPITER Study Reprint, # 28 Exhibit BB - Ardehali Am Opening Report, # 29 Exhibit CC - AZM00497651, # 30 Exhibit DD - 2014 Crestor Label, # 31 Exhibit EE - Harrison Dep, # 32 Exhibit FF - AZM00306264, # 33 Exhibit GG - AZM00304085, # 34 Exhibit HH - AZM00837031, # 35 Exhibit II - AZM00836820, # 36 Exhibit JJ - AZM00837515, # 37 Exhibit KK - Brostoff Email, # 38 Exhibit LL - Stamm Dep, # 39 Exhibit MM - Ardehali Reply Report)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
1
RESPONSE in Opposition re (200 in 2:13-cv-03438-RMG, 252 in 2:13-cv-02078-RMG) MOTION to Exclude Certain Testimony of Plaintiffs' Expert Hossein Ardehali Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Ardehali Am Opening Report, # 2 Exhibit B - Ardehali Reply Report, # 3 Exhibit C Highlighted Am Opening Report, # 4 Exhibit D Highlighted Reply Report, # 5 Exhibit E - Palmetto Pharms v AstraZeneca Pharms, # 6 Exhibit F - In re Ethicon, # 7 Exhibit G - In re Welding Fume Prods, # 8 Exhibit H - Stamm Rebuttal Report, # 9 Exhibit I - Harrison Rebuttal Report, # 10 Exhibit J - Nixon Rebuttal Report, # 11 Exhibit K - Ardehali Dep)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
1
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
1
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Steinman Dep, # 2 Exhibit B - Harrison Dep, # 3 Exhibit C - Steinman Report, # 4 Exhibit D - Javits Award Press Release, # 5 Exhibit E - MUSC Singh webpage, # 6 Exhibit F - Raymond Dep, # 7 Exhibit G - FDA Article, # 8 Exhibit H - Blake-Ridker Article, # 9 Exhibit I - Markman Hrg Tr, # 10 Exhibit J - Ridker N Eng J Med Article, # 11 Exhibit K - AZM00499269, # 12 Exhibit L - AZM00381637, # 13 Exhibit M - AZM00437035, # 14 Exhibit N - JUPITER Study Reprint, # 15 Exhibit O - AZM00499240, # 16 Exhibit P - Reyazuddin v Montgomery Cnty, # 17 Exhibit Q - ICI Uniqema v Kobo, # 18 Exhibit R - Harrison Report, # 19 Exhibit S - Harrison Supplemental Report, # 20 Exhibit T - Harrison Reply Report, # 21 Exhibit U - Websters, # 22 Exhibit V - EX Dock v Schafer, # 23 Exhibit W - Velcro v Taiwan, # 24 Exhibit X - Creagri v Pinnaclife, # 25 Exhibit Y - Eli Lilly v Actavis, # 26 Exhibit Z - Ridker CARE Article, # 27 Exhibit AA - Saffran v Johnson & Johnson, # 28 Exhibit BB - CSB-Sys Intl v SAP Am, # 29 Exhibit CC - AZM00381151, # 30 Exhibit DD - Scott Alban Dep, # 31 Exhibit EE - AZM00637317, # 32 Exhibit FF - AZM00637338, # 33 Exhibit GG - AZM00637337, # 34 Exhibit HH - AZM00637342, # 35 Exhibit II - AZM00636824, # 36 Exhibit JJ - AZM00636721, # 37 Exhibit KK - AZM00637364, # 38 Exhibit LL - AZM00636731, # 39 Exhibit MM - AZM00636742, # 40 Exhibit NN - AZM00637663, # 41 Exhibit OO - AZM00636891, # 42 Exhibit PP - Ardehali Decl, # 43 Exhibit QQ - Grant St Grp v Realauction.com, # 44 Exhibit RR - Sloan Valve v Zurn Indus, # 45 Exhibit SS - Fujitsu v Belkin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 07/30/2015)
2015-07-30
2
RESPONSE in Opposition re (258 in 2:13-cv-02078-RMG, 206 in 2:13-cv-03438-RMG) MOTION to Exclude the Testimony of Ryan Sullivan Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development.Reply to Response to Motion due by 8/10/2015 (Attachments: # 1 Exhibit A - Stamm Daubert Mot, # 2 Exhibit B - Palmetto Pharms v AstraZeneca Pharms, # 3 Exhibit C - Sullivan 2nd Am Report, # 4 Exhibit D - Davis v US, # 5 Exhibit E - Stamm Dep, # 6 Exhibit F - Fresenius v Baxter, # 7 Exhibit G - Stamm Rebuttal Report, # 8 Exhibit H - Toshiba v Imation, # 9 Exhibit I - Mongan Dep, # 10 Exhibit J - Aredehali Am Opening Report, # 11 Exhibit K - Sullivan Dep, # 12 Exhibit L - Shionogi Annual Report 2009, # 13 Exhibit M - Sullivan Reply Report, # 14 Exhibit N - Abbott v Centocor, # 15 Exhibit O - Droplets v Overstock, # 16 Exhibit P - Sentius v Microsoft, # 17 Exhibit Q - Apple v Samsung, # 18 Exhibit R - Wooten Dep, # 19 Exhibit S - MUSC_PX_00061620, # 20 Exhibit T - MUSC_PX_00063020, # 21 Exhibit U - Martin Dep, # 22 Exhibit V - AZM00498986, # 23 Exhibit W - AZM00974277, # 24 Exhibit X - Jupiter Study Reprint, # 25 Exhibit Y - Foote Dep, # 26 Exhibit Z - Goodstein Survey Responses, # 27 Exhibit AA - Burreson v BASF, # 28 Exhibit BB - Franklin v US, # 29 Exhibit CC - AZM00501647, # 30 Exhibit DD - MUSC_PX_00061804, # 31 Exhibit EE - MUSC_PX_00061663, # 32 Exhibit FF - AZM00837031, # 33 Exhibit GG - MUSC_PX_00063007)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Main Document 326 replaced on 8/3/2015) (sshe, ). Modified on 8/3/2015 to replace with corrected redacted document as requested and provided by filing user(sshe, ). (Entered: 07/30/2015)
2015-07-30
1
REPLY to Response to Motion re (250 in 2:13-cv-02078-RMG, 198 in 2:13-cv-03438-RMG) MOTION to Exclude Certain Testimony of Plaintiffs' Expert Peter Rheinstein Response filed by AstraZeneca Pharmaceuticals LP. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 08/10/2015)
2015-08-10
1
REPLY to Response to Motion re (199 in 2:13-cv-03438-RMG, 251 in 2:13-cv-02078-RMG) MOTION to Exclude Certain Testimony of Plaintiffs' Expert Lawrence Steinman Response filed by AstraZeneca Pharmaceuticals LP. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 08/10/2015)
2015-08-10
1
REPLY to Response to Motion re (200 in 2:13-cv-03438-RMG, 252 in 2:13-cv-02078-RMG) MOTION to Exclude Certain Testimony of Plaintiffs' Expert Hossein Ardehali Response filed by AstraZeneca Pharmaceuticals LP. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 08/10/2015)
2015-08-10
1
REPLY to Response to Motion re (254 in 2:13-cv-02078-RMG, 202 in 2:13-cv-03438-RMG) MOTION to Exclude Portions of the Expert Reports and Proposed Testimony of AstraZeneca Expert David G. Harrison, M.D. Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. (Attachments: # 1 Exhibit A - Velcro Indus v Taiwan Paiho, # 2 Exhibit B - SPX Corp v Bartex, # 3 Exhibit C - Mediatek v Freescale, # 4 Exhibit D - Websters, # 5 Exhibit E - Dorlands, # 6 Exhibit F - EZ Dock v Schafer, # 7 Exhibit G - UltimatePointer v Nintendo, # 8 Exhibit H - Swimways v Zuru, # 9 Exhibit I - Inline v AOL, # 10 Exhibit J - Visteon v Garmin)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 08/10/2015)
2015-08-10
1
REPLY to Response to Motion re (201 in 2:13-cv-03438-RMG, 253 in 2:13-cv-02078-RMG) MOTION to Exclude Expert Reports and Proposed Testimony of AstraZeneca Expert Gerald V. Raymond, M.D. Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 08/10/2015)
2015-08-10
1
REPLY to Response to Motion re (256 in 2:13-cv-02078-RMG, 204 in 2:13-cv-03438-RMG) MOTION to Exclude Portions of the Rebuttal Expert Report and Proposed Testimony of AstraZeneca Expert Laura B. Stamm Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. (Attachments: # 1 Exhibit A - Fresenius Jury Instructions, # 2 Exhibit B - Baxters Jury Instruction Mem, # 3 Exhibit C - Freseniuss Jury Instruction Mem, # 4 Exhibit D - Dynetix v Synopsys, # 5 Exhibit E - Ricoh v Quanta, # 6 Exhibit F - Intelligent v Microsoft, # 7 Exhibit G - Foote Dep, # 8 Exhibit H - Martino Dep, # 9 Exhibit I - AZM00498986, # 10 Exhibit J - AZM00974277, # 11 Exhibit K - AZC-00124551, # 12 Exhibit L - AZM00836701, # 13 Exhibit M - AZM00403816, # 14 Exhibit N - AZC-00345363, # 15 Exhibit O - De Souza Dep, # 16 Exhibit P - Matesich Dep, # 17 Exhibit Q - Lorden Dep, # 18 Exhibit R - AZC-00343411, # 19 Exhibit S - AZM00636731, # 20 Exhibit T - AZM00636742, # 21 Exhibit U - Carnegie Mellon v Marvell, # 22 Exhibit V - Defs Apotex Br, # 23 Exhibit W - Pls Apotex Br, # 24 Exhibit X - Applera v MJ Research)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 08/10/2015)
2015-08-10
1
REPLY to Response to Motion re (258 in 2:13-cv-02078-RMG, 206 in 2:13-cv-03438-RMG) MOTION to Exclude the Testimony of Ryan Sullivan Response filed by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit 34 - Selec Pgs - Pltffs' Priv Log, # 2 Exhibit 35 - Parker Depo Excerpts, # 3 Exhibit 36 - Rusnak Depo Excerpts, # 4 Exhibit 37 - Amendment to Lic Agrmt CMT-FRD, # 5 Exhibit 38 - Notification of 219 Patent, # 6 Exhibit 39 - Exhibit 2 to Stamm Reply)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 08/10/2015)
2015-08-10
1
REPLY to Response to Motion re (255 in 2:13-cv-02078-RMG, 203 in 2:13-cv-03438-RMG) MOTION to Exclude Testimony of William Wecker Response filed by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit 41 - Howard v. Ford, # 2 Exhibit 42 - Applewhite v. Commonwealth, # 3 Exhibit 43 - Wilson v. Ortho-McNeil, # 4 Exhibit 44 - NAACP v. AcuSport Inc., # 5 Exhibit 45 - Stedman - Tertiary Prevention, # 6 Exhibit 46 - Stone, ACC-AHA Guidelines, # 7 Exhibit 47 - Ridker, Rosuvastatin, # 8 Exhibit 48 - FDA Questions & Answers, # 9 Exhibit 49 - Wecker Depo Excerpts)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 08/10/2015)
2015-08-10
1
REPLY to Response to Motion re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by AstraZeneca Pharmaceuticals LP. (Attachments: # 1 Exhibit 51 - Solomon Depo Excerpts, # 2 Exhibit 52 - Singh Depo Excerpts, # 3 Exhibit 53 - Harrison Depo Excerpts, # 4 Exhibit 54 - Ardehali Report Excerpts, # 5 Exhibit 55 - Steinman Report Excerpts, # 6 Exhibit 56 - Singh Depo Exh. 12, # 7 Exhibit 57 - Brostoff E-mail, # 8 Exhibit 58 - License Agreement, # 9 Exhibit 59 - License Agreement, # 10 Exhibit 60 - FDA Warning)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 08/10/2015)
2015-08-10
1
Letter from John F. Garvish II regarding the parties' trial availability. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 08/12/2015)
2015-08-12
1
NOTICE OF FILING OF OFFICIAL TRANSCRIPT of Proceedings. Hearing held on July 30, 2015, before Judge Richard M. Gergel. Court Reporter/Transcriber Amy Diaz, Telephone number/E-mail jmarkdiaz@att.net. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Parties have 7 calendar days from the filing of the transcript to file with the court a Notice of Intent to Request Redaction.. Redaction Request due 9/4/2015. Redacted Transcript Deadline set for 9/14/2015. Release of Transcript Restriction set for 11/12/2015. (adia, ) (Entered: 08/14/2015)
2015-08-14
1
MOTION for Leave to File Sur-Replies (i) in Oppn to ECF No. 335 - Reply re ECF No. 257 Motion for Summary Judgment and (ii) in Oppn to ECF No. 333 - Reply re ECF No. 258 Motion to Exclude Dr. Ryan Sullivan by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. Response to Motion due by 9/8/2015. (Attachments: # 1 Exhibit 1 - Pls Sur-Reply in Oppn to Defs Mot for Summ J, # 2 Exhibit 1-A - Brown v Charleston, # 3 Exhibit 1-B - Cave Consulting v OptumInsight, # 4 Exhibit 1-C - EZ Dock v Schafer, # 5 Exhibit 1-D - CreAgri v Pinnaclife, # 6 Exhibit 2 - Pls Sur-Reply in Oppn to Defs Daubert Mot re Sullivan, # 7 Exhibit 2-A - Magnetar v Six Flags, # 8 Exhibit 2-B - Kolmes v World Elastic, # 9 Exhibit 2-C - Toshiba v Imation, # 10 Exhibit 2-D - AZM00403816, # 11 Exhibit 2-E - AZC-00124551, # 12 Exhibit 2-F - AZM00836701, # 13 Exhibit 2-G - AZC-00719183, # 14 Exhibit 2-H - AZM00427549, # 15 Exhibit 2-I - AZM00868748, # 16 Exhibit 2-J - AZC-00345363, # 17 Exhibit 2-K - AZC-00183428, # 18 Exhibit 2-L - De Souza Dep)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 08/20/2015)
2015-08-20
1
TEXT ORDER: Plaintiffs' Motion for Leave to File Sur-replies (Dkt. No. 338 in 2:13-2078 and Dkt. No. 285 in 2:13-3438) is GRANTED. Plaintiffs may file a sur-reply to (1) Defendant's reply in support of its motion for summary judgment and (2) Defendant's reply in support of its motion to exclude the testimony of Ryan Sullivan within seven (7) days of the date of this Order. AND IT IS SO ORDERED. Entered at the direction of the Honorable Richard M Gergel on 8/24/15. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(ltap, ) (Entered: 08/24/2015)
2015-08-24
1
SUR REPLY to REPLY to Response to Motion re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. (Attachments: # 1 Exhibit A - Brown v Charleston, # 2 Exhibit B - Cave Consulting v OptumInsight, # 3 Exhibit C - EZ Dock v Schafer, # 4 Exhibit D - CreAgri v Pinnaclife)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Main Document 340 replaced on 8/24/2015) (sshe, ). Modified on 8/24/2015 to replace with corrected main document as requested and provided by filing user (sshe, ). (Entered: 08/24/2015)
2015-08-24
1
SUR REPLY to REPLY to Response to Motion re (258 in 2:13-cv-02078-RMG, 206 in 2:13-cv-03438-RMG) MOTION to Exclude the Testimony of Ryan Sullivan Response filed by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. (Attachments: # 1 Exhibit A - Magnetar v Six Flags, # 2 Exhibit B - Kolmes v World Elastic, # 3 Exhibit C - Toshiba v Imation, # 4 Exhibit D - AZM00403816, # 5 Exhibit E - AZC-00124551, # 6 Exhibit F - AZM00836701, # 7 Exhibit G - AZC-00719183, # 8 Exhibit H - AZM00427549, # 9 Exhibit I - AZM00868748, # 10 Exhibit J - AZC-00345363, # 11 Exhibit K - AZC-00183428, # 12 Exhibit L - De Souza Dep)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Main Document 341 replaced on 8/24/2015) (sshe, ). Modified on 8/24/2015 to replace with corrected main document as requested and provided by filing user (sshe, ). (Entered: 08/24/2015)
2015-08-24
1
MOTION for Leave to File Sur-Sur-Reply by AstraZeneca Pharmaceuticals LP. Response to Motion due by 9/18/2015. (Attachments: # 1 Exhibit A - AstraZeneca's Sur-Sur-Reply)No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 09/01/2015)
2015-09-01
1
TEXT ORDER: Defendant's unopposed motion for leave to file a sur-sur-reply is GRANTED. Defendant must file the sur-sur-reply, not to exceed five (5) pages, within three (3) days of the date of this Order. AND IT IS SO ORDERED. Entered at the direction of the Honorable Richard M Gergel on 9/2/15.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(ltap, ) (Entered: 09/02/2015)
2015-09-02
1
SUR SUR REPLY to REPLY to Response to Motion re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement Response filed by AstraZeneca Pharmaceuticals LP. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) Modified on 9/3/2015 to edit docket text per filing user request as to sur sur reply(sshe, ). (Entered: 09/03/2015)
2015-09-03
1
NOTICE of Request for Protection from Court Appearance by Marguerite S Willis for October 19-23, 2015 Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG. Filing corrected for event type.(sshe, ) (Entered: 09/11/2015)
2015-09-10
1
MOTION to Withdraw as Attorney of Bryant Lee by AstraZeneca Pharmaceuticals LP. Response to Motion due by 10/13/2015. No proposed order.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 09/24/2015)
2015-09-24
1
TEXT ORDER Defendant's motion to withdraw Bryant Lee as attorney of record and removed from ECF notifications regarding this case is GRANTED. ((346) Motion to Withdraw as Attorney in case 2:13-cv-02078-RMG; (293) Motion to Withdraw as Attorney in case 2:13-cv-03438-RMG) Entered at the Direction of Honorable Richard M Gergel on 10/1/2015.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 10/02/2015)
2015-10-02
1
NOTICE of Hearing: The Court sets a trial date certain in these cases, with trial to begin on Monday, March 7, 2016, subject to the Court's obligations under the Speedy Trial Act. Jury Selection will take place on March 1, 2016. AND IT IS SO ORDERED.Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(ltap, ) (Entered: 10/23/2015)
2015-10-23
1
NOTICE of Request for Protection from Court Appearance by Marguerite S Willis for 01/04-05/2016 (Notice of Request for Protection from Court Appearances by Christopher Sipes) Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 12/10/2015)
2015-12-10
1
ORDER granting (350 in 2:13-cv-02078-RMG, 297 in 2:13-cv-03438-RMG) Notice of Request for Protection from Court Appearance for Christopher Sipes for 01/04-05/2016, filed by AstraZeneca Pharmaceuticals LP Signed by Honorable Richard M Gergel on 12/11/2015. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 12/11/2015)
2015-12-11
1
NOTICE of Hearing: Bar Meeting set for 1/14/2016 10:00 AM in Charleston Courtroom To Be Determined, J. Waties Waring Judicial Center, 83 Meeting St, Charleston before Honorable Richard M Gergel. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 01/07/2016)
2016-01-07
1
TEXT ORDER The Court will not hear oral argument on any pending motions at the January 14, 2016 Bar Meeting. The Court intends to set a hearing on the pending motion for summary judgment at the January 14, 2016 Bar meeting. AND IT IS SO ORDERED. Entered at the Direction of Honorable Richard M Gergel on 1/8/2016. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 01/08/2016)
2016-01-08
1
NOTICE of Hearing on (257 in 2:13-cv-02078-RMG, 205 in 2:13-cv-03438-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement : Motion Hearing set for 2/17/2016 at 10:00 AM in Hon. Sol Blatt, Jr., Courtroom, J. Waties Waring Judicial Cntr, 83 Meeting St, Charleston before Honorable Richard M Gergel. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(ltap, ) (Entered: 01/14/2016)
2016-01-14
1
Minute Entry. Proceedings held before Honorable Richard M Gergel: Bar Meeting held on 1/14/2016. Day certain jury trial to be rescheduled. Oral arguments to be set. Jury trial expected to take 2-3 weeks. Court Reporter Jack Bryan, CourtSmart. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG (erav,) (Entered: 01/14/2016)
2016-01-14
1
NOTICE OF FILING OF OFFICIAL TRANSCRIPT of Bar Meeting held on 1-14-16, before Judge Richard M. Gergel. Court Reporter/Transcriber Bryan/Potocki, Telephone number/E-mail 843-723-2208/potockidebra@bellsouth.net. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Parties have 7 calendar days from the filing of the transcript to file with the court a Notice of Intent to Request Redaction.. Redaction Request due 2/5/2016. Redacted Transcript Deadline set for 2/16/2016. Release of Transcript Restriction set for 4/14/2016. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(dpotocki, ) (Entered: 01/15/2016)
2016-01-15
1
TEXT ORDER: The parties have filed redacted versions of certain briefs and provided the Court with in camera unredacted copies. (See Dkt. Nos. 156, 257-1, 325, 335). The parties have also provided the Court with certain exhibits with their summary judgment briefing that are not part of the ECF record. (See, e.g., Dkt. Nos. 273-1, 325-11). To ensure that the entire record considered by the Court is part of the ECF record, the parties are directed to, within 5 days of the date of this order, file unredacted versions of the briefs found at Dkt. Nos. 156, 257-1, 325, and 335 under seal, using the sealed document event. The parties are further directed to, within 5 days of this order, file on ECF any exhibits submitted to the Court in camera with the parties' briefing on Defendant's summary judgment motion. These exhibits may be filed under seal using the sealed document event on ECF and should be linked to the appropriate motion or brief. AND IT IS SO ORDERED. Entered at the direction of the Honorable Richard M Gergel on 2/3/16. (ltap, ) (Entered: 02/03/2016)
2016-02-03
1
NOTICE of Cancellation of Hearing: Day Certain Jury Trial, March 7, 2016. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(erav,) (Entered: 02/04/2016)
2016-02-04
1
Sealed Document in re document (156 in 2:13-cv-02078-RMG, 105 in 2:13-cv-03438-RMG). (Attachments: # 1 Exhibit J - Paul Ridker MD Dep Excerpts (ECF No 156-10))Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 02/04/2016)
2016-02-04
1
Sealed Document in re document (325 in 2:13-cv-02078-RMG, 273 in 2:13-cv-03438-RMG). (Attachments: # 1 Exhibit C - Steinman Report (ECF No 325-3), # 2 Exhibit K - AZM00499269 (ECF No 325-11), # 3 Exhibit M - AZM00437035 (ECF No 325-13), # 4 Exhibit O - AZM00499240 (ECF No 325-15), # 5 Exhibit CC - AZM00381151 (ECF No 325-29), # 6 Exhibit DD - Scott Alban Dep (ECF No 325-30), # 7 Exhibit EE - AZM00637317 (ECF No 325-31), # 8 Exhibit FF - AZM00637338 (ECF No 325-32), # 9 Exhibit GG - AZM00637337 (ECF No 325-33), # 10 Exhibit HH - AZM00637342 (ECF No 325-34), # 11 Exhibit II - AZM00636824 (ECF No 325-35), # 12 Exhibit JJ - AZM00636721 (ECF No 325-36), # 13 Exhibit KK - AZM00637364 (ECF No 325-37), # 14 Exhibit LL - AZM00636731 (ECF No 325-38), # 15 Exhibit MM - AZM00636742 (ECF No 325-39), # 16 Exhibit NN - AZM00637663 (ECF No 325-40), # 17 Exhibit OO - AZM00636891 (ECF No 325-41), # 18 Exhibit PP - Ardehali Decl (ECF No 325-42))Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 02/04/2016)
2016-02-04
1
Sealed Document in re document (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG). (Attachments: # 1 Exhibit 4 - Excerpt Steinman Rebuttal Rpt (ECF 273-1), # 2 Exhibit 5 -Steinman Depo Excerpts (ECF 273-2), # 3 Exhibit 6 -Amended Opening Rpt of Ardehali (ECF 273-3), # 4 Exhibit 7 - Reply Rpt of Ardehali (ECF 273-4), # 5 Exhibit 8 - Ardehali Depo Excerpts (ECF 273-5), # 6 Exhibit 9 - Solomon Depo Excerpts (ECF 273-6), # 7 Exhibit 10 - Pahan Depo Excerpts (ECF 273-7), # 8 Exhibit 11 - Singh Depo Excerpts (ECF 274), # 9 Exhibit 12 - Brostoff Depo Excerpts (ECF 274-1), # 10 Exhibit 13 - Parker Depo Excerpts (ECF 274-2), # 11 Exhibit 27 - Steinman Depo (ECF 281-1), # 12 Exhibit 28 - Ardehali Depo (ECF 281-2), # 13 Exhibit 30 - Email Heistad to Ridker (ECF 282-1), # 14 Exhibit 34 - Email Brostoff to Goldstein (ECF 283-2), # 15 Exhibit 35 - Email Henderson to Bill (ECF 283-3), # 16 Exhibit 36 - Alban Depo Excerpts (ECF 283-4), # 17 Exhibit 38 - Email Brostoff to Hood (ECF 283-6), # 18 Exhibit 41 - Email from Schrager (ECF 284-2), # 19 Exhibit 42 - Lic Agreement MUSC-CMT 2010 (ECF 285), # 20 Exhibit 43 - Lic Agreement MUSC-CMT 2012 (ECF 285-1), # 21 Exhibit 46 - Finnegan Depo Excerpts (ECF 285-4))Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 02/05/2016)
2016-02-05
1
Sealed Document in re document (335 in 2:13-cv-02078-RMG, 283 in 2:13-cv-03438-RMG). (Attachments: # 1 Exhibit 52 - Singh Depo Excerpts (ECF 335-2), # 2 Exhibit 54 - Ardehali Report Excerpts (ECF 335-4), # 3 Exhibit 56 - Singh Depo Ex-12 (ECF 335-6), # 4 Exhibit 58 - License Agreement (ECF 335-8), # 5 Exhibit 59 - License Agreement (ECF 335-9))Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Willis, Marguerite) (Entered: 02/05/2016)
2016-02-05
1
JOINT STIPULATION by AstraZeneca Pharmaceuticals LP. (Willis, Marguerite) (Entered: 02/12/2016)
2016-02-12
1
Minute Entry. Proceedings held before Honorable Richard M Gergel: Motion Hearing held on 2/17/2016 re (205 in 2:13-cv-03438-RMG, 257 in 2:13-cv-02078-RMG) MOTION for Summary Judgment That The '800 Patent is Invalid and for Summary Judgment of No Willful Infringement filed by AstraZeneca Pharmaceuticals LP. Court to issue a written order. Court Reporter Debbie Potocki. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(erav, ) (Entered: 02/17/2016)
2016-02-17
1
Letter from John F. Garvish II on behalf of Plaintiffs. (Attachments: # 1 Exhibit A - Mot for Summ J Hrg PowerPoint Slides)Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(Gruetzmacher, Max) (Entered: 02/17/2016)
2016-02-17
1
ORDER granting (257) Defendant's Motion for Summary Judgment in case 2:13-cv-02078-RMG ((205) in case 2:13-cv-03438-RMG) and dismissing this case with prejudice. Signed by Honorable Richard M Gergel on 2/19/2016. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(sshe, ) (Entered: 02/19/2016)
2016-02-19
1
SUMMARY JUDGMENT in favor of Defendant against Plaintiffs. The court has ordered that having granted the Defendant's Motion for Summary Judgment, this case is DISMISSED WITH PREJUDICE. (sshe, ) (Entered: 02/19/2016)
2016-02-19
1
NOTICE OF FILING OF OFFICIAL TRANSCRIPT of hearing on summary judgment held on 2-17-16, before Judge Richard M. Gergel. Court Reporter/Transcriber Debra Potocki, Telephone number/E-mail 843-723-2208. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Parties have 7 calendar days from the filing of the transcript to file with the court a Notice of Intent to Request Redaction.. Redaction Request due 3/14/2016. Redacted Transcript Deadline set for 3/24/2016. Release of Transcript Restriction set for 5/23/2016. Associated Cases: 2:13-cv-02078-RMG, 2:13-cv-03438-RMG(dpotocki, ) (Entered: 02/22/2016)
2016-02-22
1
Consent MOTION for Extension of Time by AstraZeneca Pharmaceuticals LP. Response to Motion due by 3/21/2016. No proposed order.(McWilliams, Susan) (Entered: 03/04/2016)
2016-03-04
1
TEXT ORDER granting 369 Consent Motion for Extension of Time until March 18, 2016 to file petition for attorney's fees and cost. Entered at the direction of the Honorable Richard M Gergel on 3/4/16.(ltap, ) (Entered: 03/04/2016)
2016-03-04
1
JOINT STIPULATION by AstraZeneca Pharmaceuticals LP. (Willis, Marguerite) (Entered: 03/14/2016)
2016-03-14
1
ORDER re 371 Joint Stipulation that the Defendant need not bring an application for costs and/or attorney fees until 30 days after a) the issuance of a mandate by the United States Court of Appeals for the Federal Circuit, or b) the expiration of the time for Plaintiffs to file an appeal of the final judgment, should no appeal be filed. Signed by Honorable Richard M Gergel on 3/15/2016. (sshe, ) (Entered: 03/16/2016)
2016-03-16
1
NOTICE OF APPEAL as to 367 Summary Judgment by Charleston Medical Therapeutics Inc, MUSC Foundation for Research Development. - Filing fee $ 505, receipt number 0420-6455773. The Docketing Statement form, Transcript Order form and CJA 24 form may be obtained from the Fourth Circuit website at www.ca4.uscourts.gov (Gruetzmacher, Max) (Entered: 03/18/2016)
2016-03-18
1
Report on the Filing or Determination of an Action or Appeal Regarding a Patent or Trademark. (sshe, ) (Entered: 03/21/2016)
2016-03-21
1
***DOCUMENT E-MAILED re 373 Notice of Appeal, to Federal Circuit. Appeal package includes Notice of Appeal document, Certified public docket sheet, Order and Judgment. (sshe, ) (Entered: 03/23/2016)
2016-03-23
1
DELETION OF DOCKET ENTRY NUMBER 374 Reason: Transmittal Sheet for Notice of Appeal to USCA sent by clerk in error; appeal sent correctly to Federal Circuit Corrected Filing Document Number 376 Document E-mailed (sshe, ) (Entered: 03/23/2016)
2016-03-23
1
USCA MANDATE and ORDER as to 373 Notice of Appeal, filed by MUSC Foundation for Research Development, Charleston Medical Therapeutics Inc. Upon consideration of the parties' joint motion to withdraw this appeal, it is Ordered that the motion is granted and appeal is dismissed. Each side shall bear its own costs. (egra, ) (Entered: 07/29/2016)
2016-07-29
1